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Four	 stranded	 G-quadruplexes	 (G4s)	 are	 non-canonical	 nucleic	 acid	 secondary	 structures	
that	 are	 primarily	 found	 in	 nucleosome-depleted	 promoters	 and	 mark	 sites	 of	 elevated	
transcription	 within	 the	 human	 genome.	 Although	 numerous	 studies	 have	 indicated	 an	
association	 between	 G4	 formation	 and	 active	 transcription,	 the	 causal	 nature	 of	 this	
relationship	remains	unknown.	The	work	in	this	thesis	first	addresses	whether	promoter	G4s	
form	 as	 a	 result	 of	 transcription	 or	 whether	 G4	 formation	 enhances	 transcription.	 In	








accessible	 chromatin,	 the	 impact	 of	 rapid	 chromatin	 compaction	 on	 promoter	 G4	 folding	
was	 then	 assessed.	 Chromatin	 compaction	 was	 found	 to	 cause	 a	 depletion	 of	 some	




found	 to	 diminish	 the	 loss	 of	 G4s	 and	 mitigated	 loss	 of	 RNA	 Pol	 II	 at	 promoters	 upon	
chromatin	compaction,	indicating	a	role	of	G4s	in	promoting	polymerase	occupancy.	
	
Overall,	 these	 results	 show	 that	 G4	 folding	 within	 promoters	 is	 fostered	 by	 the	
establishment	of	accessible	chromatin	and	functions	to	enhance	transcription	by	promoting	
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structures	 known	 as	 guanine-quadruplexes	 (G4s),	 which	 have	 been	 implicated	 in	 various	
cellular	 functions.	 DNA	 G4s	 are	 particularly	 prevalent	 at	 promoters	 and	 accumulating	
evidence	implicates	them	in	transcriptional	regulation.	At	the	onset	of	my	studies,	however,	
the	mechanism	underlying	the	spatiotemporal	regulation	of	G4	formation	in	transcriptional	














transcription,	 I	 also	 overview	 key	 principles	 of	 transcription	machinery.	 Finally,	 I	 describe	






In	 1953,	 Rosalind	 Franklin	 and	 Maurice	 Wilkins	 reported	 high	 quality	 X-ray	 diffraction	
images	 of	 DNA	 fibers	 (Franklin	 and	 Gosling,	 1953;	 Wilkins	 et	 al.,	 1953).	 Franklin’s	






can	adopt	alternative	hydrogen	bonds	 to	classic	Watson-Crick	ones	 to	 form	non-canonical	




In	1910,	Bang	 reported	 that	 concentrated	guanylic	 acid	 formed	a	 gel-like	 viscous	 solution	
(Bang,	1910).	This	unusual	physical	property	was	not	further	investigated	until	1962,	when	
X-ray	 fiber	 diffraction	 patterns	 illustrated	 four-fold	 helix	 structures	 that	 had	 further	 been	
suggested	 as	 planar	 tetramolecular	 structures	 (Gellert	 et	 al.,	 1962).	 Further	 evidence	
suggesting	 the	existence	of	G4s	showed	that	synthetic	guanine	 (G)-rich	DNA	derived	 from	
the	 human	 genome	 (Sen	 and	 Gilbert,	 1998)	 and	 from	 Oxytricha	 telomeric	 sequence	
(Williamson	et	al.,	1989)	formed	secondary	structures	and	caused	reduced	electrophoretic	
mobility.	 In	 1990s,	 the	 presence	 of	 RNA	 G4s	 were	 subsequently	 reported	 in	 vitro	
(Christiansen	et	al.,	1994;	Kim	et	al.,	1991).	
	
Rather	 than	 interacting	 with	 cytosine	 via	 Watson-Crick	 hydrogen	 bonds	 (Figure	 1.2A),	
guanine	 residues	 in	 G-rich	 sequences	 act	 as	 both	 donor	 and	 acceptor	 of	 Hoogsteen	
hydrogen	bonds	and	associate	with	their	adjacent	Gs	to	form	a	planar	tetrameric	quartet,	
known	 as	 G-quartet	 or	 G-tetrad	 (Figure	 1.2B).	 A	 monovalent	 cation	 in	 the	 quartet	 core	
provides	further	stability	to	the	G-tetrad	by	neutralising	the	electrostatic	repulsion	from	O6	
of	each	guanine,	with	 the	order	of	 stability	K+>	Rb+>	Na+>	Cs+>	 Li+	 (Baumann,	2010).	 Self-
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stacking	of	multiple	G-tetrads	via	π-π	interactions	further	stabilises	the	structure	and	forms	




Figure 1.1: Canonical B-DNA and non-B-form DNA secondary structures. 
(Top left) B-form DNA is the canonical right-handed double helix. (Top right) Z-DNA is a left-handed double 
helical structure that form in alternating purine-pyrimidine sequences. (Middle left) Four-stranded DNA 
structure formed from stacks of planar arrangements of four Hoogsteen-hydrogen bonded guanines. (Bottom-
left) H-DNA is a three-stranded non-canonical DNA helix in which a single-stranded DNA binds to the major 
groove of DNA duplex. (Bottom-right) Cruciform DNA is a four-armed non-B-DNA structure, which has inverted 





Figure 1.2: Structures of G-tetrads and G-quadruplexes. 
(A) Watson-Crick hydrogen bonding between guanine and cytosine in canonical DNA duplex. (B) Schematic of a 
guanine (G)-tetrad and a G-quadruplex. Four guanines associate via Hoogsteen base-pairing to form a planar G-
tetrad. A central monovalent cation (M+) stabilises a G-tetrad by interacting with guanine O6 electrons. A G-
quadruplex is then stabilised by the stacking of multiple G-tetrads via π-π interaction. The stacks of G-tetrads 




The	 G4	 consensus	 sequence	 G≥3NxG≥3NxG≥3NxG≥3Nx,	 which	 is	 derived	 from	 biophysical	
structural	and	computational	analysis,	has	been	proposed	as	a	G4	motif	(Eddy	and	Maizels,	
2006;	Huppert	and	Balasubramanian,	2005;	Todd	et	al.,	2005).	Within	the	G4	motif,	G-tracts	




One	 source	 of	 G4	 heterogeneity	 is	 because	 of	 the	 strand(s)	 harbouring	 the	 G-tracts.	 G-
quadruplexes	 can	 be	 assembled	 from	 one	 or	 several	 DNA	 strands.	 Genes	 containing	 a	
continuous	G4	consensus	sequence	with	three	or	more	G-tracts	can	form	intramolecular	G4	
structures,	whereas	intermolecular	G4s	can	arise	from	two	or	four	different	G-rich	strands,	
known	as	bimolecular	G4s	and	 tetramolecular	G4s	 respectively	 (Burge	et	al.,	2006;	Murat	
and	 Balasubramanian,	 2014)	 (Figure	 1.3).	Moreover,	 DNA-RNA	 hybrid	 intermolecular	 G4s	








While	 early	 studies	 suggested	 that	 the	 relatively	 simple	 G3-5N1-7G3-5N1-7G3-5N1-7G3-5N1-7	
consensus	sequence	forms	the	most	stable	G4s	and	that parallel	conformation	is	favoured	
when	one	or	more	 loops	 is	 short	 (Bugaut	 and	Balasubramanian,	 2008;	Hazel	 et	 al.,	 2004;	
Piazza	et	al.,	2015),	more	recent	biophysical	studies	have	shown	that	intervening	loops	with	
up	 to	 21	 nucleotides	 permit	 G4	 folding	 (Bourdoncle	 et	 al.,	 2006;	 Guédin	 et	 al.,	 2010).	
Furthermore,	 a	 nuclear	 magnetic	 resonance	 (NMR)	 solution	 structure	 revealed	 the	







Figure 1.3: Topologies of G-quadruplexes. 
Schematic representation of a series of G4 topologies differing in strand numbers and strand polarity. G4s can 
be assembled from one (intramolecular) or more (intermolecular) DNA strands. G-rich DNA can also interact 
with RNA strand to form hybrid intermolecular G4s. Depends on the orientation of backbone strands, G4s can 
be parallel, antiparallel or hybrid (i.e. a mixture of parallel and antiparallel). Length of the nucleotide loops can 
vary and bulges can exist if there is extra nucleotide(s) interrupt between guanines within the tract. These all 





The	 folding	 of	 G4	 motifs	 in	 DNA	 or	 RNA	 oligonucleotides	 into	 G4	 structures	 can	 be	
demonstrated	 by	 biophysical	methods,	 and	many	 of	 these	 experimental	 techniques	 have	
been	used	 to	 investigate	 the	 structural	properties	of	G4s.	 For	example,	 circular	dichroism	
(CD)	 spectroscopy	 is	 a	 common	method	used	 to	determine	 and	discriminate	between	G4	
topologies	 (Baumann,	 2010;	 del	 Villar-Guerra	 et	 al.,	 2018).	 In	 general,	 G4s	 with	 parallel	
conformations	show	a	peak	at	260	nm	and	a	trough	at	240	nm,	while	antiparallel	G4s	have	a	
peak	at	295	nm	and	a	trough	at	260	nm.	Ultraviolet	(UV)	spectroscopy	is	another	approach	
to	characterise	G4	structures,	which	 is	based	on	the	 fact	 that	 the	UV	 light	absorbance	 for	
different	molecules	varies.	A	UV	signal	at	295	nm	marks	a	G4	structure,	while	a	decrease	in	
UV	absorbance	at	the	same	wavelength	suggests	the	melting	of	G4	structures	(Mergny	et	al.,	
1998).	 A	 UV	 melting	 experiment,	 which	 employs	 UV	 spectroscopy	 in	 conjunction	 with	
thermal	 denaturation,	 can	 be	 used	 to	 measure	 G4	 melting	 temperature	 and	 provide	
information	about	G4	thermal	stability	(Mergny	and	Lacroix,	2009;	Mergny	et	al.,	2005).	The	
thermal	stability	of	G4s	can	also	be	measured	by	a	Förster	resonance	energy	transfer	(FRET)	
melting	 assay.	 In	 this	 assay,	 the	 5ʹ	 and	 3ʹ	 ends	 of	 the	 G4-forming	 oligonucleotide	 are	
respectively	 labelled	 with	 a	 donor	 and	 an	 acceptor	 fluorophore.	When	 G4	 folds	 (i.e.	 the	





X-ray	 crystallography	 can	 capture	 G4	 conformations	 at	 atomic	 resolution	 (Campbell	 and	
Parkinson,	2007;	Huppert,	2008).	In	addition	to	G4	conformation,	X-ray	crystallography	also	
provides	details	of	inter-	and	intramolecular	interactions	and	ligand	binding.	This	technology	
has	 been	 widely	 used	 in	 characterising	 ligand-bound	 quadruplex	 structures,	 as	 the	 X-ray	
diffraction	 data	 infers	 hydrogen	 bonding	 and	 electrostatic	 interactions	 between	 G4	 and	
ligands	 (Campbell	 et	 al.,	 2012).	 To	 date,	 over	 50	 crystallised	G4	 structures,	 either	 ligand-
bound	 or	 alone,	 have	 been	 characterised.	 However,	 X-ray	 crystallography	 only	 reveals	
structures	 in	 a	 solid	 state,	 which	 may	 not	 be	 the	 same	 as	 in	 solution.	 For	 polymorphic	
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structures,	X-ray	crystallography	generally	captures	the	form	that	is	easy	to	be	crystallised,	
rather	 than	the	 form	that	 is	naturally	 favoured.	An	alternative	method	 for	high-resolution	
characterisation	of	G4	structures	is	NMR	spectroscopy,	which	analyses	G4s	in	solution	and	
provides	 insights	 into	 their	 structure	 dynamics	 (Webba	 da	 Silva,	 2007).	 Notably,	 an	NMR	




G4	 topologies.	 However,	 the	 existence	 of	 such	 features	 in	 cells	 requires	 further	
investigations.	
	
Besides	 the	 techniques	 mentioned	 above,	 other	 approaches	 have	 also	 been	 adopted	 to	
identify	G4	structures.	For	example,	through	the	use	of	optical	tweezers	in	conjunction	with	






methods	 can	 only	 reveal	 structures	 in	 vitro	 and	 do	 not	 account	 for	 the	 effect	 of	 flanking	
regions	around	G4	structures.	
1.2.2 Biochemical	methods	to	study	G4s	
Chemical	 and	 enzymatic	 approaches	 have	 also	 been	 developed	 to	 characterise	 G4	






consistent	 with	 G4	 formation	 (Figure	 1.4A).	 DMS	 has	 been	 useful	 to	 probe	 G4	
conformations.	For	example,	Siddiqui-Jain	and	his	colleagues	demonstrated	that	the	G-rich	
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strand	 in	 the	 P1	 promoter	 of	MYC	 can	 form	 two	 different	 intramolecular	 G4	 structures	
(chair-form	 and	 basket-form)	 by	 using	 DMS	 footprinting	 (Siddiqui-Jain	 et	 al.,	 2002).	
Destabilisation	 of	 chair-form	G4	 by	 a	 single	G	 to	 A	mutation	 resulted	 in	 increase	 of	MYC	













with	the	original	synthesised	sequences	 in	conditions	that	do	not	stabilise	G4s	 (e.g.	 in	the	
presence	of	 Li+)	 (Dexheimer	 et	 al.,	 2006;	Guo	et	 al.,	 2007;	Qin	 et	 al.,	 2007)	 (Figure	 1.4B).	
More	recently,	coupled	with	high-throughput	sequencing	and	computational	analyses,	this	
assay	allows	genome-wide	identification	of	sites	that	can	potentially	form	G4s	(G4-seq;	see	
section	 1.2.4)	 (Chambers	 et	 al.,	 2015).	 One	 limitation	 of	 the	 polymerase-stalling	 assay	
however,	 is	 that	 it	 does	 not	 provide	 characterisation	 of	 G4	 structural	 conformations.	
Furthermore,	this	approach	is	generally	employed	for	in	vitro	studies	of	G4	structures.	
	
Similar	 approaches	 can	 also	 be	 applied	 to	 probe	 RNA	 G4s	 in	 vitro	 (Figure	 1.4C-D).	 For	
instance,	 as	 reverse	 transcriptase	 pauses	 at	 RNA	 G4	 structures,	 a	 reverse	 transcriptase	
stalling	assay	was	developed	to	study	both	site-specific	RNA	G4s	and	genome-wide	RNA	G4s	
(rG4-seq)	 (Kwok	 and	 Balasubramanian,	 2015;	 Kwok	 et	 al.,	 2016a).	 Furthermore,	 2-
methylnicotinic	 acid	 imidazolide	 (NAI)	 selectively	 acylates	 2’-hydroxyl	 group	 of	
the	 unconstrained	 nucleotides	 and	 the	 2’-OH	 acylation	 stalls	 the	 reverse	 transcriptase	





Figure 1.4: Biochemical techniques to detect DNA and RNA G-quadruplexes. 
(A) DNA G4s are identified by dimethyl sulfate (DMS) footprinting, where DMS selectively methylates the N7 of 
guanine residues, allowing its digestion by piperidine. The detection of G4 structures is subsequently analysed 
by denaturing PAGE. The absence of the bands suggests the protection of G4 formation. (B) Detection of DNA 
G4s by DNA polymerase stalling. DNA is synthesised in the presence of K+ to detect DNA G4-dependent arrest 
sites. (C) RNA G4s are characterised by SHALiPE, which compares the differences in RNA 2’-OH acylation 
caused by 2-methylnicotinic acid imidazolide (NAI) and the reverse transcriptase stalling sites between G4-
resolving conditions (e.g. Li+) and G4-favouring conditions (e.g. K+), to determine the formation of RNA G4s by 
denaturing PAGE. The absence of the bands suggests the protection of G4 formation. (D) Characterisation of 
RNA G4s by reverse transcription extension stalling. RNA is reverse transcribed in the presence of K+ to identify 
RNA G4-dependent reverse transcriptase stalling.  
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1.2.3 Computational	study	of	G-quadruplexes	
Computational	 algorithms	 have	 been	 employed	 to	 predict	 the	 presence	 of	 potential	 G4-
forming	 sequences	 in	 the	 human	 genome.	 One	 such	 algorithm	 is	 called	 Quadparser	










PQS,	 with	 67%	 harbouring	 a	 consensus	 G4	 sequence.	 Some	 of	 the	 proto-oncogene	
promoters	 containing	 PQSs,	 include	 MYC,	 BCL2,	 VEGF	 and	 KIT,	 have	 been	 extensively	





genomic	 contexts	 that	 influence	 G4	 thermodynamic	 stability.	 To	 address	 some	 of	 these	
issues,	 more	 recent	 computational	 methods	 additionally	 incorporate	 analysis	 of	 the	
possibilities	of	higher-order	assemblies	and	G-richness	and	G-skewness	(Bedrat	et	al.,	2016;	
Belmonte-Reche	and	Morales,	 2020;	 Stegle	et	 al.,	 2009).	 For	 example,	G4Hunter	 takes	G-
richness	 and	 G-skewness	 of	 the	 sequence	 into	 account	 and	 provides	 a	 score	 of	 G4	
propensity	 as	 an	 output	 (Bedrat	 et	 al.,	 2016).	 This	 model	 identifies	 2-	 to	 10-fold	 more	
sequences	that	are	likely	to	be	capable	of	forming	G4s	in	human	genome.	Similarly,	G4RNA	
screener	 provides	 a	 motif-independent	 method	 to	 identify	 potential	 RNA	 G4s	 in	 vitro	
(Garant	et	al.,	2017).	However,	these	algorithms	have	the	incidence	of	false	negatives	(i.e.	
G4s	that	can	form	in	vitro	but	escapes	the	computational	prediction)	and	false	positives	(i.e.	





Extending	 the	detection	of	G4s	 in	human	genome	by	 computational	methods,	 a	 genome-
wide	DNA	polymerase	stop	assay	using	high-throughput	sequencing	(G4-seq)	provided	the	
first	map	of	G4s	with	potential	to	form	a	structure	in	the	human	genome	(Chambers	et	al.,	








which	 are	 not	 identified	 by	 previous	 computational	 predictions.	 Conversely,	 not	 all	 G4	
sequences	 predicted	 by	 algorithms	 were	 identified	 by	 G4-seq,	 emphasising	 the	 need	 for	
direct	 G4	 mapping	 in	 the	 genome.	 Subsequently,	 whole	 genome	 G4	 mapping	 studies	
employing	 G4-seq	 have	 been	 extended	 to	 12	 different	 species	 from	 prokaryotes	 to	


















Figure 1.5: A schematic of G4-seq. 
Sequencing is done twice in G4-seq. Read 1 provides sequencing reference in non-G4-forming conditions. 
Synthesised DNA is subsequently removed and the original DNA template is resequenced (read 2) under G4-
stabilising conditions (in the presence of K+ or PDS). Stalled polymerases result in a drop of sequencing quality 
and generate base mismatch (red) at the beginning of the G4 structure. Differences in base mismatches 
between read 1 and 2 are analysed to provide G4 map in the human genome. Figure is adapted from Chambers 





As	 G4s	 have	 been	 suggested	 to	 be	 enriched	 in	 functional	 regions	 of	 the	 human	 genome	
(Chambers	 et	 al.,	 2015;	Huppert	 and	Balasubramanian,	 2007),	many	 small	molecules	 that	
recognise	 and	 stabilise	G4s	 have	 been	developed	 to	 explore	 the	 potential	 role	 of	 cellular	
G4s.	G4	 ligands	generally	have	planar	aromatic	structures,	which	are	thought	to	allow	the	
stabilisation	of	G4s	 via	 the	π-π	 stacking	onto	 the	 terminal	G-tetrad	 (Neidle,	 2010)	 (Figure	




G4	affinity.	 Rodriguez	et	 al.	 showed	 that	PDS	 stabilised	a	G4	 structure	 in	proto-oncogene	
SRC	(Rodriguez	et	al.,	2012).	When	applied	to	human	cancer	cells,	PDS	induced	replication-	
and	 transcription-dependent	 DNA	 damage	 at	 sites	 containing	 clusters	 of	 sequences	 that	
have	 the	 potential	 to	 form	 G4s,	 thus	 promoting	 growth	 arrest	 in	 human	 cancer	 cells	
(Rodriguez	et	al.,	 2012).	 The	bisquinolinium	compound	PhenDC3,	another	widely	used	G4	





G4-stabilising	 ligands	 since	 experimental	 characterisation	 was	 performed	 on	 DNA	 G4	
oligonucleotides.	It	is	important	to	consider	however,	that	they	may	also	bind	RNA	G4s.	For	
instance,	PDS	also	binds	and	stabilises	RNA	G4s	both	in	vitro	and	in	cells	(Biffi	et	al.,	2013a;	
Kwok	 et	 al.,	 2016a).	 Moreover,	 one	 PDS	 analogue,	 carboxyPDS	 (cPDS)	 (Figure	 1.6),	
selectively	interacts	with	RNA	G4s	over	their	DNA	counterparts	(Di	Antonio	et	al.,	2012).	
	
G4-binding	 ligands	 have	 also	 been	 used	 to	 detect	 G4	 structures	 in	 cells.	 G4	 structures	 in	
human	cells	were	visualised	by	treatment	with	derivatives	of	PDS	and	PhenDC3	followed	by	
cell	 fixation	 and	 subsequent	 conjugation	 of	 fluorophores	 to	 the	 small	molecules	 via	 click	





stranded	 DNA	 (ssDNA)	 (Shivalingam	 et	 al.,	 2015;	 Zhang	 et	 al.,	 2018).	More	 recently,	 the	




fluctuation	 of	G4s,	 suggesting	 that	G4	 folding	 is	 dynamic	 in	 living	 cells.	Moreover,	G4s	 in	
living	 cells	 have	 also	 been	 visualised	 using	 a	 fluorescent	 probe	DAOTA-M2	 in	 conjunction	
with	fluorescence	lifetime	imaging	microscopy	(FLIM)	(Summers	et	al.,	2021).	In	this	study,	
Summers	et	al.	demonstrated	 that	 loss	of	 FancJ	and	RTEL1	 in	mammalian	 cells	 led	 to	 the	
increase	of	the	DAOTA-M2	lifetime,	which	suggested	the	increase	of	G4s.	This	indicates	the	
role	of	FancJ	and	RTEL1	 in	resolving	G4	structures	 in	cells.	Although	G4	 ligands	allow	real-
time	live	cell	imaging,	the	genomic	location	of	the	binding	event	in	such	studies	is	missing.	
 
Figure 1.6: Examples of G4-stabilising ligands. 
Planar aromatic small molecules interact with the terminal G-tetrad via π-π stacking to stabilise G4 structures 




An	 alternative	 set	 of	 tools	 that	 have	 been	 developed	 to	 probe	 G4	 structures	 in	 cells	 are	
antibodies	 that	 specifically	 bind	 to	 G4	 structures.	 The	 single-chain	 variable	 fragment	
antibody	(scFv)	Sty49,	which	was	derived	via	ribosome	display	and	raised	against	telomeric	
G4s	 from	 Stylonichia	 lemnae,	 provided	 the	 first	 direct	 evidence	 that	 G4s	 exist	 in	 vivo	
(Schaffitzel	 et	 al.,	 2001).	 Stylonychia	 possesses	 two	 morphologically	 and	 functionally	
different	nuclei,	the	micronucleus	and	the	transcriptionally	active	macronucleus.	The	Sty49	
staining	 in	 a	 replicating	macronucleus	 suggested	 that	G-quadruplexes	 are	 resolved	during	
DNA	 replication,	 as	 the	 Sty49	 signal	was	not	observed	 in	 the	 replication	band,	 the	 region	
where	replication	and	telomere	elongation	take	place.	
	
More	 recently	 developed	 antibodies	 enable	 the	 detection	 of	 G4s	 in	 human	 cells.	 For	
instance,	immunofluorescence	(IF)	staining	in	fixed	human	cells	using	the	scFv	antibody	BG4,	
which	 has	 high	 affinity	 for	 several	 G4	 conformations	 in	 vitro,	 revealed	 G4	 formation	 in	
telomeric	 and	 non-telomeric	 DNA	 (Biffi	 et	 al.,	 2013b)	 (Figure	 1.7).	 RNA	 G4s	 were	 also	









DNA	 from	human	 breast	 cancer	 cells	 using	 hf2	 scFv	 (Lam	 et	 al.,	 2013).	 Nevertheless,	 the	
specificity	of	these	antibodies	may	not	be	absolute.	For	example,	the	monoclonal	antibody	
1H6	has	been	shown	to	strongly	bind	to	G4	structures	with	a	(T4G4)2	sequence	but	not	bind	





Figure 1.7: Visualisation of G4s in human cells using scFv antibody BG4. 
(A) Immunofluorescence staining showing BG4 foci (red) in cell nuclei (blue) (left) and the absence of BG4 foci 
after DNase I treatment (right). Dotted lines show the boundary of nuclei. (B) Immunofluorescence staining 
showing BG4 foci (red) at telomeres of metaphase chromosomes. Scale bar, 20 µm. This figure is adapted from 
Biffi et al., 2013b. 
1.3.3 High-throughput	sequence	mapping	of	endogenous	G4s	
To	further	 investigate	the	formation	of	G4s	at	specific	genomic	 loci	within	an	endogenous	
chromatin	 context,	 efforts	 have	 been	 made	 to	 adapt	 high-throughput	 next	 generation	
sequencing	tools	to	probe	native	G4	structures	in	cells.	DNA	G4s	in	chromatin	from	human	
cells	 have	 been	 mapped	 using	 BG4	 antibody-based	 chromatin	 immunoprecipitation	
followed	by	next	generation	sequencing	(G4	ChIP-seq)	(Hänsel-Hertsch	et	al.,	2016)	(Figure	





lower	 than	 the	number	observed	by	G4-seq,	 suggesting	 that	G4	 formation	 in	 cells	 can	be	
governed	 by	 potential	 factors,	 such	 as	 local	 chromatin	 context	 and	 protein	 binding.	 By	
contrast,	G4	ChIP-seq	peaks	are	more	numerous	than	the	BG4	foci	detected	by	 IF	staining	
(Biffi	 et	 al.,	 2013b),	 suggesting	 that	 the	 ChIP-seq	 method	 has	 higher	 sensitivity	 and	
resolution.	
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Figure 1.8: Endogenous G4 structures in human chromatin are detected by G4 ChIP-seq. 
Example genome browser view for SRC and MYC. Tracks shows G4 ChIP-seq (top red) and input (bottom red) in 
HaCaT cells; accessible chromatin sites determined by ATAC-seq and FAIRE-seq (black); and reference G4 sites 
that can form G4 structures on the forward (+ss) and reverse (-ss) strand in vitro observed by G4-seq (OQs; 
purple). G4 ChIP-seq peaks which are located in nucleosome-depleted regions are masked in orange. Genomic 
coordinates are indicated above. The figure is adapted from Hänsel-Hertsch et al., 2016. 
As	well	as	BG4,	G4	ChIP-seq	has	also	been	performed	using	the	parallel	G4-specifc	antibody	
D1,	which	 is	 directly	 expressed	 in	 human	 cervical	 carcinoma	 cells	 (Liu	 et	 al.,	 2016).	 Over	
8,000	 peaks	 were	 identified	 by	 this	 method,	 with	 a	 strong	 overlap	 with	 computationally	
predicted	G4s.	Notably,	about	15%	of	G4s	identifed	by	ChIP-seq	using	D1	are	unique;	they	






bound	 by	 DNA	 helicase	 Pif1	 and	 telomere-binding	 factor	 Rif1	 strongly	 overlapped	 with	
computational	 predicted	 G4s	 (Kanoh	 et	 al.,	 2015;	 Paeschke	 et	 al.,	 2011).	 Furthermore,	
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human	 helicases	 such	 as	 ATRX,	 XPB	 and	 XPD	 have	 been	 found	 to	 bind	 G4-folded	
oligonucleotides	in	vitro,	and	have	been	mapped	to	computationally	predicted	G4	motifs	in	
chromatin	from	human	cells	using	ChIP-seq	(Gray	et	al.,	2014;	Law	et	al.,	2010).	However,	
these	 approaches	 do	 not	 directly	 show	 the	 existence	 of	 a	 G4-folded	 structure.	 More	
recently,	Zheng	et	al.	developed	an	artificial	G4	probe	(G4P)	by	engineering	a	segment	from	
the	G4-binding	 domain	 of	DHX36,	 an	DNA	 and	RNA	helicase	 that	 binds	 and	 unwinds	G4s	
(Chen	 et	 al.,	 2018b;	 Heddi	 et	 al.,	 2015;	 Zheng	 et	 al.,	 2020).	 G4P	 shows	 high	 affinity	 and	
specificity	 for	 G4s	 in	 vitro.	 By	 expressing	G4P	 in	 human	 living	 cells	 followed	 by	 ChIP-seq,	
over	120,000	G4	sites	were	detected	 in	cells.	Why	more	sites	were	 identified	by	ChIP-seq	
with	G4P	than	with	BG4	is	not	clear,	but	it	is	possible	that	the	small	size	of	G4P	plays	a	role;	





Besides	 G4	 mapping	 using	 antibodies	 or	 proteins,	 chemical	 mapping	 also	 allows	 G4	
detection	 in	 cells.	 By	 using	 potassium	 permanganate-dependent	 single-strand	 nuclease	
(permanganate/S1	 Nuclease)	 footprinting	 combined	 with	 high-throughput	 sequencing,	
ssDNA	 regions	 of	 the	 genome	 in	mouse	 B	 cell	 chromatin	were	 identified	 (Kouzine	 et	 al.,	
2017).	By	combining	mapped	ssDNA	patterns	with	computational	prediction	of	non-B-DNA	
sequence	motifs,	 the	 authors	 inferred	 sites	 of	 G4	 formation	 (~20,000	 G4s)	 in	 chromatin.	
These	G4	 structures	were	 found	enriched	at	promoters.	 Furthermore,	 the	data	 suggested	




RNA	G4	binding	proteins	 in	 the	human	 transcriptome,	 and	have	 shown	 that	 such	binding	
sites	comprise	G4	motifs,	these	techniques	do	not	provide	proof	of	the	existence	of	an	RNA	
G4-folded	 structure	 (Herdy	 et	 al.,	 2018;	 Murat	 et	 al.,	 2018;	 Sauer	 et	 al.,	 2019).	 High-




in	cell	 cytoplasm	(Biffi	et	al.,	2013a;	Conlon	et	al.,	2016).	However,	 it	 is	notable	 that	DMS	
can	 irreversibly	 trap	 the	unfolded	G4	 state	 (Di	Antonio	 et	 al.,	 2020)	 and	 thus	 shifting	 the	
dynamic	 equilibrium	 of	 structural	 states	 towards	 unfolded	 states.	 Mapping	 endogenous	
RNA	G4	structures	still	awaits	the	development	of	techniques	that	use	G4	structure-specific	
probes.	Preliminary	results	from	our	 lab	have	suggested	that	endogenous	RNA	G4s	can	be	
mapped	 by	 RNA	 immunoprecipitation	 (RIP)	 using	 the	 BG4	 antibody	 (Varshney	 D.,	












transcription.	 Genome-wide	 G4	 landscapes	 mapped	 by	 G4-seq	 in	 12	 different	 species	
confirmed	 that	 sequences	 with	 G4-forming	 potential	 are	 enriched	 at	 mammalian	 gene	
promoters.	This	enrichment	is	conserved	in	mouse	and	Trypanosoma	brucei,	indicating	the	
conservation	of	possible	similarities	in	the	G4	biology.	In	a	chromatin	context,	G4	structures	
mapped	 by	 G4	 ChIP-seq	 were	 also	 found	 to	 be	 enriched	 in	 promoters	 of	 active	 genes	
(Hänsel-Hertsch	 et	 al.,	 2016).	 Remarkably,	 G4	 ChIP-seq	 revealed	 that	 endogenous	 G4	
structures	mapped	predominantly	to	nucleosome-depleted	regions	(Figure	1.8)	and	marked	





During	DNA	 replication,	 transient	 opening	 of	 the	DNA	duplex	may	 expose	 a	 single-strand	
region	 containing	 G4	motifs,	 thereby	 favouring	 the	 formation	 of	 G4	 structures.	 Genome-
wide	 bioinformatic	 analysis	 has	 suggested	 that	 the	majority	 of	 human	 replication	 origins	
(~80%)	 are	 proximal	 to	 the	 sites	 containing	 predicted	 G4	 consensus	 motifs,	 and	 that	
increased	 number	motifs	 are	 associated	with	more	 frequently	 used	 origins	 (Cayrou	 et	 al,	
2012;	Besnard	et	al,	2012).	These	suggest	that	G4s	may	support	DNA	replication	initiation.	
However,	the	relationship	between	G4s	and	replication	origins	 in	human	cells	are	unclear,	
as	 replication	 origins	 are	 difficult	 to	 define	 in	 humans	 and	 show	 extensive	 variability	
(Leonard	&	Méchali,	2013).	
	
Conversely,	 since	 folded	G4	 structures	are	 stable	under	physiological	 conditions	and	have	
been	shown	to	arrest	DNA	polymerases	 in	vitro	 (Weitzmann	et	al.,	1996;	Woodford	et	al.,	
1994),	 the	 existence	 of	 G4	 structures	 may	 also	 present	 in	 replication	 as	 a	 potential	
impediment.	Many	independent	studies	subsequently	provided	evidence	that	this	is	true	in	
vivo	and	suggested	that	G4	structures	may	act	as	‘roadblocks’	during	DNA	replication.	Early	
evidence	 for	 this	 came	 from	 a	 loss-of-function	 study	 of	 a	DNA	helicase.	 In	 dog-1	 (FANCJ)	
helicase	deficient	Caenorhabditis	elegans,	G-rich	repetitive	DNA	elements	with	G4-forming	
potential	are	deleted	(Kruisselbrink	et	al.,	2008),	suggesting	that	DNA	polymerase	is	unable	
to	 process	 G4-associated	 regions.	 An	 independent	 study,	 which	 used	 the	 same	 genetic	
system,	 showed	 that	 a	 single	 unresolved	G4	 structure	 persisted	 on	 the	 leading	 strand	 of	
DNA	through	mitotic	divisions	and	imposed	a	new	block	during	each	subsequent	replication	
process.	 Failed	 replication	 of	 the	 G4-forming	 site	 caused	 a	 single-strand	 DNA	 gap,	 which	
further	induced	double-strand	DNA	breaks	in	subsequent	divisions	(Lemmens	et	al.,	2015).	
	
By	 arresting	 the	 progress	 of	 DNA	 polymerase	 during	 replication,	 the	 formation	 of	 G4	
structures	can	trigger	replication	stress,	which	can	 in	turn	cause	DNA	damage	and	 lead	to	
genome	instability.	Works	in	model	organisms	provide	evidence	that	G4s	are	determinants	
of	 genome	 instability.	 In	 addition	 to	 the	 studies	 of	 FANCJ-deficient	C.	 elegans	mentioned	
above,	Piazza	et	al.	showed	that	the	human	CEB1	minisatellite,	which	harbours	G4	motifs,	
becomes	 unstable	 when	 introduced	 in	 Pif1-deficient	 yeast	 or	 in	 yeast	 cultured	 in	 the	
presence	 of	 G4	 ligands	 (Piazza	 et	 al.,	 2010,	 2017).	 Furthermore,	 mutational	 analysis	 of	
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CEB25	in	yeast	suggests	that	increased	G4	thermostability,	which	is	achieved	by	shortening	
the	G4	 loop	 length	(from	9	nt	to	 less	than	4	nt),	causes	greater	genomic	 instability	 in	vivo	
(Piazza	et	al.,	2015).	
1.4.1.3 Epigenetics	
Emerging	 evidence	 also	 indicates	 that	 G4	 structures	 interact	with	DNA	modifications	 and	
histone	modifications.	During	 replication	 stress	 following	 depletion	 of	 nucleotide	 pools	 in	
chicken	 DT40	 cells,	 heritable	 epigenetic	 reprogramming	 was	 induced	 by	 small	 molecule	
mediated	G4	 stabilisation	or	 loss	of	 the	REV1	protein,	which	 is	 required	 for	 replication	of	




al.,	 2017).	 The	 transcription	 of	 CDKN1A	 is	 regulated	 by	 a	 similar	 mechanism,	 in	 which	 a	
TRF2-G4	 interaction	 is	 required	 for	 REST-LSD1	 recruitment	 (Hussain	 et	 al.,	 2017).	 DNA	
methyltransferases	 (DNMTs),	 which	 methylate	 cytosine	 at	 C-5	 and	 are	 predominantly	
located	at	CpG	dinucleotides	 in	mammalian	cells,	 also	 showed	preferential	binding	 to	G4-
forming	DNA	over	double-stranded	DNA	in	vitro	as	defined	by	protein	binding	assays	(Cree	
et	al.,	2016;	Mao	et	al.,	2018).	Furthermore,	the	binding	of	DNMT1	to	G4	structures	inhibits	
it	 enzymatic	 activity,	 and	 the	 presence	 of	 G4	 structures	 in	 cells	 is	 highly	 associated	with	
hypomethylation	at	DNMT1	binding	sites	(Mao	et	al.,	2018)	(Figure	1.9).	This	implies	that	G4	




base	damage	 in	the	genome,	 is	also	associated	with	G4s.	G	bases	 in	predicted	G4-forming	
motifs	 have	 low	 redox	 potential	 and	 are	 susceptible	 to	 8-oxoG	 formation	 (Fleming	 and	
Burrows,	2017).	 It	has	been	 indicated	 that	8-oxoG	within	 telomeric	G4	structures	disrupts	
G4	structures	by	reducing	the	thermal	stability	of	G4s,	and	as	a	result	stimulates	telomerase	
function	 and	 promotes	 telomere	 instability	 (Fouquerel	 et	 al.,	 2016,	 2019).	 Emerging	
evidence	 has	 also	 suggested	 that	 the	 interplay	 between	 8-oxoG	 and	 G4s	 can	 regulate	




contrast,	 the	 removal	 of	 8-oxoG	 of	 the	 G4	 motif	 on	 the	 template	 strand	 turned	 off	 the	
transcription.	 Furthermore,	 a	 recent	 study	 observed	 that	 the	 binding	 sites	 of	 OGG1	 and	
APE1,	 proteins	 that	 are	 involved	 in	 8-oxoG-induced	 BER,	were	 predominant	 at	 G4	motifs	
(Roychoudhury	 et	 al.,	 2020).	 Roychoudhury	 et	 al.	 also	 found	 that	 G4	 formation	 was	
promoted	 by	 the	 binding	 of	 APE1	 and	 APE1	 subsequently	 facilitated	 G4-mediated	 gene	
expression.	
	
Figure 1.9: DNMT1 is recruited to the G4-forming sites associated with hypomethylation. 
Example genome browser view shows tracks of whole genome bisulfite sequence (top, black), CpG islands 
(green), G4 ChIP-seq (blue) and DNMT1 ChIP-seq (red) at the hypomethylated region from Chromosome 
6. Regions masked in blue shows that the presence of G4s is associated with DNMT1 binding and low 
methylation, while orange-masked regions are hypermethylated sites enriched with DNMT1 but do not possess 





G4	 structures	 have	 been	 found	 enriched	 in	 the	 beginning	 of	 5’-untranslated	 regions	 (5’-
UTRs),	 suggesting	 that	 they	 may	 have	 functions	 in	 translation	 (Chambers	 et	 al.,	 2015;	
Huppert	 et	 al.,	 2008).	 Many	 studies	 have	 reported	 the	 relationship	 between	 G4s	 and	
translation	individually.	For	example,	Kumari	et	al.	has	demonstrated	that	the	folding	of	the	
RNA	 G4	 in	 the	 5’-UTR	 of	 the	 transcript	 of	 human	 NRAS	 proto-oncogene	 leads	 to	
translational	inhibition	in	vitro	(Kumari	et	al.,	2007).	Similarly,	it	has	been	shown	that	folding	
of	 the	 thermodynamically	 stable	BCL-2	RNA	G4,	which	 is	well-characterised	 biophysically,	
inhibits	 translation	 both	 in	 vitro	 and	 in	 human	 cells	 (Shahid	 et	 al.,	 2010).	 Moreover,	
inhibiting	 the	 eukaryotic	 initiation	 factor	 4A	 (eIF4A),	 which	 is	 the	 helicase	 that	 unwinds	
structured	 5ʹ	 UTRs	 and	 facilitates	 the	 recruitment	 of	 ribosomes	 to	 initiate	 translation,	
resulted	 in	 reduced	 translation	 efficiency	 of	mRNAs	with	 longer	 5ʹ	UTRs	 enriched	 in	 two-	
tetrad	 G4s	 (Wolfe	 et	 al.,	 2014).	 This	 indicates	 that	 the	 formation	 of	 RNA	 G4s	 impedes	
recruitment	 or	 the	 scanning	 of	 ribosomes	 during	 translation	 initiation.	 The	 occurrence	 of	
RNA	 G4s	 in	 RNA	 coding	 regions	 is	 relatively	 less	 abundant	 compared	 to	 5’-UTRs.	
Interestingly,	a	computational	study	has	suggested	that	most	stable	G4s	that	are	predicted	
to	fold	 in	coding	sequences	are	 largely	 lost	through	the	use	of	synonymous	codons	during	
evolution	 (Mirihana	 Arachchilage	 et	 al.,	 2019).	 The	 interactions	 of	 RNA	 G4s	 with	 RNA-




In	 addition	 to	 translation,	 RNA	G4s	 have	 also	 been	 suggested	 to	 play	 other	 roles	 in	 RNA	
biology,	 such	 as	 alternative	 splicing.	 The	 splicing	 factor	 hnRNPH	 has	 been	 shown	 to	 bind	
RNA	G4s	in	vitro,	and	dysregulation	of	hnRNPH	correlates	with	elevated	RNA	G4s	(Conlon	et	




extracts,	many	 RNA	G4	 interacting	 proteins	were	 identified	 using	 liquid	 chromatography-
tandem	mass	 spectrometry	 (Herdy	 et	 al.,	 2018).	 These	 include	 RNA	 helicases	 DDX5	 and	
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DDX17,	which	 have	 been	 reported	 to	 have	G4-relevant	 roles	 in	 splicing	 (Dardenne	 et	 al.,	
2014).	More	recently,	accumulating	evidence	also	suggests	that	RNA	G4s	may	have	a	role	in	
stress	 granule	 formation.	 For	 instance,	 RNA	 G4-binding	 proteins	 DHX36	 and	 DDX3X	 are	
associated	with	 stress	 granule	 formation	 (Chalupníková	 et	 al.,	 2008;	 Valentin-Vega	 et	 al.,	






Mammalian	 telomeres	 at	 chromosome	 ends	 are	 composed	 of	 single-stranded	 tandem	
repeats	 of	 TTAGGG	 DNA	 sequences	 associated	 with	 protein	 shelterin	 complexes,	 which	
maintain	genome	integrity	and	protect	telomeric	DNA	from	DNA	damage	(Shay	and	Wright,	
2019).	These	G-rich	regions	have	been	shown	to	form	stable	DNA	G4	structures	(Parkinson	
et	al.,	2002).	 It	has	been	demonstrated	that	mammalian	telomere	DNA	 is	 transcribed	 into	
telomeric	repeat-containing	RNA	(TERRA)	(Azzalin	et	al.,	2007;	Schoeftner	and	Blasco,	2008),	
and	TERRA	is	reported	to	form	RNA	G4s	in	vitro	and	in	human	cells	(Martadinata	and	Phan,	
2009;	Xu	et	 al.,	 2008,	 2010).	Moreover,	 telomeric	DNA	and	RNA	were	 found	 to	 assemble	
into	 a	 hybrid	 DNA-RNA	 G4	 conformation	 (Bao	 and	 Xu,	 2020;	 Xu	 et	 al.,	 2009).	 Therefore,	
various	G4	structures	may	exist	at	telomeres	and	play	a	role	in	telomere	biology.	
	
To	 date,	 many	 studies	 have	 reported	 the	 relationship	 between	 G4s	 and	 telomere	
maintenance.	 For	 instance,	 Paeschke	 and	 colleagues	 have	 demonstrated	 the	 existence	 of	
antiparallel	 telomeric	 DNA	 G4s	 in	 the	 ciliate	 Stylonychia	 lemnae	 and	 shown	 that	 the	
maintenance	 of	 telomere	 G4	 structures	 in	 vivo	 requires	 the	 ciliate	 telomere	 end-binding	
proteins	 (TEBPs),	 TEBPα	 and	 TEBPß	 (Paeschke	 et	 al.,	 2005).	 As	 telomeric	 G4s	 have	 been	
observed	in	human	telomeres	using	BG4	IF	and	G4	ChIP-seq	(Biffi	et	al.,	2013b;	Henderson	
et	al.,	2014;	 Liu	et	al.,	2016),	and	 telomere	binding	proteins	Rif1	and	TRF2	bind	 to	G4s	 in	
vitro	(Biffi	et	al.,	2012;	Kanoh	et	al.,	2015),	it	has	been	suggested	that	G4s	may	be	involved	
in	 telomere	 capping.	 Indeed,	 it	 has	 been	 found	 that	 in	 budding	 yeast	 that	 has	 mutated	
cdc13-1,	the	gene	encodes	the	Cdc13	capping	protein,	the	telomere	capping	is	lost	and	the	
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growth	 inhibited	 (Smith	 et	 al.,	 2011).	 By	 the	 overexpression	 of	 DNA	G4	 binding	 proteins,	
treatment	with	G4-stabilising	 ligands	or	 loss	of	 the	DNA	G4-resolving	helicase	Sgs1,	which	
were	 shown	 to	 stabilise	 telomeric	 DNA	G4s	 in	 vitro,	 the	 growth	 of	 cdc13-1	mutants	was	




in	 the	 long	 non-coding	 TERRA	 has	 been	 proposed	 to	 act	 as	 a	 scaffold	 in	 telomeres	 to	
maintain	chromatin	homeostasis	(Takahama	et	al.,	2013).	Human	telomere-binding	proteins	
TRF2	and	FUS	can	bind	to	both	the	TERRA	RNA	G4	structure	and	the	telomere	DNA	G4	 in	
vitro	 (Biffi	 et	 al.,	 2012;	 Takahama	 et	 al.,	 2013).	 This	 co-binding	 enables	 FUS	 and	 TRF2	 to	
recruit	 histone	 methyltransferases	 which	 are	 critical	 for	 heterochromatin	 formation	 at	
telomeres	(Takahama	et	al.,	2013).	
	
G4	 structures	 have	 also	 been	 reported	 to	 have	 multiple	 roles	 in	 telomerase-mediated	
telomere	extension.	On	the	one	hand,	an	 in	vitro	study	has	shown	that	the	folding	of	anti-
parallel	 telomeric	 G4	 structures	 inhibits	 Oxytricha	 nova	 telomerase	 and	 subsequent	
telomere	 elongation	 (Zahler	 et	 al.,	 1991),	 suggesting	 that	 telomeric	 G4	 structure	 may	
negatively	regulate	telomere	extension.	On	the	other	hand,	parallel	telomeric	G4	structures	
can	be	partially	resolved	and	extended	by	telomerase	in	vitro	(Moye	et	al.,	2015),	and	works	
in	 yeast	 and	 in	 human	 cells	 have	 shown	 that	 telomerases	 are	 recruited	 upon	 the	
stabilisation	 of	 parallel	 telomere	 G4s	 (Moye	 et	 al.,	 2015;	 Zhang	 et	 al.,	 2010a).	 These	




and	 5’-UTRs	 (Chambers	 et	 al.,	 2015;	 Hänsel-Hertsch	 et	 al.,	 2016;	 Huppert	 and	
Balasubramanian,	 2007).	 Particularly	 striking	 is	 their	 enrichment	 in	 genes	 associated	with	
cancer,	 and	 in	 regions	 that	 undergo	 somatic	 copy	 number	 alterations	 (CNAs)	 related	 to	
cancer	 development	 (Chambers	 et	 al.,	 2015;	 Georgakopoulos-Soares	 et	 al.,	 2017;	 Hänsel-
Hertsch	 et	 al.,	 2016),	 raising	 the	 question	 of	 what	 the	 relationship	 is	 between	 G4s	 and	
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cancer.	In	support	of	this,	several	lines	of	evidence	suggest	that	G4	structures	preferentially	
exist	 in	 cancer	 states	 when	 compared	 to	 healthy	 states.	 For	 example,	 using	 the	 BG4	
antibody	 to	 detect	 DNA	 G4	 structures	 in	 different	 types	 of	 patient-derived	 tissues	 by	
immunohistochemistry,	 Biffi	 et	 al.	 found	 that	 the	 presence	 of	 DNA	 G4s	 was	 significantly	
higher	 in	 the	 nuclei	 of	 stomach	 and	 liver	 cancer	 tissues	 than	 the	 corresponding	 non-





fold	 higher	 than	 in	 NHEK	 cells.	 Furthermore,	 a	 recent	 study	 of	 the	 G4	 landscape	 in	
chromatin	 from	 patient-derived	 aggressive	 breast	 cancer	 xenografts	 suggested	 that	
promoters	of	highly	amplified	genes,	whose	expression	is	increased,	also	harbour	a	greater	
number	 of	 G4s	 (Hänsel-Hertsch	 et	 al.,	 2020).	 The	 study	 also	 showed	 that	 differentially	
enriched	 G4s	 identified	 across	 22	 samples	 were	more	 likely	 to	 be	 found	 at	 CNAs.	 These	
findings	 suggest	 that	 potentially	 important	 aspects	 of	 intratumour	 heterogeneity	 (i.e.	
differences	 of	 molecular	 and	 phenotypical	 profiles	 for	 cell	 populations	 within	 the	 same	
tumour)	are	reflected	in	the	G4	landscape.	
	
G4	 structures	 are	 associated	 with	 a	 growing	 number	 of	 biological	 processes	 that	 are	
important	 in	 cancer	 development,	 including	 telomere	 biology,	 DNA	 replication,	 genome	
instability	 and	 cancer-related	 gene	 regulation.	 This	 has	 stimulated	 exploration	 of	 G4-
targeting	as	a	method	of	intervention	for	cancer	therapy.	Telomerase,	which	plays	a	role	in	
the	maintenance	of	telomere	homeostasis,	is	overexpressed	in	the	vast	majority	of	human	
tumours	 (85-90%)	 (Kim	 et	 al.,	 1994;	 Shay	 and	 Wright,	 2019).	 Since	 the	 formation	 of	
telomeric	G4	structures	inhibits	telomerase	activity	(Zahler	et	al.,	1991),	attempts	have	been	
made	 to	 exploit	 inhibition	 of	 telomerase-mediated	 telomere	 extension	 by	 G4-stabilising	
ligands	 for	 cancer	 therapeutics	 (Sun	 et	 al.,	 1997).	 Subsequently,	 evidence	 emerged	 that	
some	G4	ligands	caused	DNA	damage	at	telomeres.	One	mechanism	by	which	they	appear	
to	 do	 so	 is	 via	 PARP1,	 a	 key	 regulator	 of	 the	 nonhomologous	 end	 joining	 (NHEJ)	 repair	
pathway.	 In	 both	 cellular	 and	 xenograft	models,	 stabilisation	 of	 telomeric	 G4s	 by	 the	 G4	
ligand	 RHPS4	 specifically	 recruits	 PARP1	 and	 activates	 the	 poly-ADP	 ribosylation,	 a	 post-
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translational	 modification	 of	 proteins	 at	 telomeres,	 and	 RHPS4	 treatment	 in	 PARP1	
knockdown	 cancer	 cells	 inhibits	 cell	 growth	 (Salvati	 et	 al.,	 2010).	 By	 contrast,	 the	
displacement	of	 the	telomeric	shelterin	protein	hPOT1	using	the	G4	 ligand	BRACO-19	also	
caused	 telomere	 DNA	 damage	 and	 subsequently	 cell	 death,	 suggesting	 potential	
applications	 for	 chemotherapeutics	 (Neidle,	 2010).	 DNA	 damage	 can	 also	 be	 induced	
throughout	the	genome	using	G4	ligands.	For	example,	the	G4-interacting	drug	PDS	induced	
DNA	damage	in	human	cancer	cells	and	promoted	cell	death	(Rodriguez	et	al.,	2012).	
Figure 1.10: Human liver cancer tissue shows more DNA G4s than matched non-neoplastic tissue. 
(A) Examples for liver cancer tissues (left) and non-neoplastic tissues (right) stained by immunohistochemistry 
using G4-specific antibody BG4. The nuclei of non-neoplastic liver tissue are mostly BG4-negative, with 
haematoxylin counterstaining (blue) evident, while neoplastic tissue shows the extensive presence of BG4-
positive nuclei (brown). Scale bar, 50 µm. (B) Quantification of BG4 positive nuclei in tissues from 9 individual 
patients. Error bars represent the standard error of the mean (s.e.m.). This suggests that there are more DNA 




by	 targeting	 their	 promoter	 G4s.	 Apart	 from	 PDS,	 which	 has	 been	 shown	 to	 inhibit	 the	
expression	of	numerous	oncogenes	(Rodriguez	et	al.,	2012),	multiple	G4	ligands	have	shown	
promise	 for	 this	 purpose.	 One	 example	 is	 CM03.	 CM03-treated	 human	 pancreatic	 ductal	
adenocarcinoma	 (PDAC)	 cells	 showed	 a	 global	 reduction	 in	 the	 expression	 of	 many	 G4-
containing	genes,	and	the	tumour	growth	of	PDAC	xenografts	and	KPC	mouse	models	was	
arrested	 by	 CM03	 without	 causing	 general	 toxicity	 (Marchetti	 et	 al.,	 2018).	 Another	
approach	 has	 been	 made	 to	 exploit	 the	 synthetic	 lethality	 (increased	 cell	 death	 in	
combination,	but	not	alone)	of	G4	ligands	and	specific	genetic	changes	found	in	cancer	cells.	
For	 example,	 PDS	 treatment	was	 shown	 to	 cause	 cell	 lethality	 in	 BRCA2-deficient	 cells,	 a	
gene	 involved	 in	homologous	 recombination	 (HR)	 repair	 pathway	 (McLuckie	 et	 al.,	 2013).	
The	 study	 also	 demonstrated	 the	 synthetic	 lethality	 of	 cells	 treated	 with	 both	 PDS	 and	
NU7441,	an	 inhibitor	of	 the	DNA-PK	kinase	crucial	 for	NHEJ	 repair	pathway.	Furthermore,	
exposure	of	BRCA1/2	deficient	tumours	to	CX-5461	causes	cell	lethality	(Xu	et	al.,	2017).	CX-
5461	 was	 previously	 thought	 to	 be	 an	 RNA	 Pol	 I	 inhibitor,	 but	 was	 shown	 to	 be	 a	 G4	






this	 study,	was	 designated	 as	 a	 ‘key’	 gene	whose	 deficiency	 imparts	 significant	G4	 ligand	









A	 key	 determinant	 of	 transcriptional	 output	 is	 the	 accessibility	 of	 regulatory	 elements.	
Chromatin	accessibility	 is	determined	by	the	occupancy	and	topology	of	nucleosomes	and	
chromatin-binding	 factors,	 non-histone	 macromolecules	 that	 bind	 to	 DNA	 directly	 or	
indirectly,	 that	 occlude	 accessibility	 of	 DNA	 (Klemm	 et	 al.,	 2019).	 The	 nucleosome	 is	 the	
fundamental	element	of	chromatin,	composed	of	an	octamer	of	histone	proteins	wrapped	
with	DNA	 (~147bp).	Nucleosome	occupancy	 is	 dynamic	 across	 the	 genome	 (Poirier	 et	 al.,	
2008),	 creating	 regions	 that	 range	 in	 accessibility	 from	 closed	 chromatin	 to	 permissive	
chromatin	 and	 highly	 dynamic	 open	 chromatin.	 Across	 the	 genome,	 the	 accessibility	 of	
chromatinised	 DNA	 is	 regulated	 by	 external	 stimuli	 and	 varies	 between	 cell	 types.	
Transcription	 factors	 (TFs)	play	 critical	 roles	 in	 this	 regulatory	process,	 through	 sequence-
specific	 DNA-binding	 (Klemm	 et	 al.,	 2019).	 TFs	 gain	 access	 to	 histone-bound	 DNA	 during	
nucleosome	 turnover	 and	 displace	 nucleosomes	 to	 generate	 accessible	 regions	 for	




TFs,	 chromatin-remodeling	 enzymes	 play	 a	 central	 role	 in	 regulating	 chromatin	 state.	 For	








and	Kouzarides,	 2011).	One	 important	 example	 is	 histone	acetylation,	which	 is	 critical	 for	
modulating	chromatin	structure.	The	acetylation	of	histones	 is	regulated	by	two	groups	of	
histone	 modifying	 enzymes,	 histone	 acetyltransferases	 (HATs)	 and	 histone	 deacetylases	
(HDACs)	(Bannister	and	Kouzarides,	2011;	Wang	et	al.,	2009)	and	results	in	decompaction	of	
chromatin	structure	(Li	and	Reinberg,	2011;	Robinson	et	al.,	2008).	The	acetylation	of	lysine	
side	 chains	 in	 histones	 neutralises	 the	 lysine	 positive	 charge	 and	 destabilises	 the	
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interactions	 between	DNA	 and	 histones,	which	 is	 important	 for	 the	 preclusion	 of	 histone	
binding	(Bannister	and	Kouzarides,	2011).	For	example,	accumulating	evidence	has	indicated	
that	HAT1	acetylates	histone	H4	 in	cells,	and	depletion	of	HAT1	results	 in	 the	decrease	of	
acetylation	 in	 H4	 (Barman	 et	 al.,	 2006;	 Parthun,	 2007).	 Acetylation	 has	 also	 been	 found	
present	within	the	histone	core.	GCN5	is	a	HAT	protein	that	acetylates	lysine	56	in	histone	
H3	(H3K56),	whose	side	chain	points	 to	DNA	major	groove	 (Parthun,	2007;	Tjeertes	et	al.,	
2009).	 This	 suggests	 that	 acetylation	 of	 H3K56	 also	 affects	 histone-DNA	 interactions.	
Furthermore,	acetylation	was	also	found	to	be	associated	with	rapid	nucleosome	turnover	
(Wang	et	al.,	2009),	which	in	turn	increases	chromatin	accessibility.	Histone	methylation	is	
another	 important	 example	 of	 post-translational	 histone	 modification.	 Unlike	 histone	
acetylation,	 histone	methylation	 does	 not	 have	 impact	 on	 the	 charge	 of	 histone	 proteins	
(Bannister	and	Kouzarides,	2011).	Histone	methylation	occurs	on	the	side	chains	of	 lysines	
and	arginines.	Amongst	histone	methylations,	H3K4,	H3K9,	H3K27	and	H3K36	are	the	most	
common	 and	 well-studied	 sites.	 These	 lysine	 methylations	 mark	 gene	 repression	 except	
H3K4me3	which	marks	 accessible	 chromatin	 and	 active	 transcription	 (Barski	 et	 al.,	 2007;	
Hyun	 et	 al.,	 2017;	 Saksouk	 et	 al.,	 2015).	 Moreover,	 methylation	 of	 H3K9	 marks	




Increasing	 evidence	 indicates	 that	 the	 interaction	 between	 histone	 modifications	 and	
chromatin	remodelers	 is	crucial	 in	regulating	chromatin	(Swygert	and	Peterson,	2014).	For	
example,	human	BRG1,	a	SWI/SNF	subunit,	 recognises	the	acetylation	of	H4K8	and	H4K12	
and	 activates	 interferon-ß	 gene	 transcription	 (Agalioti	 et	 al.,	 2002).	 In	 some	 cases,	
chromatin	 remodelers	 directly	 modify	 histones.	 The	 NURD	 remodeler	 complex	 has	 two	
HDAC	subunits,	which	enable	histone	deacetylation	to	repress	gene	transcription	(Xue	et	al.,	
1998).	 Therefore,	 chromatin	 status	 is	 regulated	 through	 the	 recognition	 of	 histone	
modifications	 by	 chromatin	 remodelers	 or	 through	 the	 modification	 of	 histones	 by	
remodeler	 complexes,	 and	 open	 chromatin	 is	 necessary	 for	 active	 transcription.	 Once	





in	 eukaryotic	 cells	 (Armache	 et	 al.,	 2003).	 The	 C-terminal	 domain	 (CTD)	 of	 RNA	 Pol	 II	
contains	 tandem	 heptad	 repeats	 (consensus	 Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7)	 and	 the	
phosphorylation	 of	 Ser2	 and	 Ser5	 is	 critical	 for	 regulating	 progression	 through	 the	
transcriptional	 process	 (Eick	 and	 Geyer,	 2013).	 Transcription	 by	 RNA	 Pol	 II	 comprises	








promoter-proximal	 regions	 (around	 10	 nucleotides	 downstream	 of	 the	 transcription	 start	
site).	The	pausing	is	finely	regulated	by	protein	complexes	that	establish	or	release	paused	
RNA	 Pol	 II,	 including	 5,6-Dichlorobenzimidazole	 1-β-D-ribofuranoside	 (DRB)-sensitivity-









Figure 1.11: Key steps of RNA Pol II-mediated transcription. 
RNA Pol II associates with initiation factors and assembles at promoter DNA to form a preinitiation complex. 
DNA is subsequently opened, exposing the DNA template strand. Serine 5 in RNA Pol II CTD gets 
phosphorylated and transcription initiates. When the RNA grows to a critical length, RNA Pol II is bound by 
elongation factors, DSIF and NELF, and transcription pauses. P-TEFb phosphorylates elongation factors and 
serine 2 in Pol II CTD and thus RNA Pol II engages into transcription elongation. Finally, polymerase dissociation 
from DNA and transcription terminates (not shown). Figure is adapted and modified from Cramer, 2019.  
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that	 poly(A)	 sequence	 is	 recognised	 and	 bound	 by	 human	 cleavage	 and	 polyadenylation	
specificity	factor	(CPSF)	(Nag	et	al.,	2007).	The	poly(A)-CPSF	interaction	induces	transcription	
pausing,	 which	 further	 recruits	 the	 cleavage	 stimulatory	 factor	 (CstF)	 to	 the	 terminating	
sites	 (Nag	 et	 al.,	 2007).	 Recruited	 CstF	 stimulates	 the	 CPSF-mediated	 cleavage	 and	
consequently	release	of	paused	Pol	 II	 (Kuehner	et	al.,	2011).	Although	much	less	 is	known	
about	 the	 termination	 machinery,	 it	 performs	 important	 functions	 in	 cells.	 For	 example,	
termination	prevents	RNA	Pol	II	from	interfering	with	downstream	elements	and	promotes	
polymerase	recycling	(Rosonina	et	al.,	2006).	Interestingly,	it	has	been	reported	that	during	
the	 transcription	 of	 mitochondrial	 gene	 CSB	 II,	 the	 nascent	 RNA	 and	 non-template	 DNA	
strand	 forms	 an	 RNA-DNA	 hybrid	 G4	 structure	 and	 promotes	 transcription	 termination	




As	 described	 in	 section	 1.4.1,	 Hänsel-Hertsch	 et	 al.	 have	 shown	 that	 endogenous	 G4	
structures	 mark	 sites	 of	 active	 transcription	 (Hänsel-Hertsch	 et	 al.,	 2016).	 Moreover,	
enhanced	G4	formation	is	associated	with	increased	transcriptional	activity.	These	findings	







promoter,	 strongly	 inhibited	KRAS	promoter	activity	 (Cogoi	and	Xodo,	2006).	 Isoallozazine	
ligands	were	also	used	as	G4-stabilising	small	molecules,	and	cells	treated	with	these	ligands	
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showed	 a	 50%	 reduction	 in	 KIT	 expression	 (Bejugam	 et	 al.,	 2007).	 Furthermore,	 whole	
transcriptome	 RNA-seq	 revealed	 that	 treatment	 with	 CM03,	 which	 shows	 preferential	
binding	 to	 and	 stabilisation	 of	 G4	 structures	 over	 duplex	 DNA	 in	 vitro,	 resulted	 in	 a	




Although	 G4	 ligand-mediated	 G4	 stabilisation	 is	 reported	 to	 result	 in	 downregulation	 of	
transcription,	 it	 is	 important	 to	 note	 that	 repression	 of	 transcription	may	 not	 be	 directly	
caused	 by	 the	 formation	 of	G4s.	 Illustrating	 this,	 treatment	with	 the	G4-stabilising	 ligand	
PDS	induced	DNA	damage	and	promoted	growth	arrest	in	human	cancer	cells	(Rodriguez	et	
al.,	 2012).	 The	 study	 also	 showed	 that	 PDS	 treatment	 led	 to	 reduced	 expression	 of	 G4-
containing	genes.	However,	PDS-induced	DNA	damage	rather	than	G4	structures	may	be	the	
cause	 of	 altered	 gene	 expression	 in	 cells.	 It	 remains	 possible	 that	 previous	 studies	which	







structure,	 such	 as	 G4s,	 may	 contribute	 to	 RNA	 Pol	 II	 pausing.	 Computational	 analysis	 of	
human	genes	showed	preferential	promoter-proximal	RNA	Pol	II	pausing	in	the	presence	of	




Other	 studies	 have	 also	 investigated	 the	 interaction	 of	 gene	 body	 G4s	with	 transcription	
elongation.	 For	 example,	 by	 introducing	 a	 reporter	 gene	 construct	 which	 contains	 a	 G4-






strand	 impair	RNA	Pol	 II	 progression.	Agarwal	et	al.	 also	 found	 that	 transcription	was	not	
impacted	 by	 placement	 of	 the	 G4-forming	 sequence	 on	 the	 non-template	 strand	
downstream	 of	 the	 promoter	 (Agarwal	 et	 al.,	 2014).	 In	 support	 of	 this	 observation,	 a	
genome-wide	 analysis	 revealed	 that	 human	 genes	 with	 a	 greater	 number	 of	 G4s,	
particularly	 those	 with	 G4s	 located	 on	 the	 non-template	 strand	 up	 to	 500	 base	 pairs	
downstream	 of	 the	 transcription	 start	 site,	 are	 associated	 with	 higher	 than	 average	
transcription	levels	and	RNA	Pol	II	occupancy	(Du	et	al.,	2008).	This	suggests	that	G4s	on	the	
non-template	 strand	 may	 maintain	 an	 open	 DNA	 state	 and	 thereby	 aid	 transcription	
reinitiation.	In	opposition	to	this	model,	another	study	reported	that	G-rich	sequence	in	the	





Overall,	 the	precise	 relationship	between	DNA	G4s	and	 transcription	 remains	unclear	and	
the	subject	of	much	debate.	Furthermore,	most	studies	to	date	have	used	reporter	assays	or	
in	vitro	approaches	to	investigate	the	relationship,	without	considering	chromatin	context.	





During	 transcription	 initiation,	 the	 RNA	 polymerase	 preinitiation	 complex	 (PIC)	 binds	 and	
unwinds	the	DNA	duplex	to	promote	the	engagement	of	RNA	Pol	II	in	active	transcription.	It	
has	 been	 proposed	 that	 negative	 torsional	 stress	 and	 supercoiling	 induced	 by	 counter-
rotation	of	the	transcription	machinery	affects	upstream	DNA	topology	(Harada	et	al.,	2001;	




showed	 that	 transcribing	 RNA	 polymerases	 drive	 the	 supercoil-sensitive	 far	 upstream	






of	 R-loops	 also	 causes	 DNA	 damage	 and	 genome	 instability	 (Santos-Pereira	 and	 Aguilera,	
2015).	 Similar	 to	 G4	 structures,	 DNA	 features	 that	 favour	 R-loop	 formation	 include	 GC-
richness	and	negative	torsional	tension	(Ginno	et	al.,	2012).	The	R-loop	landscape	mapped	
by	 ChIP-seq	 using	 enzymatically	 dead	 RNase-H1	 (which	 shows	 specificity	 for	 DNA-RNA	
hybrids)	revealed	that	R-loops	preferentially	form	in	promoter	regions	that	are	likely	to	form	
G4s	in	vitro	(Chen	et	al.,	2017).	The	co-occurrence	of	G4	and	R-loop	was	termed	a	‘G-loop’,	
in	which	 a	 G4	 forms	 on	 the	 non-template	 strand	 and	 the	 R-loop	 on	 the	 template	 strand	
(Duquette	 et	 al.,	 2004).	 When	 transcribing	 a	 plasmid	 genome,	 which	 contains	 G-rich	
sequences	 downstream	 of	 the	 promoter,	 in	 vitro	 or	 in	 Escherichia	 coli,	 Duquette	 et	 al.	
observed	stable	formation	of	loop	structures	by	electron	microscopy	(Duquette	et	al.,	2004).	
By	 the	 addition	 of	 digoxygenin-UTP	 during	 transcription	 and	 gold	 beads	 coupled	 to	 anti-
digoxygenin	 antibodies,	 the	 authors	 were	 able	 to	 detect	 RNA	 in	 this	 loop	 structure,	
suggesting	that	it	indeed	forms	an	R-loop.		Cleavage	of	one	strand	of	the	loop	by	GQN1,	an	
endonuclease	that	specifically	cleaves	G4	DNA	in	the	5’	of	the	stacked	G-tetrads	(Sun	et	al.,	




loop	 extension	 regions	 possesses	 more	 experimentally	 observed	 G4	 structures	 on	 the	






as	 gene	 promoters	 (Chambers	 et	 al.,	 2015;	 Hänsel-Hertsch	 et	 al.,	 2016;	 Kudlicki,	 2016;	
Varizhuk	et	al.,	2017).	Moreover,	endogenous	G4	structures	in	human	chromatin,	which	are	
located	 predominantly	 in	 nucleosome-depleted	 regions,	 mark	 elevated	 levels	 of	
transcription	 with	 the	 increase	 of	 chromatin	 accessibility	 (Hänsel-Hertsch	 et	 al.,	 2016).	




transcription.	 However	 at	 the	 onset	 of	 this	 study,	 models	 and	 data	 linking	 G4s	 to	
transcription	were	largely	based	on	computationally	predicted	G4	sequences	and	relied	on	










Aim	 1:	 Emerging	 evidence	 suggests	 that	 endogenous	 G4	 structures	 are	 associated	 with	
active	 gene	 transcription	 (Hänsel-Hertsch	 et	 al.,	 2016).	 In	 vitro	work	 has	 suggested	 that	
active	transcription	can	promote	the	formation	of	G4s	(Duquette	et	al.,	2004;	Kouzine	et	al.,	





















Genome-wide	 enrichment	 of	 G4s	 at	 promoter	 proximal	 regions	 was	 first	 identified	 by	
computational	 methods	 that	 predict	 the	 folding	 of	 G4s	 by	 analysing	 the	 underlying	
sequence	(Eddy	and	Maizels,	2006;	Huppert	and	Balasubramanian,	2005;	Todd	et	al.,	2005).	
Many	such	G4	motifs	were	subsequently	verified	to	fold	into	G4	structures	in	vitro.	However,	
determining	 whether	 G4s	 fold	 at	 these	 loci	 in	 cells	 was	more	 challenging.	 This	 goal	 was	
helped	by	the	advent	of	G4	structure-specific	antibodies,	such	as	Sty49,	HF2,	BG4,	1H6	and	
D1	 (Biffi	 et	 al.,	 2013b;	 Fernando	 et	 al.,	 2008;	 Henderson	 et	 al.,	 2014;	 Liu	 et	 al.,	 2016;	
Schaffitzel	et	al.,	2001)	 (see	section	1.3.2).	Among	these,	BG4,	a	 recombinant	single-chain	
variable	 fragment	 (scFv)	 antibody	 was	 isolated	 by	 phage-display	 against	 TERRA,	 an	 RNA	
telomeric	G4	(Biffi	et	al.,	2013b).	BG4	was	found	to	bind	specifically	to	DNA	and	RNA	G4s	in	
vitro	(Kd	=	0.5	to	18	nM)	without	detectable	binding	to	other	DNA	or	RNA	structures	(Biffi	et	
al.,	 2013b,	 2013a).	 Remarkably,	 BG4	 did	 not	 display	 preferential	 binding	 to	 a	 specific	 G4	





ChIP-seq)	 (Hänsel-Hertsch	 et	 al.,	 2016,	 2018).	 Formation	 of	 G4	 structures	 was	 detected	
within	cross-linked	chromatin	at	high	resolution,	thus	identifying	specific	genomic	loci	that	
fold	 into	G4s	 in	 cells.	 This	approach	 interestingly	 revealed	 that	endogenous	G4	structures	
mapped	 predominantly	 to	 nucleosome-depleted	 regions	 and	 marked	 sites	 of	 active	
transcription.	BG4	also	co-localised	with	RNA	Polymerase	 II	 (RNA	Pol	 II)	and	trimethylated	
histone	 H3	 Lys4	 (H3K4me3),	 a	 histone	 modification	 that	 marks	 transcriptionally	 active	
euchromatin,	 as	 seen	by	 immunofluorescent	 staining	 (Hänsel-Hertsch	et	 al.,	 2016).	Genes	
containing	 a	 G4	 ChIP-seq	 peak	 in	 their	 promoter	 regions	 showed	 significantly	 higher	
transcription	 levels	 than	 those	 lacking	 a	 promoter	 G4	 ChIP-seq	 peak.	 Notably,	 previously	
published	 ChIP-seq	 peaks	 for	 transcription	 factors	 (TFs)	 such	 as	 XPB	 and	 SP1	 were	 also	
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found	 highly	 enriched	 in	 the	 G4	 ChIP-seq	 data,	 suggesting	 interactions	 of	 these	 proteins	
with	G4s	(Hänsel-Hertsch	et	al.,	2016).	
	
Several	 independent	studies	 indicated	 that	G4	structures	act	as	a	binding	site	 for	TFs.	For	
instance,	SP1,	a	transcription	factor	ubiquitously	involved	in	regulating	house-keeping	genes,	
was	observed	to	specifically	bind	a	G4	structure	from	the	KIT	promoter	in	vitro	(Raiber	et	al.,	
2012).	 The	 binding	 of	 SP1	 to	 G4	 showed	 affinity	 comparable	 to	 its	 previously	 defined	
canonical	duplex	DNA	binding	site	and	mutations	 in	G4	sequence	resulted	 in	 reduced	SP1	
binding.	 Transcriptionally-associated	 helicases	 XPD	 and	 XPB	were	 also	 shown	 to	 bind	G4s	
using	 gel	mobility	 shift	 assay,	while	 XPD	was	 also	 found	 to	 unwind	G4	 structures	 in	 vitro	
























transcription.	 However,	 these	 observations	 rely	 on	 in	 vitro	 systems	 or	 on	 genomic	
correlations	of	G4s	with	sites	of	active	transcription	in	cells.	The	causal	relationship	between	
G4s	 and	 the	 transcription	process	 still	 needs	 to	be	established.	 Some	 indications	 towards	
such	a	functional	relationship	have	been	reported	(see	section	1.6.3).	For	example,	negative	
torsional	 stress	 caused	 by	 RNA	 polymerase	 preinitiation	 complex	 promotes	 DNA	 duplex	
melting	 to	 form	 a	 single-stranded	 transcription	 bubble	 (Kouzine	 et	 al.,	 2004).	 This	 is	
hypothesised	 to	 promote	 the	 formation	 of	 transcription	 associated	 G4s.	 Furthermore,	
nascent	 RNA	 produced	 during	 transcription	may	 anneal	 to	 its	 template	 DNA,	 forming	 an	
RNA-DNA	hybrid	 known	as	R-loop.	R-loops	 appear	 to	 form	predominately	 in	GC-rich	non-
template	DNA	strand	at	the	promoter	proximal	region	(Ginno	et	al.,	2012).	The	formation	of	
R-loops	during	active	transcription	could	also	promote	the	formation	of	G4	structures.	This	
co-occurrence	 of	 G4	 and	 R-loop	 was	 termed	 ‘G-loop’,	 where	 G4	 forms	 on	 non-template	
strand	and	R-loop	on	template	strand.	The	presence	of	G-loop	formation	was	observed	co-
transcriptionally	 in	vitro	or	in	E.coli	and	visualised	by	electron	microscopy	(Duquette	et	al.,	




In	 spite	 of	 these	 studies,	 we	 still	 lack	 a	 clear	 understanding	 of	 the	 causal	 association	
between	 G4	 formation	 and	 active	 transcription.	 In	 other	 words,	 is	 active	 transcription	
necessary	 for	 the	 formation	 and	 maintenance	 of	 G4s,	 in	 particular	 promoter	 G4s.	 To	
systematically	explore	the	relationship	between	transcription	and	promoter	G4s,	I	employed	
K562,	 human	 chronic	 myelogenous	 leukemia	 cells	 which	 have	 been	 extensively	
characterised	by	ENCODE	 (Gerstein	et	al.,	2012).	To	examine	whether	active	 transcription	
promotes	G4	formation	or	G4	formation	enhances	transcription,	I	used	small	molecules	5,6-
dichlorobenzimidazole1-b-D-ribofuranoside	 (DRB)	 and	 triptolide	 to	 inhibit	 RNA	 Pol	 II	
mediated	 transcription	 elongation	 and	 initiation	 respectively,	 and	 then	 assessed	 the	




Figure 2.1: Investigating the response of endogenous G4s to transcriptional inhibition. 
Graphical representation of experimental design examining how endogenous G4s respond to transcriptional 
inhibition. Active transcription induced torsional stress is hypothesised to promoter G4 folding. To examine 
whether the formation of G4s is promoted by active transcription, transcription elongation and initiation are 


















poly-histidine	 (Figure	 2.2A).	 The	 quality	 of	 recombinant	 BG4	 was	 first	 assessed	 using	 a	




(DE3),	a	histidine-rich	strain,	 these	contaminants	are	 likely	 to	be	arnA	 (70kD),	SlyD	 (27kD)	
and	 the	 smaller	 proteins	 that	 are	 often	 co-purified	 with	 His-tagged	 target	 proteins	
(Andersen	et	al.,	2013;	Robichon	et	al.,	2011).	
	
A	 titration	 of	 bovine	 serum	 albumin	 (BSA)	 was	 used	 as	 protein	 standards	 to	 allow	
determination	 of	 BG4	 concentration.	 To	 measure	 the	 concentration	 of	 BG4	 antibody	
extracted	from	E.	coli,	a	standard	curve	was	generated	by	plotting	the	band	intensity	of	the	







Figure 2.2: Validation of BG4 antibody. 
(A) Protein sequence of BG4 with 6 His-tag, 3x FLAG and linker highlighted in green, blue and red respectively. 
(B) Coomassie blue staining of purified FLAG-tagged BG4 antibody and BSA standards separated by SDS PAGE. 
First lane contained molecular weight marker with proteins of denoted molecular weight. BG4 antibody is 
indicated with a red asterisk. (C) Protein standard curve generated using densitometry analysis performed on 
the BSA standards at the following concentrations: 0.025, 0.05 and 0.10 g/L. (a.u. = arbitrary unit). 
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Enzyme-linked	 immunosorbent	 assay	 (ELISA)	was	 then	 performed	 to	 evaluate	 the	 affinity	




respective	MYC	 and	mutated	MYC	 oligonucleotides	were	 confirmed	 by	 circular	 dichroism	
(CD)	spectroscopy.	G4	structures	depict	a	circular	ellipticity	maxima	at	265	nm	and	minima	
at	 245	 nm	 (del	 Villar-Guerra	 et	 al.,	 2018).	 This	 pattern	 is	 altered	 upon	 mutation	 of	 the	
central	stack	of	guanines,	which	indicates	disruption	of	the	G4	structure	(Figure	2.3A).	
	
Binding	 curves	 determined	 by	 ELISA	 showed	 that	 BG4	 bound	 to	MYC	 G4	 oligonucleotide	
with	 low	 nanomolar	 affinity	 (Kd	 =	 4.8	 ±	 0.4	 nM)	with	 negligible	 binding	 to	mutated	MYC	
oligonucleotide	 (Figure	 2.3B),	 which	 is	 comparable	 to	 BG4	 binding	 affinity	 previously	
described	 (Kd	 =	 1.5	 ±	 0.2	 nM)	 (Biffi	 et	 al.,	 2013b).	 The	 E.	 coli	 contaminants	 observed	 in	








Figure 2.3: BG4 selectively binds to MYC G-quadruplex (G4). 
(A) Circular dichroism spectra of MYC G4-folding oligonucleotides (red) and MYC-mut, oligonucleotides that are 
unable to fold into a G4 (blue). Sequences of MYC oligonucleotides are indicated and mutations were 
highlighted in yellow. (B) Binding affinity measurements performed by ELISA show the binding of BG4 
antibody to MYC G4 structure and absence of binding to non-G4-forming control oligonucleotides (MYC-mut). 
BG4 binding curves were fitted using nonlinear regression analysis. Calculated dissociation constants (Kd) are 
indicated. Error bars represent the s.e.m. (n=3). (a.u. = arbitrary unit) 
2.3.2 Characterisation	of	endogenous	G4s	in	K562	cells	
Originally,	 Hänsel-Hertsch	 et	 al.	 mapped	 endogenous	 G4	 structures	 within	 chromatin	 of	
HaCaT	cells	using	G4	ChIP-seq	(Hänsel-Hertsch	et	al.,	2016).	G4s	were	found	predominantly	
in	nucleosome-depleted	regions	of	the	genome.	Moreover,	endogenous	G4s	were	enriched	








Prior	 to	 sequencing,	G4-ChIP	 efficiency	was	measured	using	quantitative	 PCR	 (ChIP-qPCR)	
for	 previously	 defined	positive	 and	negative	 control	 regions	 (Hänsel-Hertsch	 et	 al.,	 2018).	
Primers	 flanking	G4	ChIP	peak	observed	upstream	of	 the	RPA3	gene	and	a	G4	 free	region	
upstream	of	the	TMCC1	gene	were	used	for	amplification.	The	recovery	fractions	(referred	
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to	 as	 %	 input)	 were	 calculated	 by	 normalising	 the	 amplification	 results	 (i.e.	 the	
quantification	 cycle	 value,	 Cq)	 of	 immunoprecipitated	 DNA	 to	 those	 of	 input	 DNA.	 In	
addition,	 fold	enrichment	of	RPA3	 signal	over	TMCC1	 signal	was	determined	 to	assess	G4	
ChIP	signal-to-noise	 ratio.	ChIP-qPCR	results	 showed	that	 recovery	 fractions	at	RPA3	were	
more	than	5%	and	at	TMCC1	 less	 than	0.5%	for	all	biological	 replicates	 (Figure	2.4A).	BG4	
immunoprecipitated	DNA	was	enriched	20-fold	more	at	RPA3	than	at	the	negative	control	
TMCC1	 (Figure	 2.4B).	 The	 G4	 ChIP	 is	 considered	 to	 be	 of	 acceptable	 quality	 when	 RPA3	
yields	 DNA-input	 recovery	 ≥	 5%	 and	 the	 relative	 fold	 enrichment	 is	 over	 5-fold	 (Hänsel-
Hertsch	 et	 al.,	 2018).	 Thus,	 ChIP-qPCR	 results	 suggested	 sufficient	 quality	 for	 subsequent	
sequencing.	
	
Figure 2.4: G4 ChIP-qPCR for selected G4 ChIP peaks in K562 cells. 
(A) The recovery ratio of regions of interest determined by ChIP-qPCR. RPA3 region or TMCC1 region was used 
as a positive control or a negative control respectively. The ratio is normalised by input genomic DNA. (B) G4 














Figure 2.5: Biological replicates of G4 ChIP-seq are highly reproducible. 
Scatter plots (read counts per million in log2 scale) showing the correlation of G4 ChIP-seq reads between 






Figure 2.6: G4 ChIP peaks in K562 cells predominantly overlap with motifs that can form G4s in vitro. 
(A) Venn diagram indicate positional overlap of G4 ChIP peaks and motifs that form G4s in vitro (G4-seq). 
(B) Genome browser view of example genes in K562 cells. Tracks from top to bottom are G4 ChIP-seq (yellow), 
input (red) and consensus G4 ChIP peaks (yellow) for K562 cells, and in vitro forming G4s (G4-seq) (blue) on the 
forward (+ss) and reverse (-ss) strand. G4 ChIP-seq peaks are masked in red. 
As	highlighted	by	G4-seq,	canonical	G4	structures,	defined	as	G≥3N1-7G≥3N1-7G≥3N1-7G≥3,	are	not	
the	 only	 G4s	 that	 can	 fold	 in	 vitro	 (Chambers	 et	 al.,	 2015).	 Non-canonical	 G4s	 including	
those	 with	 long	 loops	 and	 single	 nucleotide	 bulges	 were	 also	 observed	 as	 folded	 in	 the	
human	 genome.	 Furthermore,	 both	 canonical	 and	 non-canonical	 G4	 structures	 were	
identified	 by	 G4	 ChIP-seq	 in	 HaCaT	 cells	 (Hänsel-Hertsch	 et	 al.,	 2016).	 Motif	 analysis	 of	
consensus	 G4	 peaks	 from	 K562	 cells	 showed	 that	 only	 25%	 of	 sites	 identified	 by	 BG4	
comprised	a	canonical	G4	motif	(Figure	2.7A).	A	large	number	of	G4	peaks	consisted	of	non-
canonical	G4	motifs	comprising	long	loops	(18.1%),	bulges	(16.6%)	and	2-tetrad	(25.3%)	G4	
structures.	 The	 remaining	 peaks	 (in	 the	 ‘other’	 category)	 may	 be	 structures	 containing	
multinucleotide	 bulges	 or	 topologies	 comprising	 both	 long	 loops	 and	 bulges,	 which	 are	
difficult	to	account	for	computationally.	
	
To	 test	 if	 the	occurrence	of	 these	motifs	 in	G4	ChIP	peaks	 is	 statistically	 significant	when	
compared	 to	 random	 chance,	 peaks	were	 randomly	 shuffled	 across	 the	 genome	 and	 the	
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ratio	 of	 G4	 motifs	 in	 consensus	 G4	 peaks	 to	 randomly	 shuffled	 peaks	 was	 calculated	
(referred	to	as	fold	enrichment).	For	all	canonical	and	non-canonical	G4	motifs,	except	two-
tetrad	G4s,	 this	 ratio	was	 found	 to	 be	 greater	 than	 one	 (Figure	 2.7B),	 indicating	 that	 the	
likelihood	of	detecting	these	motifs	occurring	within	the	G4	ChIP-seq	peaks	is	unlikely	to	be	




abundant	 within	 the	 genome	 and	 therefore	 were	 found	 not	 to	 be	 significantly	 enriched	
within	the	consensus	G4	peaks.	
 
Figure 2.7: Motif analysis of consensus G4 peaks identified using ChIP-seq in K562 cells. 
(A) Proportion of each structural class of G4 motif as shown in pie chart. Loop size 1-3, 4-5 and 6-7 represent 
G4s have at least one loop of indicated length. Long loop comprises G4 with loops longer than 7nt, whereas 
simple bulge represents G4 structure containing a 1-7 base bulge within one of its G-stretch. 2-tetrads/complex 
bulge comprise G4 structures with only 2 G-tetrads stacked together or containing more than one bulges, and 
other indicates G4 structures that do not fall into any of the former categories. (B) Fold enrichment over 














Figure 2.8: G4s in K562 cells are enriched within functional genomic regions. 
Fold enrichment of consensus G4 peaks compared to randomly shuffled G4 peaks in regions that have the 
potential to form G4s in vitro (G4-seq) and the proportion of G4 peaks within different genomic features. TSS, 




al.,	2016),	 I	next	established	a	map	of	chromatin	accessibility	 for	K562	cells	 to	enable	 the	
comparison	 with	 G4s.	 I	 performed	 the	 assay	 for	 transposase-accessible	 chromatin	 using	
sequencing	(ATAC-seq)	to	study	the	chromatin	accessibility	in	K562	chromatin.	The	original	
protocol	 employs	 hyperactive	 transposase	 Tn5	 to	 directly	 digest	 cell	 lysates	 and	 captures	
the	accessible	chromatin	regions	for	sequencing	(Buenrostro	et	al.,	2013,	2015).	However,	




contamination,	with	only	18%	of	reads	mapped	to	mtDNA.	 It	 is	 reasoned	that	by	avoiding	
detergent	lysis,	mitochondrial	membranes	stay	intact	while	the	nuclear	membrane	remains	




corresponding	 fragment	 size	 distributions	 from	 two	 different	 ATAC-seq	 protocols.	 The	
original	protocol	 (left	panel)	did	not	show	a	clear	distribution	of	mono-nucleosomal	or	di-
nucleosomal	DNA,	whereas	the	modified	ATAC-seq	(right	panel)	showed	clear	nucleosomal	
fragment	 distribution	 as	 previously	 observed	 (Yan	 et	 al.,	 2020),	 suggesting	 higher	 quality	




Figure 2.9: Fragment size distribution of two different ATAC-seq protocols in K562 cells. 
Fragment size distribution for two different protocols, original and modified ATAC-seq in K562 cells. The 
nucleosomal structure patterns are as indicated (see ref. Yan et al., 2020).	




over	 nuclear	 chromosomes,	 more	 than	 40,000	 consensus	 peaks	 were	 identified	 as	
accessible	 chromatin	 regions	 in	 K562	 cells,	 whereas	 ~23,000	 peaks	 were	 reported	 in	
previously	 published	 data	 (Liu	 et	 al.,	 2017)	 (Figure	 2.11A).	 The	majority	 of	 the	 published	
ATAC-seq	 peaks	 (19,800/23,028,	 86%;	 GEO	 accession	 no.	 GSE99173)	 were	 identified	 by	
ATAC-seq	 I	 performed	 in	 K562	 cells.	 Furthermore,	 regions	 immediately	 upstream	 of	 TSS	
demonstrated	 increased	chromatin	accessibility	as	exemplified	 in	genome	browser	view	in	
Figure	 2.11B.	 I	 then	 investigated	 the	 relationship	 between	 endogenous	 G4s	 in	 K562	
chromatin	as	defined	by	G4	ChIP-seq	with	sites	of	open	chromatin	as	defined	by	ATAC-seq.	
Consensus	G4	peaks	were	 found	 to	be	predominantly	 located	at	 sites	of	open	chromatin,	
with	the	majority	of	G4	peaks	(88.2%)	overlapping	a	subset	of	ATAC-seq	peaks	in	K562	cells	





Figure 2.10: Three biological replicates of ATAC-seq in K562 cells are highly reproducible. 
Scatter plots (read counts per million in log2 scale) showing the correlation of genome-wide ATAC-seq signal 
between biological replicates in K562 cells. Pearson’s correlation coefficient (r) is shown in each diagram. 
 
Figure 2.11: ATAC-seq data compare well with published data. 
(A) Venn diagram showing the overlap of open chromatin regions (i.e. peaks) identified by ATAC-seq in K562 
cells by this study and previously published ATAC-seq data (GSE99173). (B) Example of genome browser view 
of open chromatin sites in K562 cells. Tracks from top to bottom are three biological replicates of ATAC seq 




Figure 2.12: G4 ChIP peaks in K562 cells are predominantly located in open chromatin regions. 
(A) Overlap between G4 ChIP peaks and ATAC-seq peaks. (B) Example genome browser view of G4 ChIP-seq and 
ATAC seq in K562 cells showing co-localisation (red-masked) of NDRs and G4s in the upstream region of genes. 
Tracks from top to bottom are three biological replicates of ATAC-seq (green), consensus ATAC peaks (green), 
three biological replicates of G4 ChIP-seq (yellow), input for G4 ChIP-seq (red) and consensus G4 ChIP peaks 
(yellow) in K562 cells. Genomic coordinates indicate track range. 
2.3.3 G4	structures	mark	promoters	with	increased	RNA	polymerase	II	occupancy	
and	enhanced	transcription	
Since	 consensus	G4s	 in	 K562	 chromatin	 are	 predominantly	 enriched	 in	 promoters	 (Figure	
2.8),	I	further	examined	the	relationship	between	promoter	G4s	and	transcriptioal	activity.	
First,	 I	 used	 the	 published	 RNA-seq	 dataset	 to	 look	 at	 steady-state	 transcript	 levels	 (GEO	
accession	no.	GSE88473;	Dunham	et	al.,	2012).	Genes	marked	by	a	promoter	G4	peak	were	
found	to	show	significantly	higher	expression	(log2TPM	at	non-G4-marked	promoter	=	2.2,	
log2TPM	 at	 G4-marked	 promoter	 =	 3.8;	 p	 <	 2.2	 x	 10-16)	 as	 measured	 by	 RNA-seq	 when	
compared	to	those	lacking	a	G4	peak	but	containing	a	promoter	G4	motif	that	forms	in	vitro	
(G4-seq;	Figure	2.13).	These	findings	are	 in	agreement	with	previous	studies	within	HaCaT	
cells	 and	 primary	 keratinocytes	 where	 promoter	 marked	 by	 G4s	 shows	 higher	
transcriptional	levels	(Hänsel-Hertsch	et	al.,	2016).	
 
In	 the	 eukaryotic	 genome,	 RNA	 Pol	 II	 is	 recruited	 to	 the	 promoters	 of	 coding	 genes	 and	
higher	 levels	 of	 RNA	 Pol	 II	 occupancy	 at	 the	 TSS	 are	 associated	 with	 increased	 gene	
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expression	 (Cho	et	 al.,	 2016;	Quinodoz	 et	 al.,	 2014).	 Since	 the	presence	of	 promoter	G4s	
positively	 correlate	 with	 enhanced	 gene	 expression,	 I	 reasoned	 that	 this	 would	 also	 be	
reflected	 in	 elevated	 RNA	 Pol	 II	 occupancy.	 To	 test	 this,	 ChIP-seq	 for	 RNA	 Pol	 II	 was	
performed	 on	 five	 independent	 biological	 replicates	 of	 K562	 cells.	 The	 data	 obtained	
showed	 high	 reproducibility	 as	 seen	 by	 the	 Pearson’s	 correlation	 coefficient	 r	 >	 0.97	







remainder	 of	 the	 study	 will	 mainly	 focus	 on	 promoter	 G4s	 (TSS	 ±	 500	 bp)	 of	 actively	
transcribed	genes	as	defined	by	their	RNA	Pol	II	occupancy. 
 
Figure 2.13: Endogenous G4 formation is correlated with elevated gene expression in K562 cells. 
Box plot for the distribution of gene expression levels (displayed in transcripts per million (TPM), log2 scale) at 
promoters that feature an ATAC-seq peak and a G4 motif that form G4 in vitro (G4-seq) in comparison to 
promoters that have a G4 ChIP-seq peak, ATAC-seq peak and G4 motif that form G4 in vitro (G4-seq) in K562 





Figure 2.14: Five biological replicates of RNA Pol II ChIP-seq show high reproducibility. 
Scatter plots (read counts per million in log2 scale) showing the correlation of genome-wide RNA Pol II ChIP-seq 




Figure 2.15: Endogenous promoter G4 formation correlates with elevated RNA Pol II occupancy in K562 
cells. 
Box plot of RNA Pol II ChIP-seq signal (displayed in read counts per million (CPM), log2 scale) at promoters in 
accessible chromatin (ATAC +) with or without an endogenous G4 (G4 ChIP + and G4 ChIP -) but having 
sequence motifs that can fold into G4 structures in vitro (G4-seq) in K562 cells. Wilcoxon test: p < 2.2 x 10-16. 
2.3.4 5,6-Dichlorobenzimidazole	1-β-D-ribofuranoside	 (DRB)	 inhibits	 transcription	
elongation	in	K562	cells	
Having	 established	 that	 the	 formation	 of	 endogenous	 G4	 structures	 is	 correlated	 with	
elevated	RNA	Pol	II	occupancy	and	increased	expression	in	K562	cells,	the	next	aim	was	to	
evaluate	whether	active	transcription	is	required	for	the	formation	of	promoter	G4s.	To	test	
this,	 I	 asked	 whether	 inhibition	 of	 transcription	 by	 RNA	 Pol	 II	 leads	 to	 loss	 of	 G4s.	 As	
described	in	Chapter	1,	RNA	Pol	II	mediated	transcription	is	an	intricately	regulated	process	
which	comprises	initiation,	pausing,	elongation	and	termination	phases	(Chen	et	al.,	2018a;	
Harlen	 and	 Churchman,	 2017).	 Since	 G4s	 are	 highly	 enriched	 at	 promoters	 where	















elongation	 (Egloff	 et	 al.,	 2012;	 Eick	 and	Geyer,	 2013),	 the	 reduction	 of	 Pol	 II	 Ser2-P	 thus	
signifies	 the	 successful	 inhibition	 of	 transcription	 elongation.	Meanwhile,	 total	 RNA	 Pol	 II	
protein	 levels	 did	 not	 show	 significant	 changes,	 suggesting	 that	 transcription	 elongation	
inhibition	by	DRB	did	not	affect	overall	RNA	Pol	II	levels.	
 
Figure 2.16: 5,6-Dichlorobenzimidazole 1-ß-D-ribofuranoside (DRB) inhibits transcription elongation. 
Western blotting with antibodies against phosphorylated RNA Pol II Ser2 (Pol II Ser2-P), total RNA Pol II and ß-
actin in whole cell lysates from K562 cells treated with or without 100 µM DRB for 1 h. ß-actin provides a 




I	 then	 performed	 G4	 ChIP-seq	 after	 DRB-mediated	 transcription	 elongation	 inhibition	 to	
assess	 any	 effects	 on	 G4	 formation.	 G4	 ChIP-seq	 was	 performed	 on	 four	 independent	
biological	 replicates	 treated	with	100	µM	of	DRB	 in	DMSO	 for	1	h	or	with	DMSO	control.	
This	 identified	7,154	genome-wide	consensus	G4	peaks	 (i.e.	G4	ChIP-seq	peaks	present	 in	
more	than	two	biological	replicates.)	in	DMSO-treated	K562	cells	(Figure	2.17).	These	peaks	
showed	 similar	 genomic	 distribution	 to	 consensus	 G4	 peaks	 described	 in	 section	 2.3.2	







Figure 2.17: Overlap of G4 ChIP peaks between DRB-treated and DMSO-treated K562 cells. 
Venn diagram showing overlap of consensus G4 ChIP-seq peaks in DMSO-treated and DRB-treated (100 µM, 
1hour) K562 cells. 
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The	 signal	 differences	 in	G4	ChIP-seq	between	DRB-treated	 and	DMSO-treated	 cells	were	
next	 statistically	 assessed.	 Only	 regions	 that	 showed	 2-fold	 or	 more	 signal	 compared	 to	
input	 (i.e.	with	 significant	G4	ChIP	signal	enrichment)	were	selected	as	 regions	of	 interest	
(ROI).	 I	 first	 assessed	 the	 change	 of	 genome-wide	 G4	 ChIP-seq	 signals.	Within	 the	 5,551	
genome-wide	G4	sites	investigated,	the	majority	of	G4	sites	(>95%)	did	not	show	statistically	
significant	 changes	 (p	<	0.01)	 in	 the	G4	ChIP	 signal	 (Figure	2.18A).	Only	227	promoter	G4	
sites	exhibited	 significantly	decreased	 signal	 (p	<	0.01)	 in	 response	 to	DRB	 inhibition,	 and	
these	regions	were	not	considered	for	 further	analysis.	 I	 then	further	 focused	the	analysis	
on	 G4s	 within	 gene	 promoters	 (4,023	 sites).	 In	 a	 manner	 similar	 to	 genome-wide	 G4	




Figure 2.18: Majority of the sites show unchanged G4 ChIP-seq signal after DRB treatment. 
(A) Bland Altman (MA) plot showing the fold change in G4 ChIP-seq signal at genome-wide regions of interest 
(ROI) between DRB-treated versus DMSO-treated K562 cells. G4 peaks showing statistically significantly (p < 
0.01) increase and decrease in G4 ChIP-seq signals are highlighted in red and blue respectively; black dots 
indicate regions that do not change. CPM, read counts per million. (B) MA plot similar to panel A illustrating the 
fold change in G4 ChIP-seq signal at promoter G4s (TSS ± 500 bp; p < 0.01). 
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To	 assess	 G4	 formation	 with	 an	 alternative	 methodology,	 BG4	 immunofluorescence	 (IF)	
staining	(Biffi	et	al.,	2013b)	was	performed	in	parallel	with	G4	ChIP-seq	(Figure	2.19).	As	a	
suspension	cell	line,	K562	are	not	suited	to	IF	staining.	I	therefore	used	U2OS	cells,	human	
bone	osteosarcoma	epithelial	 cells	 that	 have	been	widely	 used	 in	 BG4	 IF	 staining.	 BG4	 IF	
employs	a	three-layer	signal	amplification	system,	where	BG4	signal	in	fixed	permeabilised	








cell	nuclei	 in	each	condition	 (Figure	2.19B).	Similar	 to	 the	number	of	BG4	 foci	 reported	 in	
previous	 study	 (Biffi	 et	 al.,	 2013b),	 an	 average	 of	 40	 BG4	 foci	 were	 identified	 in	 both	








Figure 2.19: BG4 immunofluorescence signal is not altered following DRB treatment. 
U2OS cells were paraformaldehyde fixed, RNase A treated and stained with BG4 antibody. Confocal images 
were captured using a Leica SP5 microscope. (A) BG4 staining (red) in the nuclei stained by DAPI (blue) of DRB-
treated or DMSO-treated U2OS cells. (B) Graph quantifying the number of BG4 foci identified in individual cells. 
(C) Graph showing the average BG4 signal intensity in individual cells (a.u. = arbitrary unit). In panel B and C, 
each dot represents a single cellular nucleus. 150-200 nuclei were counted per condition and the Mann-






tested	whether	 the	 inhibition	of	 transcription	 initiation	would	 impact	 the	 formation	of	G4	
structures	at	promoters.	For	this,	triptolide	(TPL)	was	used	to	inhibit	transcription	initiation	
(Titov	 et	 al.,	 2011).	 During	 transcription	 initiation,	 the	 ATP-dependent	 activity	 of	 XPB	 is	
required	to	unwind	the	DNA	double	helix	to	allow	RNA	Pol	II	engage	into	active	transcription.	
TPL	 covalently	 binds	 to	 XPB	 and	 inhibits	 its	 ATPase	 activity,	 preventing	 transcription	
initiation	and	ultimately	inducing	the	degradation	of	RNA	Pol	II	(Wang	et	al.,	2011).		
		











band	 was	 normalised	 by	 loading	 control	 ß-actin	 (Figure	 2.20B).	 The	 normalised	 protein	





Ser5-P	 and	 RNA	 Pol	 II	 Ser2-P	 was	 detected,	 signifying	 that	 the	 majority	 of	 transcription	





Figure 2.20: Triptolide (TPL) inhibits transcription initiation by RNA Pol II. 
(A) Western blotting with antibodies against phosphorylated Pol II Ser2 (Pol II Ser2-P), phosphorylated Pol II 
Ser5 (Pol II Ser5-P), total Pol II and ß-actin in whole cell lysates from untreated K562 cells and TPL treated cells. 
ß-actin served as a loading control. Protein standards were used as molecular weight markers to determine 
protein size. (B) Quantification of protein levels detected in (A). The result was normalised by expression level of 




I	 next	 explored	 how	 the	 endogenous	 G4	 landscape,	 especially	 within	 gene	 promoters,	 is	
affected	by	the	inhibition	of	transcription	initiation.	For	this,	 I	treated	cells	for	2	h	with	10	
µM	 TPL	 to	 achieve	 maximal	 transcriptional	 inhibition.	 G4	 ChIP-seq	 from	 more	 than	 two	
independent	biological	 replicates	 identified	6,173	and	10,631	consensus	G4	peaks	 (i.e.	G4	
ChIP-seq	 peaks	 present	 in	 at	 least	 two	 biological	 replicates)	 in	 DMSO-treated	 and	 TPL-
treated	 K562	 cells	 respectively	 (Figure	 2.21).	 The	 majority	 of	 the	 consensus	 G4	 peaks	
(5,972/6,173;	96.7%)	identified	in	DMSO-treated	cells	were	also	found	in	TPL-treated	K562	
cells.	Although	an	 increase	of	 consensus	peak	number	was	observed	after	TPL	 treatment,	




Figure 2.21: Overlap of G4 ChIP peaks between TPL-treated and DMSO-treated K562 cells. 
Venn diagram showing positional overlap of consensus G4 ChIP-seq peaks in DMSO-treated and TPL-treated (10 
µM, 2 hours) K562 cells. The majority of G4 peaks in DMSO-treated cells are found in TPL-treated cells. 
The	G4	ChIP	signals	from	DMSO-	and	TPL-treated	cells	were	quantified	and	compared.	Using	






Specifically,	 focusing	 the	 analysis	 on	 promoter	 G4s	 suggested	 a	 very	 similar	 trend	 to	
genome-wide	 G4s.	 While	 no	 reduction	 in	 G4	 ChIP	 signal	 was	 observed	 following	 TPL	
treatment,	 ~10%	 of	 promoter	 G4s	 showed	 significantly	 increased	 G4	 formation	 after	 the	
inhibition	of	transcription	initiation	with	TPL	(p	<	0.01;	499/4,268,	10.5%	up;	Figure	2.22B).	
Since	TPL	inhibits	the	ATPase	activity	of	Pol	II-associated	DNA	helicases	XPB	and	XPD,	which	
function	 to	 resolve	 DNA	 G4s	 (Gray	 et	 al.,	 2014;	 Titov	 et	 al.,	 2011),	 my	 observation	 of	
increased	promoter	G4	formation	following	TPL	treatment	is	likely	to	arise	from	the	absence	





Figure 2.22: TPL treatment does not lead to decreases in G4 ChIP-seq signals. 
(A) MA plot showing the fold change in G4 ChIP-seq signal at genomewide regions of interest (ROI) between 
TPL-treated versus DMSO-treated K562 cells. G4 peaks showing statistically significantly (p < 0.01) increase and 
decrease in G4 ChIP-seq signals are highlighted in red and blue respectively; black dots indicate regions that do 
not change. CPM, read counts per million. (B) MA plot similar to panel A illustrating the fold change in G4 ChIP-
seq signal at promoter G4s (TSS ± 500 bp; p < 0.01). 




higher	 BG4	 signal	 intensity	 compared	 to	DMSO-treated	 nuclei	 (DMSO:	 28	 versus	 TPL:	 39;	
Figure	2.23C).	This	may	be	because	BG4	IF	lacks	the	spatial	resolution	to	identify	additional	
G4s	as	 separate	 foci.	 Importantly,	BG4	 IF	did	not	 show	any	decrease	 in	number	of	 foci	or	






Figure 2.23: BG4 IF staining did not detect changes after TPL treatment. 
U2OS cells were paraformaldehyde fixed, RNase A treated and stained with BG4 antibody. Confocal images 
were captured using a Leica SP5 microscope. (A) BG4 staining (red) in the nuclei stained by DAPI (blue) of TPL-
treated or DMSO-treated U2OS cells. (B) Graph quantifying the number of BG4 foci identified in individual cells. 
(C) Graph showing the average BG4 signal intensity in individual cells (a.u. = arbitrary unit). ****: p < 0.0001. In 
panel B and C, each dot represents a single cellular nucleus. 150-200 nuclei were counted per condition and 




It	 is	 established	 that	 G-rich	 sequences	 have	 the	 potential	 to	 fold	 into	 G-quadruplex	
structures	 in	 the	 human	 genome,	 which	 are	 enriched	 in	 functional	 regions	 such	 as	 gene	
promoters	and	5’-UTRs	(Chambers	et	al.,	2015;	Huppert	and	Balasubramanian,	2005,	2007;	
Kudlicki,	 2016;	 Varizhuk	 et	 al.,	 2017).	 Endogenous	 G4	 structures	 predominantly	 locate	 in	
















In	 K562	 cells,	 the	majority	 of	 consensus	 G4s	 identified	with	 G4	 ChIP-seq	were	 located	 in	
NDRs	 and	were	 found	 highly	 enriched	within	 gene	 promoters	 (defined	 as	 TSS	 ±	 500	 bp).	
These	 promoter	 G4s	 marked	 genes	 with	 significantly	 higher	 transcriptional	 output	 than	
promoters	 lacking	 a	 G4	 structure.	 These	 results	 extend	 our	 original	 observations	 from	
HaCaT	 cells	 and	 primary	 keratinocytes	 (Hänsel-Hertsch	 et	 al.,	 2016),	 and	 establish	 the	
general	 principle	 that	 endogenous	 G4s	 are	 primarily	 found	 within	 open	 chromatin	 at	
promoters.	 Beyond	 that,	 G4-containing	 promoters	 also	 displayed	 greater	 RNA	 Pol	 II	












show	a	statistically	 significant	decrease	 (p	<	0.01)	 in	 the	G4	ChIP	signal	upon	 inhibition	of	
transcription	elongation	by	DRB	or	upon	inhibition	of	transcription	initiation	by	TPL.	Notably,	
both	 genome-wide	 G4s	 and	 promoter	 G4s	 showed	 a	 similar	 response	 to	 transcriptional	







Moreover,	 transcription	 inhibition	 by	 TPL	 partially	 led	 to	 increased	 G4	 formation	 at	
promoters.	TPL	functions	by	inhibiting	Pol	II	associated	helicases	XPB/XPD	(Titov	et	al.,	2011).	
XPD	have	been	shown	 to	 resolve	G4	 structures	 in	 vitro	 and	are	 found	associated	with	G4	
sites	 in	 chromatin	 (Gray	 et	 al.,	 2014;	Hänsel-Hertsch	 et	 al.,	 2016).	 The	 inhibition	of	 these	
helicases	 would	 therefore	 be	 expected	 to	 result	 in	 diminished	 resolution	 of	 secondary	
structures	at	promoters,	including	G4s,	and	explains	the	increase	in	G4	signal	observed	upon	
TPL	treatment.	Recently,	Roychoudhury	et	al.	mapped	G4s	in	human	adenocarcinoma	cells	








I	 further	 performed	 experiments	 supporting	 the	 findings	 of	 G4	 ChIP-seq	 using	 BG4	 IF	
staining.	 This	 method	 has	 been	 previously	 used	 to	 detect	 differences	 in	 G4	 formation	
following	treatment	with	G4	stabilising	ligands	or	in	cancer	versus	non-cancerous	cells	(Biffi	
et	al.,	2013b,	2014).	Unlike	G4	ChIP-seq	that	is	able	to	detect	G4	formation	at	specific	sites,	
BG4	 IF	 staining	 only	 provides	 a	 partial	 view	 of	 G4	 foci	 that	 are	 detectable	 by	 IF.	 No	
significant	decrease	in	BG4	signal	was	observed	following	transcriptional	inhibition,	which	is	
consistent	 with	 results	 seen	 by	 G4	 ChIP-seq.	 BG4	 IF	 detects	 an	 average	 of	 40	 foci	 per	
nucleus,	whereas	G4	 ChIP	 suggests	 the	 formation	 of	 thousands	 of	G4s	within	 the	 human	
genome.	It	is	therefore	plausible	that	each	BG4	focus	represents	a	cluster	of	closely-located	
endogenous	G4s.	Even	though	G4	IF	has	previously	been	used	to	detect	large	differences	in	
G4	 formation,	 for	example	upon	 treatment	with	G4	stabilising	 ligands	 (Biffi	et	al.,	2013b),	
the	ability	of	BG4	IF	staining	in	detecting	small	changes	in	G4	population	may	be	limited.	It	is	
interesting	that	TPL	treatment	elicits	as	an	increase	of	BG4	signal	intensity,	which	confirms	







activity	 and	RNA	Pol	 II	 occupancy,	 and	 that	 the	 folding	of	 promoter	G4s	 is	 not	 reliant	 on	
transcriptional	 activity.	 These	 findings	 contest	 earlier	 suggestions	 that	 the	 formation	 of	
promoter	 G4s	 is	 promoted	 by	 the	 generation	 of	 single	 stranded	 DNA	 during	 active	
transcription	 (Kouzine	et	 al.,	 2004).	Meanwhile,	 the	 findings	 in	 this	 chapter	 also	 raise	 the	
question	of	what	drives	G4	formation	in	cells.	A	previous	study	has	suggested	a	correlation	
between	 chromatin	 accessibility	 and	 G4	 formation	 (Hänsel-Hertsch	 et	 al.,	 2016).	 In	 that	
study,	treatment	of	cells	with	inhibitors	of	histone	acetylation	caused	some	de-compaction	







The	 interplay	 between	 promoter	 G4s	 and	 chromatin	
structure	
3.1 Background	
Transcription	 is	 a	 strictly	 modulated	 cellular	 process,	 which	 is	 tightly	 linked	 with	 the	
dynamic	 regulation	 of	 chromatin	 remodelers,	 modification	 of	 histone	 tails,	 binding	 of	
transcription	factors	and	activity	of	RNA	polymerases	(see	section	1.5).	While	G4	structures	
are	 suggested	 to	 be	 involved	 in	 active	 transcription,	 growing	 evidence	 also	 indicates	 the	
interplay	 between	 G4s	 and	 chromatin	 structures.	 Early	 evidence	 from	 computational	
approaches	 predicted	 that	 regulatory	 G4s,	 such	 as	 those	 within	 promoters,	 are	 located	
outside	of	nucleosome-bound	regions	within	the	human	genome	(Wong	and	Huppert,	2009).	
In	 agreement	with	 this,	most	 endogenous	G4s	 identified	by	G4	ChIP-seq	overlapped	with	
accessible	 open	 chromatin	 regions	 (Hänsel-Hertsch	 et	 al.,	 2016).	Moreover,	 genome-wide	








to	 G4	 ligands,	 including	 CX-3543	 and	 PhenDC3	 (Wang	 et	 al.,	 2019;	 Zyner	 et	 al.,	 2019).	
Moreover,	 the	 non-histone	 chromatin	 architectural	 protein	 HMGB1	 has	 also	 been	
demonstrated	to	bind	and	stabilise	the	KRAS	promoter	G4	(Amato	et	al.,	2018).	Depletion	of	
chromatin	 remodelers,	 such	 as	 SMARCA4,	 SMARCB1	 and	 SMARCE1,	 was	 also	 found	 to	
sensitise	cells	to	killing	with	G4	stabilising	ligands,	suggesting	a	functional	interplay	between	
chromatin	 architecture	 and	 G4s	 (Zyner	 et	 al.,	 2019).	 Further	 evidence	 also	 suggests	 an	
association	 between	 G4s	 and	 histone	 modifications.	 For	 instance,	 histone-lysine	
methyltransferase	KMT5C,	which	methylates	lysine	20	of	H4	(H4K20)	and	causes	chromatin	
condensation,	 has	 been	 reported	 to	 form	 a	 ternary	 complex	with	 TERRA	 binding	 protein	
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In	 addition	 to	 these	 interactions,	 G4s	 have	 also	 been	 implicated	 in	 facilitating	 three-
dimensional	 chromatin	 organisation.	 Topologically	 associated	 domains	 (TADs)	 play	
fundamental	 roles	 in	 regulating	 high-order	 chromatin	 structures	 (Ke	 et	 al.,	 2017).	 The	
precise	formation	of	TAD	boundaries,	which	is	critical	for	gene	regulation,	is	modulated	by	
the	binding	of	CCCTC-binding	factor	(CTCF)	and	cohesion	proteins	(Hong	and	Kim,	2017;	Rao	
et	 al.,	 2014).	 Genomic	 G4	 motifs,	 which	 conform	 to	 the	 canonical	 G4	 sequence,	 were	
computationally	 determined	 to	 be	 located	 downstream	 of	 forward	 CTCF	 motifs	 and	
upstream	of	reverse	CTCF	motifs,	whereas	cohesion	protein	binding	sites	were	found	to	be	
located	in	close	proximity	to	G4s	(Hou	et	al.,	2019).	This	indicates	a	potential	role	of	G4s	in	
loop	 extrusion	 and	 preventing	 cohesin	 flow-through.	 Furthermore,	 it	 has	 also	 been	
suggested	 that	 two	half	G-quadruplexes	 (i.e.	 sequences	comprising	 two	 runs	of	Gs)	 found	




ChIP-seq	 is	 not	 promoted	 by	 active	 transcription,	 which	 raises	 the	 question	 as	 to	 what	
determines	 where	 G4s,	 specifically	 promoter	 G4s,	 form	 within	 cells.	 As	 determined	 in	
Chapter	2,	G4s	primarily	form	within	accessible	chromatin.	It	has	also	been	shown	that	cells	
treated	with	entinostat,	a	small	molecule	that	induces	the	acetylation	of	histone	and	cause	
de-compaction	of	 chromatin,	 displayed	elevated	 transcriptional	 output	 identified	by	RNA-
seq	and	some	increases	in	G4s	identified	by	G4	ChIP-seq	(Hänsel-Hertsch	et	al.,	2016).	This	
suggests	 that	 formation	of	G4s	 is	correlated	with	 increased	chromatin	accessibility	and/or	
transcriptional	 activity.	 Since	 I	 have	 shown	 that	 promoter	G4	 formation	 does	 not	 require	
transcriptional	activity,	I	therefore	hypothesise	that	permissive	chromatin	is	a	determinant	
of	 promoter	 G4	 formation.	 To	 test	 this,	 I	 will	 ask	 in	 this	 chapter	 whether	 chromatin	
compaction	has	any	impact	on	the	cellular	G4	landscape.	
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Histone	acetylation	 is	 critical	 for	modulating	chromatin	 structure,	and	 is	 regulated	by	 two	
opposing	 classes	 of	 histone	 modifying	 enzymes,	 histone	 acetyltransferases	 (HATs)	 and	
histone	 deacetylases	 (HDACs)	 (Bannister	 and	 Kouzarides,	 2011;	 Wang	 et	 al.,	 2009)	 (see	
section	 1.5.1).	 Acetylation	 of	 nucleosomal	 histones	 can	 directly	 or	 indirectly	 result	 in	
alteration	 of	 chromatin	 structure	 (Davie	 and	 Moniwa,	 2000).	 Ectopic	 overexpression	 of	
HDACs	 or	 inhibition	 of	 HAT	 activity	 can	 lead	 to	 reduced	 histone	 acetylation	 to	 impact	
chromatin	 condensation.	 Several	 studies	 have	 shown	 that	 cellular	 response	 to	
environmental	 stress	 stimuli	 can	 also	 trigger	 chromatin	 compaction.	 In	 particular,	 the	
cellular	response	to	acute	oxygen	depletion	is	well-documented	for	inducing	genome-wide	
reduction	 in	 chromatin	 accessibility	 (Batie	 et	 al.,	 2018).	 For	 example,	 acute	 hypoxia	 is	




increased	 expression	 of	 the	 heterochromatin	 protein	 HP1BP3	 (Dutta	 et	 al.,	 2014).	 In	
addition,	the	study	also	found	that	hypoxic	cells	have	reduced	sensitivity	to	mononuclease	
digestion,	 suggesting	 chromatin	 compaction.	 Therefore,	 in	 this	 chapter,	 I	 investigate	




Figure 3.1: Exploring the interplay between promoter G4s and chromatin structure. 
Graphical representation of experimental design examining the response of cellular G4s to reduced chromatin 
accessibility. Chromatin compaction is induced by HAT inhibition or hypoxia and the change of G4s is 








the	 folding	 of	 promoter	 G4s	 in	 K562	 cells	 following	 chromatin	 compaction.	 The	 third	
objective	is	to	analyse	the	influence	of	reduced	chromatin	accessibility	under	conditions	of	





HAT	 inhibition	 causes	 reduced	 acetylation	 of	 histones,	 and	 consequently	 promotes	
chromatin	condensation	(Gregory	et	al.,	2001).	It	has	been	suggested	that	many	commonly	
used	HAT	inhibitors	are	thiol-reactive	and/or	protein	aggregators	(Dahlin	et	al.,	2017),	which	
may	 lead	 to	non-specific	downstream	effects	 in	cells.	This	emphasises	 the	need	 to	 refrain	
from	longer	treatment	times	 in	order	to	 limit	off-target	or	downstream	impact	on	cellular	
G4	landscape.	To	investigate	maximal	reduction	in	histone	acetylation	within	a	short	time,	I	
first	 treated	 K562	 cells	 for	 short	 durations	 with	 commercially	 available	 HAT	 inhibitors.	 I	
tested	 compounds	 that	 target	 different	 HATs,	 including	 anacardic	 acid,	 curcumin	 and	
garcinol	that	are	p300/CBP-associated	HAT	inhibitors	(Balasubramanyam	et	al.,	2003,	2004;	
Marcu	et	al.,	2006),	as	well	as	CPTH2	and	CPTH6	which	are	GCN5	inhibitors	(Chimenti	et	al.,	
2009;	Trisciuoglio	et	al.,	2012).	 I	 first	 tested	 their	 impact	on	pan-histone	acetylation	using	
Western	blotting	with	antibodies	specific	for	acetylated	forms	of	histone	H3	and	histone	H4	
(Figure	 3.2).	 However,	 following	 treatments	 for	 2	 or	 4	 h,	 only	 marginal	 changes	 were	
observed	for	H3	and	H4	acetylation.	Importantly,	4	h	treatment	of	K562	cells	with	100	µM	
garcinol	led	to	severe	cell	death,	whereby	enough	lysate	could	not	be	obtained	for	Western	




Figure 3.2: HAT inhibitors does not dramatically alter the cellular histone acetylation levels. 
Western blotting for acetylated histone H3 (H3ac) and acetylated histone H4 (H4ac) from K562 cells treated 
with HAT inhibitors. ß-actin provides the loading control. The ethanol provides the control treatment for 
curcumin, whereas DMSO provides the control treatment for the remaining HAT inhibitors. 
3.3.2 Garcinol-mediated	histone	deacetylation	causes	chromatin	compaction	
To	evaluate	how	acetylation	of	histone	H3	and	H4	changes	upon	garcinol	treatment,	K562	
cells	 were	 treated	with	 different	 concentrations	 of	 garcinol	 (0.625	 µM	 to	 5	 µM)	 for	 4	 h.	
Reducing	the	concentration	of	garcinol	reduced	the	 level	of	cell	death	that	was	previously	
observed	with	100	µM	garcinol	and	allowed	me	to	obtain	sufficient	cell	lysates	for	Western	
blotting.	 Garcinol	 treatment	 showed	 a	 dose-dependent	 decrease	 in	 histone	 H3	 and	 H4	
acetylation	(Figure	3.3).	Notably,	5	µM	garcinol	leads	to	a	substantial	reduction	of	H3ac	and	




Figure 3.3: Garcinol treatment causes reduced histone H3 and H4 acetylation in cells. 
Western blotting for acetylated histone H3 (H3ac) and acetylated histone H4 (H4ac) from K562 cells treated 
with garcinol at different concentrations. Cells were treated with garcinol for 4 h. ß-actin provides the loading 
control. DMSO provides the negative control treatment. The protein levels of H3ac and H4ac shows substantial 
reduction after the treatment with 5 µM garcinol for 4 hours. 
To	 determine	 if	 garcinol-mediated	 histone	 deacetylation	 in	 K562	 cells	 affects	 chromatin	
structure,	the	accessibility	of	chromatin	was	first	examined	by	measuring	the	accessibility	to	
digestion	by	Micrococcal	Nuclease	(MNase).	Nuclei	extracted	from	cells	were	treated	with	
0.5	units	of	MNase	and	 reaction	 stopped	at	different	 times.	Digestion	by	MNase	 requires	
DNA	 not	 to	 be	 bound	 to	 nucleosomes,	 so	 that	 the	 enzyme	 can	 cleave	 accessible	 DNA	 in	
chromatin	more	effectively	than	compacted	chromatin	that	is	bound	by	more	nucleosomes.	
Digested	DNA	 fragments	were	 subsequently	 separated	on	an	agarose	gel,	where	a	 typical	
nucleosomal	 “ladder”	 pattern	 could	 be	 observed	 (Figure	 3.4A).	 Longer	 digestion	 (45	min)	
causes	 the	 majority	 of	 genomic	 DNA	 to	 resolve	 as	 mono-nucleosomal	 DNA	 (1n).	 But	 at	
earlier	digestion	times,	a	small	but	clear	difference	could	be	observed	in	the	amount	of	poly-
nucleosomal	DNA	 in	 garcinol	 treated	 cells	when	 compared	 to	DMSO.	 To	directly	 visualise	
the	difference,	band	 intensities	 corresponding	 to	mono-	and	poly-nucleosomes	 for	 the	10	
min	time-point	were	plotted	as	signal	density	(Figure	3.4B).	Compared	to	DMSO	condition,	
less	 mono-nucleosomes	 but	 more	 poly-nucleosomes	 were	 observed	 upon	 garcinol	





Figure 3.4: Micrococcal Nuclease (MNase) digestion revealed increased chromatin compaction in garcinol-
treated K562 cells. 
(A) Electrophoresis analysis showing the nucleosome distribution for DMSO- or garcinol-treated K562 cells 
digested by MNase for increasing digestion times. 1n = mono-nucleosomes, 2n = di-nucleosomes, 3n = tri-
nucleosomes. Asterisks indicate samples quantified by the graph in (B). A decrease in mono-nucleosomal 
fragments and an increase in poly-nucleosomal are seen in garcinol-treated cells (black) when compared to 
DMSO-treated control cells (blue). 
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To	 further	 examine	 chromatin	 accessibility	 upon	 garcinol	 treatment,	 ATAC-seq	 was	
performed.	ATAC-seq	can	provide	information	on	chromatin	accessibility	at	specific	genomic	
locations.	 The	 size	 of	 fragments	 incorporated	 into	 an	 ATAC-seq	 library	 can	 provide	 a	
genome-wide	measure	of	chromatin	accessibility.	Fragments	from	ATAC-seq	libraries	were	
binned	into	different	sizes	and	the	fragment	count	for	each	bin	plotted	as	shown	in	Figure	
3.5.	 Mono-nucleosomal	 fragments	 are	 observed	 as	 a	 peak	 centered	 at	 200	 bp,	 di-
nucleosomal	fragments	as	peak	centered	at	400	bp.	This	periodic	pattern	is	well-established	
in	previous	reports	 (Buenrostro	et	al.,	2013;	Yan	et	al.,	2020).	The	 increase	 in	size	of	DNA	
fragments	 protected	 by	 nucleosomes	 is	 due	 to	 the	 spacing	 (+	 ~38	 bp)	 required	 by	 the	
transposition	event	 (Adey	et	al.,	2010).	A	clear	 reduction	 in	mono-nucleosomal	 fragments	
and	an	increase	in	longer	fragments	was	observed	upon	garcinol	treatment,	which	indicates	
reduced	 accessibility	 to	 the	 hyperactive	 Tn5	 transposase	 (Figure	 3.5).	 This	 result	 is	
consistent	 with	 the	 findings	 from	 the	 MNase	 digestion	 assay	 and	 further	 supports	 that	
garcinol	causes	genome-wide	chromatin	compaction.	
	
In	 addition	 to	 global	 fragment	 size	 analysis,	 to	 examine	 the	 chromatin	 accessibility	 at	
promoters	 upon	 garcinol	 treatment,	 changes	 in	 ATAC	 signal	 intensity	 at	 promoters	 was	
compared	 in	 DMSO-	 and	 garcinol-treated	 cells.	 In	 control	 conditions,	 gene	 promoters	
marked	by	G4	ChIP-seq	peaks	(i.e.	G4+)	were	found	to	demonstrate	a	higher	accumulation	




was	 observed	 at	 most	 promoters,	 but	 G4+	 gene	 promoters	 showed	 a	 greater	 reduction	
when	 compared	 to	 G4-	 counterparts	 (Figure	 3.6B).	 This	 suggested	 that	 chromatin	 at	 G4	
marked	promoters	was	more	 compacted	 than	at	 non-G4	promoter.	 Remarkably,	 of	 6,856	
G4+	promoters,	more	than	20%	showed	a	significant	reduction	in	ATAC-seq	signal	intensity	
in	garcinol-treated	K562	cells	 (p	<	0.05;	1,640/6,856	down;	Figure	3.7).	This	 indicates	 that	





Figure 3.5: Garcinol-induced HAT inhibition increases fragment sizes of ATAC-seq libraries. 
Read counts and size distribution for different ATAC-seq fragment sizes for DMSO-treated (grey) and garcinol-
treated (red) chromatin. Mono-nucleosomal fragments are observed as a peak centered at 200 bp and di-
nucleosomal fragments as peak centered at 400 bp. The reduction of mono-nucleosomal fragments and the 






Figure 3.6: Promoter G4s show greater chromatin accessibility but more compaction upon garcinol 
treatment. 
(A) Chromatin accessibility at promoters in DMSO treated control cells. Top panel, metagene plot of the 
normalised ATAC signal centered at the transcription start sties (TSS). Green, promoters marked with G4 ChIP-
seq peaks (G4+); blue, promoters that do not have G4 ChIP-seq peaks (G4- ). Bottom panel, normalised ATAC-seq 
signal plotted for all individual loci and represented by a heatmap. G4+ promoters feature more accessible 
chromatin than their non-G4 counterparts in normoxia. (B) Signal differences in ATAC-seq signal for genes with 
(green) or without (blue) a promoter G4 under garcinol or DMSO. Top panel, metagene plot of the normalized 
ATAC signal centered at the TSS. Bottom panel, normalised ATAC-seq signal plotted for all individual loci and 




Figure 3.7: A fifth of G4 marked promoters show chromatin compaction after garcinol induction.  
MA plot showing fold change in ATAC-seq signal following garcinol treatment (5 µM, 4 h) at G4-marked gene 
promoters. Blue, sites with significantly (p < 0.05) decreased signal following garcinol treatment. Black, sites 
with unchanged signal following garcinol treatment. CPM, read counts per million.  
3.3.3 Garcinol	treatment	increases	cellular	G4	content	
I	 next	 examined	 how	 G4	 landscape	 alters	 in	 response	 to	 the	 induction	 of	 chromatin	
compaction	by	garcinol	treatment.	To	evaluate	the	change	in	G4	ChIP	signal	at	promoters,	
G4	ChIP-seq	was	performed	on	garcinol-treated	cells.	Consensus	G4	peaks	were	first	filtered	
to	 include	 only	 those	 that	 show	 2-fold	 greater	 signal	 when	 compared	 to	 input.	 G4	 ChIP	
signal	 at	 filtered	 promoters	 was	 then	 compared	 in	 DMSO	 versus	 garcinol	 treated	 cells.	
Garcinol	treatment	did	not	significantly	decrease	the	G4	ChIP-signal	(p	<	0.05;	5/2,863	down,	
0.2%;	 Figure	 3.8).	 In	 contrast,	 several	 sites	 demonstrated	 a	 significant	 increase	 in	 G4	




Figure 3.8: G4 ChIP-seq signal increases upon garcinol treatment. 
MA plot showing the fold change in G4 ChIP-seq signal at promoters (TSS ± 500 bp) in garcinol-treated versus 
DMSO-treated K562 cells. Statistically significantly (p < 0.05) higher and lower signals are in red and blue 
respectively; black dots indicate regions not changing. CPM, read counts per million.	



















Therefore,	 the	 ß-actin	 protein	 is	 still	 used	 as	 the	 loading	 control.	 Garcinol-treated	 cells	
showed	an	 increase	 in	acAPE1	protein	 level	when	compared	to	DMSO	and	methoxyamine	
treatments.	 This	 indicates	 that	 garcinol	 treatment	 triggers	 significant	APE1	 activation	 and	
may	explain	the	increase	in	G4s	following	garcinol	treatment.	The	interaction	between	APE1	
and	 chromatin	 compaction	 is	 unclear,	 thereby	 ruling	 out	 garcinol	 as	 a	 method	 for	
addressing	my	hypothesis.	
	
Figure 3.9: Garcinol treatment induces APE1 activation. 
Western blotting for acetylated APE1 (acAPE1) in DMSO- or garcinol-treated K562 cells. The increase of acAPE1 
protein levels suggests active APE1 binding and repair. Methoxyamine- and H2O2-treated cells represent 








hypoxia)	 compared	 to	 normoxia	 (21%	 O2).	 Reduced	 oxygen	 induces	 the	 upregulation	 of	
hypoxia	 inducible	 factor	 1α	 (HIF1α)	 (Batie	 et	 al.,	 2018).	 I	 first	 confirmed	 that	 K562	 cells	




Next,	 to	 assess	 chromatin	 accessibility,	 MNase	 digestion	 was	 performed	 for	 cells	 grown	
under	normoxic	and	hypoxic	conditions.	As	before	(see	section	3.3.2),	extracted	nuclei	were	
incubated	with	0.5	unit	MNase	from	2	min	to	20	min,	and	digested	DNA	was	separated	by	
agarose	 gel	 electrophoresis	 (Figure	 3.10B).	 Reduced	 intensity	 of	 the	 mono-nucleosomal	
band	was	 observed	 in	 hypoxic	 cells	when	 compared	 to	 normoxic	 cells	 at	 every	 individual	
digestion	time-point.	The	difference	of	band	 intensities	corresponding	to	mono-	and	poly-
nucleosomes	 for	 the	 20	min	 time-point	 between	 normoxia	 and	 hypoxia	 were	 plotted	 as	
signal	 density	 (Figure	 3.10C).	 Hypoxia	was	 found	 to	 cause	 substantial	 reduction	 in	mono-
nucleosomal	fragments	and	an	increase	in	poly-nucleosomal	fragments	when	compared	to	
normoxia.	This	indicates	that	hypoxic	nuclei	had	reduced	sensitivity	to	MNase	digestion	due	
to	 chromatin	 compaction.	 In	 parallel,	 ATAC-seq	 was	 performed	 to	 examine	 chromatin	
accessibility	upon	hypoxia.	Fragment	size	analysis	of	ATAC-seq	data	also	showed	an	increase	
in	overall	fragment	size	following	hypoxia	when	compared	to	normoxia,	indicating	reduced	
accessibility	 to	 the	 hyperactive	 Tn5	 transposase	 (Figure	 3.10D).	 The	 fragment	 size	






Figure 3.10: Oxygen depletion leads to HIF1α induction and chromatin compaction. 
(A) Western blotting for HIF1α from K562 cells cultured in normoxia and hypoxia. Actin provides the loading 
control. The hypoxic response that is marked by HIF1α in K562 cells is successfully induced. (B) Agarose gel 
electrophoresis of DNA from normoxic or hypoxic K562 chromatin digested with 0.5-unit MNase for increasing 
time. 1n = mono-nucleosomes, 2n = di-nucleosomes, 3n = tri-nucleosomes. Asterisks indicate lanes scanned and 
quantified by the graph in (C). A substantial reduction in mono-nucleosomal fragments and an increase in poly-
nucleosomal are seen in hypoxia (black) when compared to normoxia (blue). (D) Read counts and size 
distribution for different ATAC-seq fragment sizes for chromatin under normoxia (grey) and hypoxia (red). 




Having	 shown	 that	 acute	 hypoxia	 causes	 global	 chromatin	 compaction,	 I	 specifically	
investigated	 the	 chromatin	 status	 at	 G4s	within	 promoters	 of	 active	 genes	 as	 defined	 by	
RNA	Pol	II	occupancy	(i.e.	co-occurrence	of	G4	ChIP-seq	peaks	and	RNA	Pol	II	ChIP-seq	peaks	
within	TSS	±	500	bp).	Similar	to	my	earlier	observations	(see	section	3.3.2;	Figure	3.6),	G4-
marked	 active	 gene	promoters	 (i.e.	 Pol	 II+	G4+)	 showed	 greater	 chromatin	 accessibility	 as	
seen	by	increased	ATAC-seq	signal	intensity	when	compared	to	their	non-G4	marked	(Pol	II+	
G4-)	 active	 gene	 counterparts	 (Figure	 3.11A).	Upon	 hypoxia,	 a	 greater	 reduction	 in	 ATAC	
signal	was	observed	at	Pol	II+	G4+	promoters	than	non-G4	counterparts	(Pol	II+	G4-)	(Figure	








Figure 3.11: G4-marked active promoters show greater chromatin accessibility in normoxia than in hypoxia. 
(A) Chromatin accessibility at promoters in normoxia as measured by ATAC-seq. Top panel, metagene plot of 
the normalised ATAC signal centered at the TSS. Green, G4 marked active gene promoters (Pol II+ G4+); blue, 
non-G4-marked active gene promoters (Pol II+ G4-). Bottom panel, normalised ATAC-seq signal plotted for all 
individual loci and collectively represented as a heatmap. Pol II+ G4+ promoters feature more accessible 
chromatin than their non-G4 counterparts in normoxia. (B) Signal differences in ATAC-seq signal for active 
genes with (green) or without (blue) a promoter G4 in hypoxia versus normoxia. Top panel, metagene plot of 
the normalised ATAC signal centered at the TSS. Bottom panel, normalised ATAC-seq signal plotted for 
individual loci and collectively represented by a heatmap. Normoxia refers to cells cultured in 21% O2 and 
hypoxia refers to cells exposed to 1% O2 for 1 h. Chromatin at Pol II+ G4+ promoters becomes more compacted 
than at the Pol II+ G4- counterparts upon hypoxia. 
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Figure 3.12: Hypoxia induces chromatin compaction at the majority of G4-marked active gene promoters. 
MA plot showing fold change in ATAC-seq signal following hypoxia at G4-marked active gene (Pol II+ G4+) 
promoters. Blue, sites with significantly (p < 0.05) decreased signal. Black, sites that are not changed in ATAC-
seq signal intensity. CPM, read counts per million. Normoxia refers to cells cultured in 21% O2 and hypoxia 
refers to cells exposed to 1% O2 for 1 h. The majority of sites are seen to become more compacted in hypoxia 
relative to normoxia. 
3.3.6 Promoter	G4	formation	is	sensitive	to	chromatin	compaction	
To	assess	 the	 impact	of	 chromatin	 compaction	via	hypoxia	on	 the	 formation	of	promoter	
G4s,	 G4	 ChIP-seq	 was	 performed	 in	 normoxic	 and	 hypoxic	 chromatin.	 As	 described	
previously	(see	section	3.3.3	and	section	3.3.5),	consensus	G4	peaks	at	active	promoters	(i.e.	
Pol	II+	G4+	promoters)	were	filtered	for	those	that	show	greater	than	2-fold	signal	compared	
to	 the	corresponding	 input.	The	G4	ChIP-seq	signal	at	 the	 filtered	regions	were	compared	









39;	 Figure	 3.14B).	 Nuclei	 in	 hypoxic	 cells	 also	 showed	 a	 significantly	 lower	 BG4	 signal	
intensity	 compared	 to	 normoxic	 nuclei	 (p	 <	 0.0001;	 normoxia:	 46	 vs.	 hypoxia:	 38;	 Figure	




Figure 3.13: Promoter G4s formation is sensitive to chromatin compaction. 
MA plot showing fold change in G4 ChIP-seq signal following hypoxia at active gene (Pol II+ G4+) promoters. 
Blue and red represent sites with significantly (p < 0.05) decreased and increased signal respectively. Black 
represents sites with no changed signal intensity. CPM, read counts per million. Normoxia refers to cells 
cultured in 21% O2 and hypoxia refers to cells exposed to 1% O2 for 1 h. Virtually, no new sites are gained 




Figure 3.14: BG4 immunofluorescence staining for G4 foci in normoxic versus hypoxic cells. 
U2OS cells were fixed in 4% paraformaldehyde, treated with RNase A and stained with the structure-specific 
BG4 antibody. Confocal images were captured using a Leica SP5 microscope. (A) Representative image of BG4 
staining (grey/red) in the nuclei (DAPI, blue) of U2OS cells under normoxia or hypoxia. (B) Graph quantifying 
the number of BG4 foci identified in each nucleus. (C) Graph showing the average BG4 signal intensity in 
individual cells (a.u. = arbitrary unit). In panels B and C, each dot represents a single nucleus. 100-150 nuclei 
were counted per condition and the Mann-Whitney test was performed for each condition across the mean 
values. Error bars represent the s.d. (n = 1). *** = p < 0.001; **** = p < 0.0001. In all panels, normoxia refers to 








alterations	 in	 APE1	 levels	 or	 activity,	 protein	 levels	 were	 assessed	 by	 Western	 blotting	
(Figure	 3.15).	 As	 before,	methoxyamine	 and	H2O2	 treatments	were	 used	 as	 negative	 and	
positive	controls.	Very	 low	levels	of	total	APE1	were	seen	following	H2O2	treatment	and	is	
consistent	with	 the	observation	 that	 this	 induces	ubiquitin-mediated	degradation	of	APE1	
(Busso	 et	 al.,	 2009).	 H2O2	 treatment	 resulted	 in	 increased	 levels	 of	 active	 APE1	 (i.e.	




when	 compared	 to	 normoxic	 cells.	 Importantly,	 no	 alterations	 in	 levels	 of	 total	 APE1	 or	
acAPE1	 were	 observed	 following	 hypoxia,	 indicating	 that	 the	 depletion	 of	 G4s	 during	
hypoxia	cannot	be	the	result	of	alterations	of	APE1	levels	or	activity.	
	
Figure 3.15: Hypoxia does not alter total or active APE1 levels. 
Western blotting for APE1 and acAPE1 in K562 cells under normoxic or hypoxic conditions. Methoxyamine and 
H2O2 treated cells represent negative and positive controls respectively. ß-actin is the loading control. 
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3.3.7 Loss	 of	 promoter	 G4s	 upon	 chromatin	 compaction	 correlates	 with	 loss	 of	
RNA	Pol	II	occupancy	
Having	 established	 that	 chromatin	 compaction	 causes	 a	 loss	 of	 endogenous	promoter	G4	
signal,	I	next	assessed	the	impact	on	RNA	Pol	II	occupancy	using	Pol	II	ChIP-seq.	As	discussed	
in	 Chapter	 2	 (see	 section	 2.3.3;	 Figure	 2.15),	 G4	 containing	 promoters	 show	 greater	
polymerase	 occupancy	 as	 opposed	 to	 their	 non-G4	 marked	 counterparts.	 Hypoxia	 was	
found	to	cause	a	global	reduction	of	RNA	Pol	II	occupancy	at	promoters	(Figure	3.16A).	This	
is	 in	agreement	with	previous	 reports	of	hypoxia-induced	 transcriptional	 repression	 (Batie	
et	al.,	2018;	Rocha,	2007).	Decreased	RNA	Pol	II	occupancy	was	found	at	the	promoters	of	
genes	 that	were	 previously	 shown	 to	 have	 reduced	 gene	 expression	 following	 hypoxia	 in	
K562	cells	(Lorenzini	et	al.,	2019).	This	is	exemplified	by	the	loss	of	RNA	Pol	II	occupancy	at	
VIM	and	IGF2BP2	promoters	following	hypoxia	(Figure	3.16B).	Notably,	promoters	that	are	







a	significant	reduction	 in	Pol	 II	 signal	 intensity	 (p	<	0.05;	1,348/8,307	down,	16.2%;	Figure	
3.17),	whereas	a	negligible	number	of	sites	(2/8307)	showed	increased	Pol	II	signal	intensity	
following	hypoxia.	G4s	therefore	mark	promoters	with	elevated	RNA	Pol	 II	occupancy	and	
hypoxia	 induced	 chromatin	 compaction	 causes	 a	 general	 loss	 of	G4	 signal	 and	RNA	Pol	 II	
occupancy.	This	raises	the	question	whether	the	loss	of	promoter	G4s	was	associated	with	





results	demonstrate	an	association	between	 loss	of	G4s	and	reduction	 in	Pol	 II	occupancy	




Figure 3.16: RNA Pol II occupancy is reduced following hypoxia treatment. 
(A) Signal differences in Pol II ChIP-seq signal for active genes with (black) or without (blue) a promoter G4 in 
hypoxia versus normoxia. Top panel, metagene plot of the normalized Pol II ChIP-seq signal centered at the TSS. 
Bottom panel, data plotted for individual loci and represented by a heatmap. RNA Pol II loading at Pol II+ G4+ 
promoters shows greater reduction upon hypoxia when compared to Pol II+ G4- promoters. (B) Example 
genome browser view showing significantly reduced Pol II occupancy at promoters (red masks) for cells 
cultured under hypoxic versus normoxic conditions. Genomic coordinates for VIM and IGF2BP2 are indicated. In 





Figure 3.17: The occupancy of RNA Pol II occupancy at G4 marked promoters is reduced following hypoxia-
induced chromatin compaction. 
MA plot showing fold change in G4 ChIP-seq signal following hypoxia at active gene promoters. Blue and red, 
sites with significantly (p < 0.05) decreased and increased signal respectively. Black represents sites with no 
changed G4 ChIP-seq signal. CPM, read counts per million. Normoxia refers to cells cultured in 21% O2 and 
hypoxia refers to cells exposed to 1% O2 for 1 h. This indicates that many G4-marked promoters lose RNA Pol II 




Figure 3.18: Promoter G4 loss correlates with Pol II loss following chromatin compaction. 
(A) Co-occurrence of the loss of G4s and RNA Pol II occupancy at promoters under hypoxia. Genomic overlap of 
promoter G4s that have increases or reductions in G4 ChIP signal (G4 logFC + or - respectively) with increases 
of reductions in RNA Pol II occupancy (Pol II logFC + or - respectively) at the same site plotted as percentage of 
co-occurrence. This suggests that reduced RNA Pol II occupancy occurs amongst entirely at sites that also show 
reduced G4 ChIP-seq signal. (B) Genome browser view displaying examples of promoters (e.g. EIF4E-BP1 and 
KCTD5) that show significant reductions in ATAC-seq (green), Pol II ChIP-seq (black) and G4 ChIP-seq peaks 
(yellow) for cells under normoxic (top) and hypoxic (bottom) conditions. Genomic coordinates are indicated 





In	 this	 chapter,	 I	 investigated	 the	 interaction	 between	 chromatin	 structure	 and	 promoter	
G4s	in	cells	by	assessing	the	impact	of	reduced	chromatin	accessibility	on	G4	formation.	To	
induce	chromatin	compaction	in	cells,	but	minimise	possible	downstream	off-target	effects	
on	 promoter	 G4	 folding,	 acute	 chemical	 treatments	 targeting	 histone	 acetyltransferases	






required.	 However,	 since	 these	 compounds	 are	 also	 often	 associated	 with	 non-specific	
downstream	 effects	 on	 cellular	 response,	 increased	 treatment	 time	 was	 considered	
undesirable.		
	
Amongst	 the	 inhibitors	 tested,	 a	 high	 concentration	 of	 garcinol	 caused	 rapid	 cell	 death	
within	4	h,	which	is	likely	to	be	due	to	the	induction	of	apoptosis.	In	human	leukemia	cells,	
garcinol	 causes	 release	 of	 cytochrome	 c	 from	mitochondria,	 activation	 of	 caspase	 3	 and	
subsequent	 cell	 apoptosis	 (Pan	 et	 al.,	 2001).	 Garcinol	 can	 also	 result	 in	 apoptosis	 by	
impeding	 the	 survival	 signalling	 pathway	 in	 cells	 (Liao	 et	 al.,	 2005)	 or	 by	 stimulating	 ROS	
formation	 and	 energy	 depletion	 (Fazio	 et	 al.,	 2015).	 To	minimise	 compounding	 effects,	 I	
treated	 cells	 with	 a	 lower	 dose	 of	 garcinol	 (5	 µM	 for	 4	 h)	 and	 was	 able	 to	 detected	
substantial	 reduction	 of	 histone	 acetylation	 levels.	 However,	 even	 at	 this	 dose,	 garcinol	
induced	cellular	DNA	damage	response	pathways,	as	evidenced	by	elevated	acetylation	of	
APE1,	 which	 marks	 increased	 APE1	 activity	 and	 induction	 of	 the	 base	 excision	 repair	
pathway.	 Multiple	 studies	 have	 linked	 G4s	 with	 DNA	 damage	 (Fleming	 et	 al.,	 2017;	
Fouquerel	et	al.,	2019),	with	increased	APE1	activity	suggested	to	increase	G4	stabilisation	





Acute	 hypoxia	 was	 used	 as	 an	 alternative	 method	 to	 induce	 chromatin	 compaction.	
Importantly,	 to	 minimise	 the	 possibility	 that	 cellular	 response	 other	 than	 chromatin	
compaction	 affect	 G4	 landscape,	 cells	 were	 exposed	 to	 hypoxia	 for	 only	 1	 hour.	 In	
comparison	to	garcinol,	hypoxia	led	to	a	more	robust	genome-wide	reduction	in	chromatin	
accessibility,	 as	 seen	 by	 MNase	 digestion	 and	 ATAC-seq	 fragment	 size	 measurements.	
Moreover,	 hypoxia	 caused	 significant	 compaction	 at	 greater	 than	 85%	 promoter	 G4s	 as	
opposed	to	~24%	seen	after	garcinol	 treatment.	 In	addition,	acute	hypoxia	 (1%	O2,	1	h)	 is	
not	known	to	be	associated	with	DNA	damage,	as	evidenced	by	the	lack	of	APE1	activation.	
Acute	 hypoxia	 thus	 provides	 a	 better	 model	 system	 for	 rapid	 induction	 of	 chromatin	
compaction	in	K562	cells.	
	
A	 fifth	 of	 promoter	 G4s	 showed	 significantly	 decreased	 G4	 ChIP	 signal	 upon	 hypoxia,	




lead	 to	 a	 loss	 of	 G4s,	 thus	 the	 loss	 of	 promoter	G4s	 in	 this	 chapter	 can	 be	 attributed	 to	
chromatin	 compaction.	 However,	 the	 detailed	 mechanism	 of	 how	 G4s	 become	 unfolded	
during	chromatin	compaction	following	hypoxia	remains	unknown.	
	
To	 sum	 up,	 whilst	 Chapter	 2	 demonstrated	 that	 the	 folding	 of	 promoter	 G4s	 in	 cells	
precedes	 active	 transcription,	 the	 work	 in	 Chapter	 3	 suggests	 that	 G4	 formation	 in	
promoters	 is	 facilitated	 by	 an	 accessible	 chromatin	 environment.	 Moreover,	 these	 data	








The	work	 in	Chapter	3	described	 studies	 that	 showed	chromatin	 compaction	 leads	 to	 the	
loss	 of	 signal	 at	 many	 promoter	 G4s,	 suggesting	 a	 causative	 link	 between	 formation	 of	
certain	promoter	G4s	and	accessible	chromatin.	Moreover,	it	was	also	found	that	promoter	
G4s	 loss	 is	 concomitant	 with	 loss	 of	 RNA	 Pol	 II	 occupancy	 upon	 chromatin	 compaction.	





Neidle,	 2008).	 Moreover,	 endogenous	 G4	 structures	 observed	 with	 G4	 ChIP-seq	 overlap	
with	binding	sites	for	many	transcription	factors	(Hou	et	al.,	2019),	suggesting	that	promoter	
G4s	 could	 recruit	 TFs.	 In	 support	 of	 these	 findings,	 several	 independent	 studies	 have	
reported	 in	vitro	 interactions	of	G4-structured	oligonucleotides	with	TFs,	such	as	SP1,	XPB,	
CNBP	and	LARK	(Borgognone	et	al.,	2010;	Gray	et	al.,	2014;	Niu	et	al.,	2019;	Raiber	et	al.,	
2012).	 The	 binding	 affinity	 of	 TFs	 to	 G4s	 has	 in	 a	 number	 of	 cases	 been	 found	 to	 be	
comparable	to	their	affinities	to	consensus	double-stranded	binding	sequences	(Cogoi	et	al.,	
2010;	Raiber	et	al.,	2012).	Furthermore,	G4s	may	directly	recruit	RNA	Pol	II	via	interactions	
with	polymerase	 subunits.	Mass	 spectrometric	proteomics	 analysis	of	proteins	 specifically	




Since	 sites	 that	 lose	promoter	G4	 signal	 upon	 chromatin	 compaction	were	 found	 to	have	
preferentially	 reduced	 Pol	 II	 occupancy,	 I	 hypothesised	 that	 artificial	 stabilisation	 of	 G4	
structures	at	these	sites	may	lead	to	retention	of	RNA	Pol	II	binding.	Furthermore,	since	G4s	
are	 found	 predominantly	 in	 accessible	 chromatin	 regions	 (Hänsel-Hertsch	 et	 al.,	 2016;	
Kouzine	et	al.,	2017;	Wong	and	Huppert,	2009),	it	is	possible	that	stabilising	G4s	may	lead	to	
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G4	 ligand	 TMPyP4	 showed	 inhibitory	 effects	 on	 transcriptional	 activity	 of	MYC	 and	KRAS	
(Cogoi	and	Xodo,	2006;	Siddiqui-Jain	et	al.,	2002).	Isoalloxazine	ligands,	which	also	stabilise	
G4s,	were	found	to	cause	a	substantial	reduction	of	KIT	expression	in	cells	(Bejugam	et	al.,	
2007).	 Furthermore,	 the	G4	binding	 ligand	PDS	was	 shown	 to	 target	 genes	 containing	G4	
motifs	 and	 PDS	 treatment	 resulted	 in	 reduced	 expression	 of	 these	 targeted	 genes	
(Rodriguez	et	al.,	2012).	Subsequently,	cells	treated	with	PDS	also	showed	a	global	increase	








Alternative	 approaches	 to	 modulate	 G4	 formation	 have	 also	 been	 used	 to	 investigate	
interplay	 between	 G4s	 and	 transcriptional	 activity	 (see	 section	 1.6.2).	 For	 example,	 the	
introduction	 of	 constructed	 plasmids,	 which	 contains	 a	 G4	motif	 on	 the	 template	 strand	
downstream	of	the	promoter	of	a	luciferase	reporter	gene,	in	human	embryonic	kidney	cells	
resulted	in	a	substantial	inhibitory	effect	on	luciferase	expression	(Agarwal	et	al.,	2014).	By	
contrast,	 transcription	 was	 not	 impacted	 when	 the	 G4	 motif	 was	 on	 the	 non-template	
strand.	Although	such	models	may	provide	 information	 regarding	 site-specific	and	 strand-
specific	 influence	 of	 G4s	 on	 transcription,	 they	 are	 limited	 by	 the	 lack	 of	 appropriate	
chromatin	 context.	 Such	 limitations	 may	 be	 significant	 since	 the	 findings	 of	 my	 studies,	
described	 thus	 far	 in	 this	 thesis,	 have	 shown	 that	 endogenous	 G4	 formation	 is	 highly	
dependent	on	the	chromatin	context.	
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In	 this	 chapter,	 I	 test	 the	 hypothesis	 that	 prior	 stabilisation	 of	 G4s	 may	 diminish	 the	
influence	of	acute	hypoxia	by	limiting	chromatin	compaction	and	RNA	Pol	II	loss.	To	achieve	
genome-wide	 G4-stabilisation	 in	 cells,	 I	 treated	 K562	 cells	 with	 the	 small	 molecule	
pyrrolidine	PDS	 (pyPDS)	 (Müller	 et	 al.,	 2010).	 pyPDS	has	 recently	 been	 conjugated	with	 a	
fluorescent	probe	 to	adapt	 it	 to	 the	visualisation	of	native	G4	 structures	 in	 living	 cells	 (Di	
Antonio	 et	 al.,	 2020),	 corroborating	 the	 binding	 of	 pyPDS	 to	 G4	 structures	 in	 cells.	
Furthermore,	 to	 minimise	 downstream	 cytotoxic	 effects,	 particularly	 DNA	 damage	
responses,	associated	with	such	G4-stabilising	ligands,	short	treatment	times	were	used.	
	
Figure 4.1: Investigating the role of stabilised promoter G4s on chromatin compaction and RNA Pol II 
occupancy following acute hypoxia. 
Graphical representation of experimental design studying how stabilisation of G4s by small molecules alters 
chromatin structure and RNA Pol II loading under hypoxia-driven chromatin compaction. Cells were treated with 
G4-stabilising ligands prior to the exposure to hypoxia. The impact of pre-stabilised G4s on chromatin 




The	 aim	 of	 this	 chapter	 is	 to	 investigate	 how	 G4	 ligand-mediated	 stabilisation	 impacts	
hypoxia	 driven	 chromatin	 compaction	 and	 loss	 of	 RNA	 Pol	 II	 at	 promoter	 G4s.	 The	 first	
objective	 is	 to	 examine	 the	 G4-stabilising	 capability	 of	 pyPDS	 in	 cells	 using	 BG4	
immunofluorescence	 and	 G4	 ChIP-seq.	 The	 second	 objective	 is	 to	 assess	 if	 pyPDS	 could	
stabilise	 G4s	 in	 cells	 in	 hypoxia-induced	 chromatin	 compaction.	 The	 third	 objective	 is	 to	
assess	 the	 impact	 of	 G4	 stabilisation	 on	 chromatin	 accessibility	 upon	 hypoxia.	 The	 final	








for	 1	 hour.	 G4	 ChIP-seq	 on	 three	 independent	 biological	 replicates,	 each	 with	 three	
technical	 replicates	 were	 performed.	 Consensus	 promoter	 G4	 peaks	 were	 defined	 and	
filtered	as	described	previously	(see	section	3.3.5	and	section	3.3.6).	Active	gene	promoters	




signals.	 However	 following	 pyPDS	 treatment,	 it	 was	 striking	 that	 of	 5,912	 Pol	 II+	 G4+	
promoter	 sites	 assessed,	 nearly	 70%	 showed	 a	 statistically	 significant	 reduction	 in	 signal	
intensity	(p	<	0.05;	4,046/5,912,	68.4%;	Figure	4.2A),	whereas	a	negligible	number	of	sites	
(1/5,912)	 showed	 increased	G4	ChIP	 signal	 intensity.	 The	 reduction	of	G4	ChIP	 signal	was	
also	found	at	genes	where	promoter	G4s	have	been	previously	suggested	to	be	stabilised	by	
G4-stabilising	ligands,	for	example	MYC	promoter	and	VEGF	promoters	(Siddiqui-Jain	et	al.,	




There	may	 be	 a	 different	 explanation	 for	 the	 observed	 signal	 loss	 in	 these	 experiments.	
Many	studies	have	shown	that	stable	G4s	can	act	as	obstacles	to	DNA	synthesis	by	stalling	
DNA	polymerases	(Han	et	al.,	1999;	Woodford	et	al.,	1994).	Indeed,	this	has	been	utilised	to	
define	 genome-wide	 G4	 formation	 using	 polymerase	 stalling	 by	 ligand-mediated	
stabilisation	of	G4s	(Chambers	et	al.,	2015;	Dexheimer	et	al.,	2006;	Qin	et	al.,	2007).	Possibly,	





Figure 4.2: Reduction of G4 ChIP-seq signal following pyPDS treatment. 
(A) MA plot showing the fold change in G4 ChIP-seq signal at active promoters (Pol II+ G4+ promoters; p < 0.05) 
in pyPDS-treated versus DMSO-treated K562 cells. Statistically significantly (p < 0.05) higher and lower signals 
are in red and blue respectively; black dots indicate unchanged regions. CPM, read counts per million. This 
shows that ~20% of sites assessed lose G4 ChIP signal. (B) Genome browser view of MYC and VEGFB exemplify 
genes that significantly change in G4 ChIP-seq peaks (yellow). Tracks compare peaks between DMSO (0.1%, 2 h) 
and pyPDS (1 µM, 2 h) conditions. Genomic coordinates indicate track range. This shows reduced G4 ChIP 
signal at the promoters (masked in red) after pyPDS treatment. 
4.3.2 G4	stabilisation	protects	G4s	from	unfolding	in	hypoxia			
To	assess	G4	formation	by	an	alternative	approach,	nuclear	G4s	were	visualised	using	BG4	IF	






BG4	 foci	 were	 identified	 following	 pyPDS	 treatment	 (1	 µM,	 2	 h),	 which	 represents	 a	
significant	increase	(p	<	0.001;	over	150	nuclei	from	1	biological	replicate)	when	compared	
to	the	average	of	43	BG4	foci	 in	DMSO-treated	control	cells	(Figure	4.3B).	However,	this	is	







The	 results,	 which	 quantified	 from	 more	 than	 150	 individual	 nuclei,	 showed	 that	 pyPDS	
treatment	 at	 low	 doses	 and	 times	 leads	 to	modest	 but	 statistically	 significant	 increase	 in	
cellular	 G4s.	 This	 was	 sufficiently	 robust	 to	 suggest	 that	 pyPDS	 leads	 to	 stabilisation	 of	
cellular	G4s.	I	therefore	proceed	to	the	next	step	to	investigate	whether	prior	stabilisation	
by	 pyPDS	 protects	 G4	 folding	 upon	 subsequent	 exposure	 to	 acute-hypoxia.	 For	 this,	 cells	
were	 pre-treated	with	 1	 µM	pyPDS	 for	 an	 hour	 and	 subsequently	 exposed	 to	 hypoxia	 or	
maintained	them	in	normoxia	for	an	additional	hour	in	presence	of	pyPDS.	Cells	pre-treated	
with	DMSO	that	were	maintained	in	normoxia	or	exposed	to	hypoxia	served	as	controls.	The	
impact	on	G4	 folding	was	 then	measured	using	BG4	 immunofluorescence.	Comparable	 to	
my	 observations	 in	 Chapter	 3	 (see	 section	 3.3.6;	 Figure	 3.14),	 only	 30	 BG4	 foci	 were	
















Figure 4.3: pyPDS treatment diminishes the impact of hypoxia on cellular G4s. 
U2OS cells were paraformaldehyde fixed, RNase A treated and stained with BG4 antibody. Confocal images 
were captured using a Leica SP5 microscope. (A) BG4 staining (grey/red) in the nuclei stained by DAPI (blue) of 
DMSO- or pyPDS-treated U2OS cells under normoxia or hypoxia. (B) Graph quantifying the number of BG4 foci 
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identified in each nucleus. Normoxia-DMSO = 43; Normoxia-pyPDS = 48; Hypoxia-DMSO = 30; Hypoxia-pyPDS = 
38. (C) Graph showing the average BG4 signal intensity in individual cells (a.u. = arbitrary unit). The mean value 
for each condition is: Normoxia-DMSO = 24; Normoxia-pyPDS = 25; Hypoxia-DMSO = 21; Hypoxia-pyPDS = 25. 
In panel B and C, each dot represents a single nucleus. An average of 150 nuclei were counted per condition 
and the one-way ANOVA test was performed for each condition across the mean values. Error bars represent 
the s.d. *** = p < 0.001; **** = p < 0.0001. In all panels, normoxia refers to cells cultured in 21% O2 and 
hypoxia refers to cells exposed to 1% O2 for 1 h. These results suggest that pyPDS-treated cells show more BG4 
foci than DMSO-treated cells in normoxia. Less BG4 foci and reduced G4 signal intensity are found in DMSO-
treated cells following hypoxia when compared to normoxia. Furthermore, the increase of BG4 foci and G4 
signal intensity are found in pyPDS pre-treated hypoxic cells relative to DMSO pre-treated hypoxic cells. 
As	 discussed	 previously	 (see	 section	 3.3.3),	 G4	 formation	 may	 be	 enhanced	 by	 cellular	
responses	to	DNA	damage,	especially	by	BER-associated	APE1	activation	(Roychoudhury	et	
al.,	 2020).	As	mentioned	previously,	 treatment	of	 cells	with	G4-stabilising	 ligands	 is	 often	
associated	with	activation	of	DNA	damage	response	(Fleming	et	al.,	2017;	Fouquerel	et	al.,	
2019;	 Rodriguez	 et	 al.,	 2012),	 which	 I	 attempted	 to	 minimise	 by	 choosing	 very	 short	
treatment	 times.	However,	 it	 is	 entirely	 reasonable	 to	 challenge	 that	 the	 increase	of	BG4	
foci	following	pyPDS	treatment	occurs	indirectly	via	induction	of	BER	and	activation	of	APE1.	
To	 examine	 this,	Western	 blotting	was	 performed	 to	 assess	 APE1	 activation	 upon	 pyPDS	
treatment	 in	 hypoxic	 or	 normoxic	 conditions	 (Figure	 4.4).	 As	 for	 prior	 experiments	 (see	
section	3.3.3	and	section	3.3.6),	methoxyamine	and	H2O2	treatments	were	used	as	negative	
and	 positive	 controls.	 Very	 low	 levels	 of	 total	 APE1	 could	 be	 observed	 following	 H2O2	
treatment	 due	 to	 the	 induction	 of	 ubiquitin-mediated	 degradation	 of	 APE1	 (Busso	 et	 al.,	
2009).	Methoxyamine	 treatment	 resulted	 in	 a	 reduction	 in	 acAPE1,	while	H2O2	 caused	an	
upward	band	shift	due	to	ubiquitination	of	APE1.	The	standard	ß-actin	loading	control	also	
showed	an	upward	band	shift	following	H2O2	treatment	due	to	its	polyubiquitination	(Reeg	
et	 al.,	 2020).	 However,	 normoxic	 and	 hypoxic	 cells	 pre-treated	 with	 pyPDS	 did	 not	





Figure 4.4: Addition of pyPDS does not increase APE1 level and its activity. 
Western blotting for APE1 and acAPE1 in DMSO- or pyPDS-treated cells upon hypoxia or normoxia. The acAPE1 
protein level suggests the activity of APE1 binding and repair. Methoxyamine and H2O2 treated cells represent 
negative and positive controls respectively. ß-actin serves the loading control. This shows that pyPDS and 
hypoxia treatment does not affect levels of total or active APE1. 
4.3.3 pyPDS	 treatment	 does	 not	 alter	 chromatin	 accessibility	 and	 RNA	 Pol	 II	
recruitment	at	promoter	G4s	











To	assess	alterations	 in	Pol	 II	occupancy	upon	pyPDS	treatment,	RNA	Pol	 II	ChIP	signals	at	
Pol	 II+	G4+	promoters,	which	were	two-fold	enriched	over	 input,	were	compared	between	
pyPDS-	 and	 DMSO-treated	 cells.	 As	 observed	 for	 ATAC-seq,	 no	 alterations	 in	 Pol	 II	
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occupancy	were	observed	under	normoxic	conditions	with	pyPDS	when	compared	to	DMSO	
(p	 <	 0.05;	 Figure	4.6).	 This	 result	 shows	 that	pyPDS	 treatment	does	not	 significantly	 alter	
RNA	Pol	II	occupancy	at	G4-marked	promoters	in	homeostatic	cells.	This	also	rules	out	the	
possibility	 of	 any	 confounding	 effects	 of	 pyPDS	 on	 chromatin	 compaction	 and	 RNA	 Pol	 II	
occupancy.	The	data	therefore	serve	as	important	controls	for	the	experiments	to	follow.	
Figure 4.5: pyPDS treatment does not affect chromatin accessibility at G4-marked active promoters under 
normoxia. 
MA plot showing fold change in ATAC-seq signal at Pol II+ G4+ promoters between pyPDS- and DMSO-treated 
cells upon normoxia. Significant increases or decreases (p < 0.05) in ATAC-seq signal in pyPDS-treated cells 
relative to DMSO-treated cells are indicated in red and blue respectively; black dots indicate regions that show 
no change in ATAC-seq signal. CPM, read counts per million. 
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Figure 4.6: pyPDS treatment does not affect RNA Pol II occupancy at G4-marked active promoters under 
normoxia. 
MA plot showing fold change in RNA Pol II ChIP-seq signal at Pol II+ G4+ promoters between pyPDS- and DMSO-
treated cells upon normoxia. Significantly increases (p < 0.05) in RNA Pol II ChIP-seq signal in pyPDS-treated 
cells relative to DMSO-treated cells are indicated in red, and black dots indicate unchanged regions. CPM, read 




next	 hypothesised	 that	 stabilised	 G4s	 may	 physically	 impede	 chromatin	 compaction	 in	
hypoxia.	 Having	 provided	 data	 to	 suggest	 that	 pre-stabilisation	 of	 G4s	 by	 pyPDS	 protects	
G4s	from	unfolding	upon	hypoxia	(see	section	4.3.2),	I	evaluated	whether	this	stabilisation	




was	 observed	 in	 pyPDS-treated	 hypoxic	 cells	 (Figure	 4.7),	 indicating	 that	 hypoxia-driven	
chromatin	 compaction	 still	 ensues	 at	 promoter	 G4s	 despite	 pre-stabilisation	 by	 pyPDS.	






Figure 4.7: Chromatin compaction still ensues in pyPDS-treated hypoxic cells. 
Chromatin accessibility differences for G4-marked active promoters (i.e. Pol II+ G4+ promoters) under hypoxia 
for cells pre-treated with pyPDS or DMSO. Top panel, metagene plot of normalised ATAC signal centered at the 
TSS showing the signal difference between DMSO- and pyPDS-treated hypoxic cells. Bottom panel, normalised 
ATAC-seq signal plotted for all individual loci and collectively represented by a heatmap. Hypoxia refers to cells 
exposed to 1% O2 for 1 h. 
  
	 115	
4.3.5 Stabilised	 G4s	 override	 chromatin	 compaction	 to	 recruit	 RNA	 Pol	 II	 to	
promoters	
Since	the	loss	of	promoter	G4s	upon	chromatin	compaction	coincides	with	the	loss	of	RNA	
Pol	 II	at	 the	same	sites	 (see	section	3.3.7;	Figure	3.18),	 it	 is	possible	 that	 the	unfolding	of	
promoter	G4s	 influences	 RNA	 Pol	 II	 occupancy.	 The	 data	 so	 far	 suggests	 that	 pyPDS	 pre-





2-fold	 Pol	 II	 ChIP	 signal	 compared	 to	 the	 corresponding	 input)	 were	 analysed.	 In	 DMSO-
treated	cells,	about	10%	of	the	Pol	II+	G4+	promoters	showed	a	significant	decrease	in	Pol	II	






significant	 loss	 of	 RNA	 Pol	 II	 in	 DMSO-treated	 cells	 upon	 hypoxia	 with	 those	 that	 show	
significant	 Pol	 II	 loss	 in	 pyPDS-treated	 hypoxic	 cells	 versus	 DMSO-treated	 normoxic	 cells	
(Figure	4.8C).	When	compared	to	DMSO-treated	normoxic	cells,	hypoxia	treatment	resulted	
in	 the	 loss	 of	 RNA	 Pol	 II	 in	 566	 promoters,	 whereas	 pre-treatment	 of	 pyPDS	 in	 hypoxia	
showed	Pol	II	loss	in	only	64	promoters.	With	the	pre-treatment	of	pyPDS,	RNA	Pol	II	loss	in	
hypoxia	was	 no	 longer	 observed	 at	 the	majority	 of	 the	 promoters	 (505/566,	 89.2%)	 that	
were	 previously	 shown	 to	 have	 reduced	 Pol	 II	 ChIP	 signal	 upon	 hypoxia.	 Together,	 these	





(Figure	 4.9).	 This	 corroborates	 my	 findings	 that	 pyPDS	 treatment	 retains	 RNA	 Pol	 II	 at	
	 116	
individual	promoter	G4s	in	hypoxia.	Importantly,	no	changes	in	RNA	Pol	II	occupancy	were	
seen	 at	 non-G4-marked	 promoters.	 This	 rules	 out	 non-specific,	 G4-independent,	 ligand-
associated	effects	on	RNA	Pol	 II	recruitment	 in	hypoxia.	Overall,	these	results	suggest	that	
the	chemical	stabilisation	of	G4	structures,	which	would	otherwise	be	lost	during	chromatin	
compaction,	 leads	 to	 retention	 of	 Pol	 II	 in	 spite	 of	 chromatin	 compaction	 signals.	 The	
findings	 are	 exemplified	 by	 genome	 browser	 views	 for	 the	 ATXN1L	 and	 FSCN1	 gene	
promoters	(Fig.	4.10).	
 
Figure 4.8: pyPDS stabilisation substantially reduces the loss of RNA Pol II sites at G4-marked promoters 
upon hypoxia. 
(A) MA plot showing fold change in RNA Pol II ChIP-seq signal between hypoxic and normoxic cells treated with 
control DMSO at G4-marked active (i.e. Pol II+ G4+) gene promoters. (B) As in panel A but for changes in Pol II 
ChIP-seq signal for cells treated with pyPDS and subjected to hypoxia compared to DMSO-treated cells under 
normoxia. In both panel A and B, significantly decreased signal (p< 0.05) in Pol II ChIP-seq is indicated in blue. 
black dots indicate sites that have unchanged Pol II ChIP signal. CPM, read counts per million. (C) Venn diagram 
showing Pol II+ G4+ promoter regions that have lost Pol II occupancy between DMSO-treated normoxic and 
hypoxic cells and overlap with sites lost in pyPDS-treated hypoxic cells compared to DMSO-treated normoxic 






Figure 4.9: Stabilisation of G4s by pyPDS retains RNA Pol II at promoters upon hypoxia. 
Signal differences in RNA Pol II occupancy for promoters of active genes with a G4 (Pol II+ G4+, black) and for 
promoters of active genes without a G4 (Pol II+ G4-, blue) in cells treated with DMSO or pyPDS under hypoxic 
condition. Top panel, metagene plot of Pol II ChIP signal centered at the TSS showing the signal difference 
between DMSO- and pyPDS-treated hypoxic cells. Bottom panel, normalised Pol II ChIP-seq signal plotted for all 
individual loci and collectively represented by a heatmap plot. Increased signal is shown in blue, and decreased 
signal is shown from yellow to red. This shows that the retention of RNA Pol II after pyPDS treatment upon 
hypoxia is only observed at G4-marked (Pol II+ G4+) promoters but not at non-G4-marked (Pol II+ G4-) promoters, 




Figure 4.10: Stabilisation of G4s by pyPDS causes retention of RNA Pol II in spite of chromatin compaction 
upon hypoxia. 
Genome browser view displaying examples of genes (e.g. FSCN1 and ATXN1L) that show changes in chromatin 
accessibility (ATAC-seq, green) and RNA Pol II occupancy (Pol II ChIP-seq, black) for cells under normoxic (top), 
hypoxic (middle) and hypoxic conditions treated with pyPDS (bottom). Genomic coordinates are indicated 
above. This demonstrates that hypoxia results in reduced chromatin accessibility and RNA Pol II loading at 
promoters. An increase of RNA Pol II occupancy at the promoter is observed after pyPDS treatment, while the 







G4	 stabilising	 ligand	 pyPDS.	 However,	 an	 overall	 reduction	 of	 G4	 ChIP-seq	 signal	 was	
observed	after	pyPDS	stabilisation,	including	genes	that	were	previously	shown	stabilised	by	
G4	ligands	in	vitro	(Siddiqui-Jain	et	al.,	2002;	Sun	et	al.,	2011).	Prior	attempts	at	G4	ChIP-seq	
in	 the	 presence	 of	 G4	 stabilising	 ligands	 within	 our	 laboratory	 have	 also	 shown	 similar	
decreases	in	G4	signal.	As	mentioned	above,	this	may	be	due	to	DNA	polymerase	stalling	at	
stable	G4	structures,	which	is	a	well-established	phenomenon	(Han	et	al.,	1999;	Woodford	
et	 al.,	 1994).	 Polymerase	 stalling	 by	 ligand-stabilised	 G4s	 has	 also	 been	 widely	 used	 to	
characterise	G4	formation	(Chambers	et	al.,	2015;	Dexheimer	et	al.,	2006;	Qin	et	al.,	2007).	
In	G4	ChIP-seq,	cells	were	cross-linked	by	formaldehyde,	which	reacts	with	the	amino	group	
of	 proteins	 or	 DNA	 to	 form	 a	 methylene	 bridge	 between	 molecules	 in	 close	 proximity	
(Hoffman	 et	 al.,	 2015).	 Furthermore,	 immunoprecipitated	 DNA	 libraries	 are	 amplified	 by	
polymerase	 chain	 reaction	 (PCR)	 and	 subjected	 to	 sequencing.	 Strand	 extension	 by	 DNA	
polymerase	is	a	key	element	for	both	of	these	steps.	In	this	chapter,	I	performed	G4	ChIP-
seq	 in	 the	 presence	 of	 pyPDS.	 The	 amino	 group	 in	 pyPDS	 may	 enable	 its	 reaction	 with	
formaldehyde	and	subsequent	cross-linking	to	DNA.	Such	cross-linked	pyPDS-stabilised	G4s	
can	 arrest	 DNA	 polymerase	 progress	 during	 PCR	 or	 Illumina	 sequencing,	 reducing	 the	
amplification	 efficiency	 and	 thus	 result	 in	 reduced	 enrichment	 when	 compared	 to	 other	
non-G4-forming	 regions	or	background.	This	would	 result	 in	 reduced	G4	ChIP	signal	at	G4	









this	 limitation,	 increase	 in	 the	 number	 of	 BG4	 foci	 confirmed	 the	 increase	 in	 G4s	 upon	
	 120	
pyPDS	 treatment	 of	 normoxic	 cells.	While	 depletion	 of	 oxygen	 substantially	 reduced	 BG4	
foci	number	and	 IF	signal	 intensity	 in	cell	nuclei,	 fewer	G4s	were	 lost	upon	pre-treatment	
with	 pyPDS,	 supporting	 my	 contention	 that	 prior	 stabilisation	 can	 protect	 G4s	 from	
unfolding	in	hypoxia.	
	
Although	 pre-treatment	 of	 pyPDS	 retained	G4s	 from	 unfolding	 in	 hypoxia,	 a	 reduction	 in	
chromatin	accessibility	was	still	observed	in	pyPDS-treated	hypoxic	cells	at	G4	marked	active	
promoters.	 These	 results	 show	 that	 global	 chromatin	 compaction	 still	 ensues	 despite	
increased	G4	stability,	suggesting	that	the	presence	of	a	folded	G4	cannot	interfere	with	a	
hypoxia-driven	increase	in	nucleosome	density	at	promoters.	Surprisingly,	this	also	suggests	
that	 G4s	 are	 able	 to	 form	within	more	 compact	 chromatin,	 however,	 this	 remains	 to	 be	
directly	demonstrated	at	the	local	level.	
	
Remarkably,	 treatment	 of	 cells	 by	 pyPDS	 and	 thus	 pre-stabilisation	 of	 G4s	 leads	 to	 a	
reduced	loss	of	RNA	Pol	II	at	promoter	G4s	upon	hypoxia.	This	suggests	that	ligand	stabilised	
G4s	 are	 able	 to	 diminish	 the	 impact	 of	 chromatin	 compaction	 on	 Pol	 II	 occupancy.	








chapter	has	 further	 revealed	 that	G4	 formation	 can	be	modulated	 to	augment	RNA	Pol	 II	
occupancy	in	an	otherwise	inhibitory	chromatin	environment.	Overall,	these	results	suggest	






5.1 Promoter	 G4	 folding,	 transcription	 activity	 and	 chromatin	
accessibility	
Endogenous	 G4s	 have	 been	 found	 to	 predominantly	 fold	 within	 regulatory,	 nucleosome-
depleted	 regions	 and	 mark	 sites	 of	 elevated	 transcription	 (Hänsel-Hertsch	 et	 al.,	 2016).	
While	 numerous	 other	 studies	 have	 indicated	 that	 G4s	 are	 associated	 with	 active	 gene	
transcription	(Hou	et	al.,	2019;	Makowski	et	al.,	2018;	Raiber	et	al.,	2012;	Sengupta	et	al.,	
2019),	there	is	some	evidence	to	suggest	that	G4s	at	active	gene	promoters	may	form	as	a	
consequence	 of	 increased	 transcriptional	 activity	 (Duquette	 et	 al.,	 2004;	 Kouzine	 et	 al.,	
2004).	 However,	 these	 hypotheses	 are	 derived	 from	 in	 vitro	 systems	 or	 from	 genomic	






abolishes	 ssDNA	 formation	 within	 the	 gene	 body	 but	 increases	 ssDNA	 formation	 at	
promoter	regions	(Wu	et	al.,	2020),	where	the	latter	is	likely	due	to	the	increased	pausing	of	
RNA	 Pol	 II	 near	 the	 TSS	 (Core	 et	 al.,	 2008).	 Surprisingly,	 no	 increase	 in	 G4	 formation	 at	
promoters	 was	 detected	 following	 DRB	 treatment,	 implying	 that	 the	 increase	 in	 ssDNA	
formation	 does	 not	 result	 in	 increased	 promoter	 G4	 folding.	 More	 importantly,	 no	
significant	 decrease	 in	 G4	 signal	 intensity	was	 observed	 at	 promoters,	 indicating	 that	 G4	
formation	does	not	rely	on	transcription	elongation.	
	
During	 transcription	 initiation,	 the	 local	 melting	 of	 promoter	 DNA	 is	 important	 to	 the	
formation	 of	 transcription	 bubble	 and	 the	 exposure	 of	 single-stranded	 template,	 which	
allows	 polymerase	 scanning	 (Cheung	 et	 al.,	 2011).	 The	 melting	 of	 promoter	 DNA	 is	
facilitated	by	negative	supercoiling,	which	has	been	shown	to	induce	the	formation	of	G4s	
(Kouzine	 et	 al.,	 2004;	 Revyakin	 et	 al.,	 2004).	 It	 therefore	 still	 remained	 possible	 that	
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promoter	 G4s	 were	 established	 during	 transcription	 initiation.	 Inhibition	 of	 transcription	
initiation	 by	 TPL	 results	 in	 elimination	 of	 most	 ssDNA	 from	 transcribed	 regions	 and	
promoters	 (Wu	 et	 al.,	 2020).	 However,	 this	 did	 not	 cause	 any	 decrease	 in	 promoter	 G4	
folding.	 These	 findings	 refute	 the	 hypothesis	 that	 increased	 ssDNA	 formation	 during	 the	
transcription	 process	 augments	 promoter	 G4	 formation,	 and	 indicate	 that	 the	 folding	 of	
promoter	 G4s	 is	 not	 a	 consequence	 of	 transcriptional	 activity.	 Contrarily,	 TPL	 treatment	
resulted	 in	 increased	 G4	 formation	 at	 many	 gene	 promoters.	 Since	 TPL	 functions	 by	
inhibition	of	Pol	 II-associated	helicases	XPB	and	XPD	(Titov	et	al.,	2011),	 this	may	result	 in	
reduced	 G4	 unfolding	 and	 cause	 the	 observed	 increase	 in	 promoter	 G4s.	 However,	 the	
impact	 of	 alterations	 in	 cellular	 XPB/XPD	 activity	 on	 the	 G4	 landscape	 has	 not	 yet	 been	
directly	tested.	G4	ChIP-seq	performed	in	XPD-deficient	cells	(Armelini	et	al.,	2005;	Saffi	et	





as	 R-loops	 form	 downstream	 of	 the	 TSS	 (Chen	 et	 al.,	 2017),	 whereas	 the	 G4s	 are	 found	
primarily	 enriched	upstream	of	 the	 TSS	 (Hänsel-Hertsch	et	 al.,	 2016).	 But	 to	demonstrate	
this	 relationship	 directly,	 R-loop	 formation	 can	 be	 inhibited	 or	 augmented	 by	
overexpression	of	RNase	H1	(De	Magis	et	al.,	2019)	or	catalytically	dead	RNase	H1	(Chen	et	




My	 findings	 also	 raised	 the	 question	 that	 if	 not	 transcriptional	 activity	 then	 what	
determined	the	formation	of	G4	within	gene	promoters.	G4	motifs	have	been	found	outside	
of	 nucleosome-bound	 regions	 within	 the	 human	 genome	 (Wong	 and	 Huppert,	 2009).	
Corroborating	 this,	 endogenous	 G4s	 have	 been	 found	 predominantly	 in	 accessible	
chromatin	 regions	 (Hänsel-Hertsch	 et	 al.,	 2016).	 Moreover,	 G4	 structures	 have	 been	
suggested	 to	 influence	 the	 positioning	 and	 occupancy	 of	 nucleosomes	 within	 chromatin	
(Kouzine	 et	 al.,	 2017).	 Increased	 chromatin	 accessibility	 following	 HDAC	 inhibition	 by	
entinostat	 was	 previously	 shown	 to	 cause	 elevated	 G4	 formation	 at	 promoters.	 It	 can	
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therefore	 be	 hypothesised	 that	 chromatin	 environment	 defines	 where	 G4s	 folds,	 with	
promoters	 providing	 the	 most	 permissive	 environment.	 To	 directly	 test	 if	 G4	 folding	
required	 highly	 accessible	 chromatin	within	 promoters,	 I	 utilised	 the	 cellular	 response	 to	
acute	hypoxia	as	a	tool	for	inducing	rapid	chromatin	compaction	at	promoters	(Chen	et	al.,	




however,	majority	of	 promoter	G4s	did	not	 show	a	 statistically	 significant	decrease	 in	G4	
ChIP	signal,	despite	showing	chromatin	compaction.	Since	G4	ChIP-seq	demonstrates	lower	
signal-to-noise	 ratio	when	compared	 to	other	ChIP-seq	approaches	 (Hänsel-Hertsch	et	al.,	
2018),	it	may	not	be	able	to	detect	small	changes	in	G4	formation	as	statistically	significant.	
However,	 these	 findings	 could	 also	 indicate	 that	 some	 promoter	 G4s	 are	 resistant	 to	
chromatin	 compaction	 conditions	 under	 acute	 hypoxia.	 In	 support	 of	 this,	 G4-stabilising	
ligands	 may	 protect	 promoter	 G4s	 from	 unfolding	 as	 a	 result	 of	 compact	 chromatin	
(discussed	below).	To	examine	this,	a	precise	mapping	of	nucleosome	positions	 is	needed.	
This	could	provide	direct	demonstration	whether	those	promoter	G4s	that	remain	folded	in	
hypoxia	 induced	 chromatin	 compaction	 are	 still	 located	 in	 nucleosome-free	 regions	 after	
hypoxia	treatment	or	not.	
	
In	 this	 study,	 chromatin	 accessibility	 is	 determined	 using	 ATAC-seq,	 which	 uses	 the	
hyperactive	 transposase	 Tn5	 to	 define	 sites	 of	 accessible	 chromatin.	 But	 precise	
determination	 of	 nucleosome	 positioning	 using	 this	 methodology	 requires	 sequencing	 at	









The	 mechanism	 of	 how	 promoter	 G4s	 become	 unfolded	 upon	 chromatin	 compaction	 in	
hypoxia	 is	 still	 unclear.	 Chronic	 hypoxia	 has	 previously	 been	 demonstrated	 to	 cause	 a	
reduction	 in	 APE1	 protein	 levels	 (Chan	 et	 al.,	 2014).	 Abrogated	 activity	 of	 APE1,	 an	
endonuclease	 involved	 in	 base	 excision	 repair,	 could	 result	 in	 decreased	G4	 formation	 in	














In	 hypoxia,	 the	 loss	 of	 promoter	G4s	was	 also	 accompanied	with	 a	 corresponding	 loss	 of	
RNA	Pol	II	occupancy.	Since,	the	reduction	in	transcriptional	activity	does	not	lead	to	a	loss	




promoter	 G4s	 was	 accompanied	 by	 a	 corresponding	 loss	 of	 RNA	 Pol	 II	 occupancy	 upon	











is	 inhibited	 by	 G4-stabilising	 ligand,	 with	 the	 inhibition	 is	 attributed	 to	 thermal	 stability	
(Chen	et	al.,	2015c).	The	reduced	unwinding	rates	of	helicase	in	the	presence	of	G4	ligands	
would	 in	 turn	allow	 increased	retention	of	G4s	upon	chromatin	compaction.	 Interestingly,	
despite	 the	 increase	 in	 cellular	G4	content,	hypoxia-associated	chromatin	 compaction	 still	
ensued,	 implying	 that	 stabilisation	 by	 pyPDS	 could	 enable	 G4s	 to	 form	 within	 compact	
chromatin.	However,	 I	am	unable	to	directly	detect	 the	 folding	of	G4s	at	specific	genomic	
locations	in	the	presence	of	pyPDS	due	its	incompatibility	with	G4	ChIP-seq	(as	discussed	in	









addressed	 with	 nascent	 RNA	 sequencing	 following	 pyPDS	 treatment	 in	 hypoxia	 and	
comparing	the	transcriptional	output	with	DMSO-treated	normoxic	and	hypoxic	cells.	
	
The	 mechanism	 by	 which	 promoter	 G4s	 aid	 the	 recruitment	 of	 RNA	 Pol	 II	 is	 not	 yet	
understood.	 A	 recent	 study	 used	 a	MYC	 promoter	 G4	 oligonucleotide	 to	 bait	 interacting	
proteins	 from	 nuclear	 extracts	 and	 found	 subunits	 of	 RNA	 Pol	 II	 by	 mass	 spectrometry	




G4s	 are	 likely	 to	 recruit	 RNA	 Pol	 II	 by	 providing	 high	 affinity	 interactions	 with	 TFs.	
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Supporting	 this,	 various	 studies	 have	 shown	 the	 interactions	 between	 G4s	 and	 TFs.	 For	
example,	TFs	such	as	SP1,	XPB,	CNBP	and	LARK	(Borgognone	et	al.,	2010;	Gray	et	al.,	2014;	
Niu	 et	 al.,	 2019;	 Raiber	 et	 al.,	 2012),	 bind	 to	 G4-forming	 oligonucleotides	 with	 binding	
affinity	comparable	to	their	defined	double-stranded	consensus	binding	motifs.	Moreover,	
recent	 data	 indicate	 that	 G4s	 may	 act	 as	 TF	 binding	 hotspots	 that	 promote	 elevated	
transcription	 by	 providing	 binding	 sites	 for	 multiple	 TFs	 (Spiegel	 et	 al.,	 2021).	 To	 test	
whether	 TFs	 are	 involved	 in	 G4-mediated	 retention	 of	 Pol	 II	 in	 hypoxia,	 ChIP-seq	







(HP)	 family	 of	 proteins	 (Ninova	 et	 al.,	 2019).	 On	 the	 other	 hand,	 modifications	 such	 as	
H3K4me3	marks	accessible	chromatin	containing	sites	of	the	RNA	Pol	 II	binding	and	active	
transcription	(Barski	et	al.,	2007).	In	specific	biological	contexts,	such	as	in	embryonic	stem	
cells,	 promoters	 of	 genes	 poised	 for	 active	 transcription	 are	 often	 found	 to	 be	 bivalently	















Hypoxia	 is	 a	 common	 phenomenon	 in	 the	majority	 of	 solid	 tumours,	 and	 hypoxia-driven	







in	particular	pre-stabilisation	of	G4s,	could	affect	 the	hypoxia	 response	 in	cells	by	altering	
the	 transcriptional	 profile.	Moreover,	 hypoxia	 is	 known	 to	 augment	 cellular	migration.	 It	
would	be	interesting	to	explore	the	impact	of	pre-treatment	with	G4	ligands	on	hypoxic	cell	
migration	 and	 invasion	 using	 assays	 such	 as	 transwell	 migration	 assay	 or	 scratch-wound	
assay.	 In	 general,	 a	 better	 understanding	 on	 the	 role	 of	 G4s	 in	 cancer	 progression	 could	
further	promote	G4s	as	therapeutic	targets	in	cancer.	
5.3 Conclusions	
The	 overall	 aim	 of	 this	 thesis	 was	 to	 investigate	 the	 causal	 relationship	 between	 G4	
formation,	active	transcription	and	chromatin.	The	key	outcomes	are:	
	
• Transcriptional	 inhibition	 does	 not	 alter	 the	 formation	 of	 G4s	 at	 gene	 promoters,	
indicating	that	promoter	G4s	precede	active	transcription.	





These	 results	 suggest	 a	 model	 for	 the	 relationship	 between	 promoter	 G4	 folding,	
transcriptional	 activity	 and	 chromatin.	 During	 active	 transcription,	 G4s	 fold	 in	 accessible	
promoter	regions	and	promote	RNA	Pol	II	recruitment	(Figure	5.1A).	Inhibiting	transcription	
by	DRB	or	TPL	eventually	causes	the	degradation	of	RNA	Pol	II,	however,	G4	formation	is	not	
perturbed	 (Figure	 5.1B).	 By	 contrast,	 chromatin	 compaction	 causes	G4	unfolding	 at	 some	





In	 conclusion,	 these	 findings	 build	 on	 earlier	 work	 showing	 that	 presence	 of	 G4s	 at	
promoters	correlates	with	increased	gene	expression	and	provide	evidence	to	suggest	that	
the	 G4	 structure	 itself	 may	 be	 sufficient	 to	 drive	 transcription	 by	 promoting	 polymerase	
occupancy.	
	
Figure 5.1: Model showing interactions between promoter G4s, RNA Pol II and chromatin status. 
(A) The folding of promoter G4 is seen in accessible promoter regions. RNA Pol II is recruited to the G4 to 
promote transcription. (B) Transcriptional inhibition does not cause loss of promoter G4 folding. (C) Chromatin 
compaction causes G4 unfolding and loss of RNA Pol II binding. (D) Ligand-mediated G4 stabilisation (red star) 
can preserve promoter G4 folding under conditions of chromatin compaction, which in turn causes retention of 







K562	 cells	 (ATCC,	 CCL-243)	were	 cultured	 in	 RPMI-1640	 (Gibco,	 21875034)	 supplemented	





Cells	were	 periodically	 cultured	 to	 between	 80	 and	 90%	 confluence.	 For	 passaging,	 K562	
cells	were	centrifuged	for	3	min	at	1,000	x	g.	Pelleted	cells	were	then	resuspended	in	fresh	
media	 and	 replated.	 U2OS	 cells	 were	 rinsed	 twice	with	 sterile	 phosphate-buffered	 saline	
(PBS;	137	mM	NaCl,	2.7	mM	KCl,	4.3	mM	Na2HPO4,	1.4	mM	KH2PO4)	and	trypsinised	using	
0.05%	 trypsin-EDTA	 (Gibco,	 25300054).	 DMEM	 containing	 10%	 FBS	 was	 then	 added	 to	
neutralise	the	trypsinisation	process,	and	cells	were	centrifuged	at	1,000	x	g	for	3	min.	The	
pelleted	 cells	were	 resuspended	 in	 growth	medium	 and	 replated	 into	 flasks.	 Cell	 seeding	
densities	varied	depending	on	the	initial	confluence.	
	
To	 prepare	 frozen	 stocks,	 cells	 were	 resuspended	 in	 90%	 FBS	 and	 10%	 DMSO.	 The	
resuspension	was	 aliquoted	 into	 cryogenic	 vials	 and	 frozen	 at	 -80	 °C	 using	 a	Mr.	 Frosty™	
Freezing	 Container	 (Nalgene).	 Cells	 were	 then	 stored	 in	 liquid	 nitrogen	 for	 long-term	













triptolide	 (Sigma,	T3652),	garcinol	 (Santa	Cruz,	 sc-200891)	and	pyPDS	 (Müller	et	al.,	2010)	
were	 dissolved	 in	 DMSO,	 and	 diluted	 in	 growth	 medium	 to	 the	 following	 final	









were	 centrifuged	1,000	x	g	 for	3	min,	media	was	discarded,	and	cells	were	washed	 twice	
with	 ice-cold	 PBS.	 Cells	were	 lysed	 in	 Pierce®	 RIPA	 lysis	 buffer	 (Thermo	 Scientific,	 89900),	
supplemented	 with	 phosSTOP	 (Sigma,	 4906845001)	 phosphatase	 inhibitor	 and	 cOmplete	
Protease	Inhibitor	Cocktail	(Roche,	11697498001),	by	sonication	using	a	Bioruptor	Plus	(30	
seconds	on/60	seconds	off	for	5	cycles;	Diagenode).	The	lysate	was	centrifuged	at	maximum	






Precision	 Plus	 Protein	 Dual	 Color	 Standards	 (Biorad,	 1610374)	 were	 used	 as	 molecular	
weight	markers	to	determine	protein	size.	Prior	to	loading,	samples	were	boiled	at	70	˚C	for	
10	 min	 in	 1×	 NuPAGE	 LDS	 sample	 buffer	 (Invitrogen,	 NP0007)	 and	 1×	 NuPAGE	 sample	
reducing	agent	(Invitrogen,	NP0009).	The	gel	tank	apparatus	was	filled	with	1×	MOPS	(3-(N-
morpholino)	 propanesulfonic	 acid)	 SDS	 running	 buffer	 (Invitrogen)	 or	 1×	 Tris-Acetate	 SDS	
running	buffer	(Invitrogen)	depending	on	the	gel	used.	Electrophoresis	was	carried	out	at	60	




the	 iBlot®	 2	 Dry	 Transfer	 System	 (Invitrogen)	 or	 wet	 transfer	 (for	 RNA	 Pol	 II	 and	
phosphorylated	 Pol	 II).	 Wet	 transfer	 was	 carried	 out	 in	 1×	 NuPAGE	 transfer	 buffer	
(Invitrogen)	 with	 20%	 methanol	 at	 100	 V	 for	 1.5	 h	 at	 room	 temperature	 (RT)	 or	 30	 V	
overnight	 at	 4	 ˚C.	 For	 overnight	 transfers,	 an	 ice	 pack	was	 placed	 in	 the	 tank	 to	 prevent	
heating	of	 the	system.	Subsequently,	 the	membrane	was	washed	with	 tris-buffered	saline	
(TBS;	50	mM	Tris-HCl	with	pH	7.5,	150	mM	NaCl)	and	blocked	using	Odyssey	Blocking	Buffer	
TBS	(Li-Cor)	for	1	h	at	RT.	The	membrane	was	then	incubated	with	primary	antibody	diluted	
in	 Odyssey	 Blocking	 Buffer	 TBS	 containing	 0.1%	 Tween-20	 (VWR	 chemicals).	 All	 primary	
antibodies	 (Table	 6.1)	 were	 used	 at	 a	 concentration	 of	 1:1,000,	 apart	 from	 the	 HIF1α	
antibody	 which	 was	 used	 at	 a	 concentration	 of	 1:500.	 After	 incubation	 with	 primary	







Table 6.1: Antibodies used for Western blotting in human cells. 



















200	 µl	 of	 E.coli	 cell	 culture	 was	 then	 inoculated	 into	 100	 ml	 auto-induction	 media	 (see	












































E.coli	 cells	were	 collected	by	 centrifugation	 at	 4,000	 x	g,	 4	 ˚C	 for	 30	min.	 The	 cell	 pellets	
were	resuspended	in	8	ml	ice-cold	TES	buffer	(50	mM	Tris-HCl	pH	8.0,	1	mM	EDTA	pH	8.0,	20%	
sucrose)	and	incubated	on	ice	for	10	min.	The	suspension	was	incubated	on	ice	in	12	ml	ice-
cold	 TES	 diluted	 1:5,	 with	 benzonase	 and	 2	 mM	 MgSO4,	 for	 another	 15	 min	 and	 then	
centrifuged	 for	 10	 min	 at	 20,000	 x	 g	 at	 4	 ˚C.	 Supernatants	 were	 filtered	 before	 being	
incubated	(rotating	for	1	h	at	RT)	with	PBS-washed	His-select	Nickel	affinity	beads	(Sigma,	
P6611).	 The	 bead	 samples	were	 loaded	 into	 the	 Proteus	 1-step	 batch	Midi	 Spin	 columns	







titration	 of	 bovine	 serum	 albumin	 (BSA)	 included	 as	 protein	 standards.	 Gels	 were	 then	
stained	 for	 30	 min	 with	 Instant	 Blue	 (Sigma,	 ISB1L)	 and	 rinsed	 with	 water	 5	 times.	 Gel	









Table 6.2: Sequences of oligonucleotides used in ELISA. 
Sequences of oligonucleotides used for assaying BG4 binding affinity. G-tracts that can form G4 structures in 
MYC G4 oligo are in bold and underlined. Mutations in the non-G4-forming control oligo (MYC-mut.) are 








blocking	 buffer	 at	 RT.	 After	 blocking,	 plates	 were	 incubated	 with	 serial	 dilutions	 of	 BG4	
(from	200	nM	to	0	nM	diluted	 in	blocking	buffer)	 for	1	h,	washed	with	ELISA	buffer/0.1%	
Tween	 20	 three	 times	 and	 incubated	 with	 HRP-conjugated	 anti-FLAG	 antibody	 (diluted	




calculated	 from	 binding	 curves	 using	 GraphPad	 Prism	 (GraphPad	 Software	 Inc.)	 and	 the	
standard	 error	 of	 the	 mean	 (s.e.m.)	 was	 calculated	 from	 three	 replicates.	 The	 following	









incubated	 with	 RNase	 and	 Proteinase	 K	 overnight	 at	 42	 ˚C	 and	 purified	 using	 a	 QIAGEN	
	 136	
MinElute	 kit.	 Equal	 amounts	 of	 DNA	 (300	 ng)	 from	 each	 sample	 were	 then	 loaded	 and	
resolved	on	2%	E-Gel	EX	precast	agarose	gels	(Thermo	Fisher,	G800802).	




(Illumina,	 20034198)	 at	 37	 °C.	 After	 1-hour	 incubation,	 tagmented	 DNA	 samples	 were	
amplified	 using	 the	 Nextera	 Index	 kit	 (Illumina,	 FC-121-1030).	 DNA	 fractions	 were	 size	
selected	 (100-1,000	 bp)	 using	 AMPure	 XP	 beads	 (Beckman	 Coulter,	 A63880)	 according	 to	
the	manufacturer’s	 instructions.	Libraries	were	sequenced	 in	paired-end	mode	with	75-bp	
read	length	on	the	NextSeq	500	platform	(Illumina).	







and	 hypotonic	 buffer	 (Chromatrap,	 100008)	 following	 the	 manufacturer’s	 instructions.	
Chromatin	was	 sonicated	 into	 100-500bp	 fragments	 using	 a	 Bioruptor	 Plus	 (Diagnode)	 at	
4	°C	and	quantified	via	Qubit	assays	(Thermo	Fisher).	
	
At	 least	 three	 biological	 replicates	 were	 performed.	 For	 each	 biological	 replicate,	 three	
independent	 technical	 replicates	 and	 matched	 inputs	 were	 performed.	 About	 300	 ng	 of	
chromatin	was	 added	 in	 each	 reaction.	 For	 immunoprecipitation,	 0.3	 µg	 of	 G4	 structure-












replicates	 (Varshney	 et	 al.,	 2015).	 About	 10	 million	 K562	 cells	 were	 fixed	 using	 1%	









0.5	 µg	 of	 DNA	 was	 put	 aside	 as	 input	 and	 15	 µg	 of	 chromatin	 was	 immunoprecipitated	




CA-630	 and	 0.5%	 sodium	 deoxycholate)	 and	 three	 times	 in	 TE	 buffer.	 The	
immunoprecipitated	 DNA	 and	 input	 DNA	 were	 retrieved	 in	 elution	 buffer	 (1%	 SDS,	
0.125mg/ml	Proteinase	K	 in	TE)	overnight	at	42 °C	and	purified	with	QIAGEN	MinElute	kit	












conjugated	 goat	 anti-rabbit	 (Thermo	 Fisher,	 A21071)	 antibody	 at	 37	 ˚C	 for	 30	 min.	
Coverslips	 incubated	 with	 60	 units	 of	 Turbo	 DNase	 (Invitrogen,	 AM2238)	 and	 coverslips	







Bioinformatic	 analyses	were	 performed	 by	 Dr	 Angela	 Simeone,	with	 input	 and	 discussion	
from	Jiazhen	Shen	and	Dr	Dhaval	Varshney.	
6.10.1 Human	reference	genome	and	relative	genomic	annotation	
Human	 genome	 assembly	 hg38	 was	 downloaded	 from	 UCSC	
(hgdownload.cse.ucsc.edu/goldenPath/hg38/bigZips/hg38.fa.gz).	 Human	 annotations	 (gtf	
file)	 were	 downloaded	 from	 Genecode	 project	 portal	
(ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_28/gencode.v28.annotati




Fastq	 reads	 were	 trimmed	 from	 adapters	 using	 cutadapt	 (Martin,	 2011)	 (cutadapt	 -a	
AGATCGGAAGAGC	 -A	 AGATCGGAAGAG).	 Resulting	 reads	 were	 aligned	 to	 hg38	 with	 bwa	
mem	-M	-t	12.	Bam	files	were	generated	by	using	samtools	view	-Sb	-F780	-q	10	-L	(ver:	1.8)	
(Li	et	al.,	2009).	All	 libraries	were	 sequenced	 twice	and	processed	and	aligned	separately.	
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Resulting	 alignments	 were	 merged	 and	 sorted.	 Duplicates	 were	 marked	 by	 Picard	
MarkDuplicates	(ver:	2.20.3,	http://broadinstitute.github.io/picard)	and	removed.	Fragment	
size	 distribution	 was	 estimated	 using	 bam	 files	 containing	 uniquely	 mapped	 reads	 with	
Picard	CollectInsertSizeMetric.	To	assess	the	amount	of	mitochondrial	contamination,	reads	
mapping	to	ChM	were	identified	and	counted	directly	from	the	alignment	bam	files.	These	
mitochondrial	 reads	were	 removed.	 For	 each	 library,	 regions	with	 local	 accessibility	were	
identified	by	 calling	peaks	with	macs2	with	default	 options	 and	excluding	 chrM.	 For	 each	
experimental	 condition,	 peak	 regions	 observed	 in	 2	 out	 of	 3	 biological	 replicates	 were	
selected	 as	 the	 consensus	 regions	 using	 bedtools	multiIntersectBed	 (ver:	 2.27.1)	 (Quinlan	
and	Hall,	2010).		
6.10.3 G4	ChIP-seq	and	RNA	Pol	II	ChIP-seq	data	analysis	








condition	 (across	 biological	 replicates)	 was	 obtained	 by	 selecting	 regions	 reproducibly	




For	 all	 ChIP-seq	 experiments,	 genome-wide	 reads	 per	 million	 (RPM)	 were	 obtained	 by	
quantifying	the	read	coverage	across	the	genome	and	scaling	it	to	a	factor	that	reflected	the	
individual	 library	 size	 (deeptools	bamCoverage	 (Ramírez	et	 al.,	 2014)	 -	 scaleFactor,	where	
factor	 =	 	 1,000,000/Lib_size).	 Similarity	 across	 individual	 libraries	was	evaluated	based	on	
RPM	at	consensus	regions	within	each	experimental	condition.	The	use	of	G4	or	RNA	Pol	II	
“signal”	 in	 this	 thesis	 refers	 to	 the	median	 RPM	 for	 the	 specified	 experimental	 condition	
(across	 biological/technical	 replicates).	 G4	 consensus	 regions	 were	 compared	 to	 the	
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enrichment	 of	 these	 sites	 over	 random	 chance	 was	 computed	 using	 the	 Genomic	
Association	 Tester	 (GAT,	 https://gat.readthedocs.io/en/latest/contents.html,	 1000	
randomizations)	 and	 the	 analysis	 was	 restricted	 to	 the	 human	 whitelist.	 The	 overlap	




Pol	 II	 and	 ATAC-seq	 data.	 After	 creating	 bed	 files	 with	 set(s)	 of	 regions	 of	 interest,	 the	
deeptools	function	computeMatrix	was	performed	on	BW	files	containing	RPM	signals.	Next,	
RPM	signals	were	combined	by	averaging	replicates	of	the	same	cell	and	then	generating	a	
new	 matrix	 of	 signals.	 The	 difference	 in	 normalised	 summarised	 signal	 between	 two	
experimental	conditions	was	obtained	by	subtracting	the	matrix	of	normalised	signal	in	one	
condition	 from	 the	 matrix	 of	 the	 other	 condition	 under	 investigation.	 Heatmaps	 were	
produced	 using	 deeptools	 plotHeatmap	 (options:	 --averageTypeSummaryPlot	 median).	
Metagene	density	 signal	 profile	 plots	were	obtained	by	plotting	 the	 average	 trend	of	 the	
signal	of	interest	(i.e.	the	difference	between	two	experimental	conditions).	
6.10.6 Differential	signal	analysis	
All	differential	 signal	analyses	were	carried	out	with	 the	R	package	edgeR.	 Initially,	 library	
size	 and	 read	 coverages	 at	 the	 regions	 of	 interest	 were	 computed.	 Prior	 to	 differential	
testing,	the	average	cpm	(counts	per	million)	signal	was	estimated	across	all	input	libraries	
and	a	threshold	value	was	defined	as	2	times	the	99th	quantile	of	the	average	distribution	of	
input	 cpm.	 Subsequently,	 regions	 for	 which	 at	 least	 one	 pull-down	 library	 exceeded	 the	
threshold	 value	 previously	 defined	 were	 kept	 for	 subsequent	 analysis.	 This	 step	 was	
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performed	 for	 each	 sequencing	 assay	 independently	 and	 only	 cases	where	 input	 libraries	
were	available	(G4	ChIP-seq,	RNA	Pol	II	ChIP-seq).	A	generalised	linear	model	(glmLRT)	with	
default	 parameters	 (negative	 binomial	 log-linear	 distribution	 of	 read	 counts)	was	 used	 to	
assess	regions	with	differential	signal.	For	the	differential	test,	batch	information,	biological	
and	 technical	 (when	present)	 replicates	were	 incorporated	 in	 the	definition	of	 the	design	
matrix.	The	differential	signal	analysis	compared	pairs	of	experimental	conditions:	hypoxia	
vs	normoxia	(G4	ChIP-seq,	ATAC-seq,	RNA	Pol	II	ChIP-seq);	all	pairwise	comparison	among:	





obtained	 by	 merging	 the	 regions	 observed	 in	 the	 treatment	 and	 control	 case	 for	 each	
experimental	 condition	 respectively.	 To	 illustrate	 the	outcome	of	 the	differential	 analysis,	
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